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Abstract 
 
Cocaine on banknotes can be indicative of drug trade; analytical methods which can 
distinguish ‘drug money’ from contaminated banknotes in general circulation are 
crucial in providing incriminating evidence. The development and application of two 
analytical methods for the detection of cocaine on banknotes are presented in this 
thesis.  
 
A competitive enzyme immunoassay (cEIA) was developed and used to quantify 
cocaine in extracts taken from both banknotes and latent fingerprints. The limit of 
detection (LOD) of 0.162 ng mL-1 achieved with the assay was comparable to that of 
conventional chromatography-mass spectroscopy techniques. When compared to 
LC-MS for the analysis of ten UK banknote samples, the two approaches produced 
results with statistically significant similarity. The immunoassay presents a simple 
and cost-effective alternative to the current techniques for the quantitation of cocaine 
at forensically significant concentrations. 
 
Secondly, a novel immunodetection method was developed for the location-specific 
staining of cocaine on banknotes. The method was based on the application of an 
acrylamide gel matrix for maintaining the position of the cocaine during subsequent 
immunostaining. The performance of the method was determined using newly-
minted UK banknotes as true negative sample matrices, resulting in staining which 
could be readily distinguished from that on newly-minted notes spiked with cocaine. 
The method was successfully applied for the detection of cocaine on the surface of 
six UK banknotes from general circulation. The developed method, for the first time, 
demonstrates the location-specific immunostaining for the visualisation of cocaine on 
banknotes.  
 
Finally, a comparison of four different techniques for the functionalisation of cocaine-
binding antibody-gold nanoparticles via protein or ligand intermediates is also 
described. The addition of antibody onto the AuNP surface was facilitated by a 
polyethylene glycol (PEG) linker with a –COOH terminal functional group, an 
aminated PEG ligand and an SPDP-Protein A/G intermediate. The study showed that 
the cocaine binding efficacy was the greatest for AuNP functionalised with the 
Protein A/G intermediate.  
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CHAPTER 1 
 
Introduction 
 
The supply and consumption of cocaine is the cause of health, social and economic 
problems on a global scale. In order to combat the effect of usage and trade, many 
countries implement laws that allow the seizure of circumstantial evidence 
associated with cocaine trafficking. Sensitive, specific and reliable analytical methods 
for the detection of cocaine in different forms and matrices are crucial for the 
provision of forensic evidence via which individuals or groups associated with 
cocaine trafficking can be prosecuted. Cocaine on paper currency, for instance, can 
be indicative of drug use or trade and thus used to provide incriminating evidence. 
Quantitative methods which enable the differentiation between ‘drug money’ (i.e. 
money which has been in direct contact with cocaine) and cocaine contamination 
from general circulation, and are in turn suitable for daily analysis in a forensic 
laboratory are crucial in providing such evidence. It is therefore of interest that a 
greater range of suitable methods for this type of analysis to be developed.  
 
Cocaine, its effects and origins, methods of production, networks of transport and 
trade, social consequences and legislation are introduced in this chapter. Current 
methods for the detection of cocaine in non-biological samples, as well as for the 
detection of cocaine and metabolites in biological samples of forensic relevance are 
discussed. Current analytical techniques used for the detection of cocaine on 
banknotes and its forensic relevance are also outlined in this chapter.    
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1.1 Cocaine 
 
1.1.1 Synthesis and origin 
Cocaine (benzoylmethylecgonine) is a naturally occurring alkaloid found in the leaves 
of the coca plant, a name that is attributed to any plant of the genus Erythroxylum 
which is native to South America. The Erythroxylum genus contains over 200 distinct 
species, of which only two (Erythroxylum coca and Erythroxylum novogranatense) 
contain significant quantities of cocaine.1,2 The use of coca leaves by the Amara 
Indians of Peru as a psychoactive substance is known to have occurred as early as 
5000 BC, based on the stockpiles of coca leaves found in ancient Peruvian burial 
sites.3,4 Coca leaves contain between 0.3 and 1.5 % cocaine, and when taken in the 
traditional ways of chewing coca leaves or by drinking coca leaf tea this can act as 
an appetite or thirst suppressor and a mild stimulant.3 Archeological evidence from 
1500 BC also indicates the use of liquid coca-leaf extract as an early anaesthetic 
during brain surgery.4 The cocaine alkaloid was first extracted from coca leaves in 
1859 by the chemist Albert Niemann, after which cocaine became commercially 
available and was widely used as a medicinal treatment for pain and fatigue, among 
other ailments.5 Social problems resulting from the use of cocaine led to a ban of the 
sale of the substance without prescription in the US in the early 1900s.4 Supply and 
production of cocaine for non-medicinal purposes became internationally prohibited 
in 1961 through the Single Convention on Narcotic Drugs, which remains in place 
today.6 
 
Cocaine, the chemical structure of which is shown in Figure 1.1, is predominantly 
encountered as an odourless, white, crystalline powder usually in the form of a salt 
such as cocaine hydrochloride (HCl).1 Cocaine can be produced in two ways; either 
synthetically, or naturally by purification from coca leaves.2 Although four pairs of 
enantiomers of the cocaine alkaloid are theoretically possible, only one (commonly 
termed l-cocaine) occurs naturally.1 Cocaine has a pKa of 8.61 and therefore exists in 
the protonated form under physiological conditions. Cocaine can be synthesised from 
ecgonine or by total synthesis via the Mannich reaction, although this is prone to 
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producing optical isomers which are less pharmacologically active than the natural 
material.1 Illicit synthetic cocaine is therefore extremely rare and accounts for less 
than 0.001 % of all cocaine seizures, and typically only occurs as a result of licit drug 
diversion or illegal prescriptions.2 Licit cocaine is manufactured for pharmaceutical 
use as a by-product of the industrial extraction of flavouring agents from coca leaves 
for use in the food industry.2 The resulting product is generally of 99.5 % purity or 
better; conversely, the purity of natural illicit cocaine typically varies from 80 to 97 %.2 
This variation in purity enables pharmaceutical cocaine HCl to be readily 
distinguishable from its natural illicit counterpart by detailed forensic analysis.7  
 
    
 
  
Figure 1.1.  The chemical structure of cocaine.1    
 
  
The modern illicit production of cocaine HCl from coca leaves is a three-step 
process; in the first a crude paste is obtained from coca leaves, followed by 
purification to a coke base, and finally the conversion of coke base to cocaine HCl as 
a salt.2 An interview with a family of coca farmers published by Streatfeild in 2003 
describes a large-scale acid-base extraction method similar to that detailed by 
Casale and Klein, the details of which have apparently changed little since the early 
1900s.2,8 According to the descriptions of the coca farmers, the coca leaves are first 
dried for half a day. The leaves are then shredded and a small amount of powdered 
cement or sodium carbonate is applied. The leaf mixture is covered in petroleum or a 
similar hydrocarbon solvent such as kerosene and soaked for a full day. The solvent 
is then removed via the addition of dilute sulfuric acid (typically battery acid) to create 
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a two-part phase separation, through which the acidified cocaine free base in the 
petroleum is extracted. Sodium hydroxide, limestone or lime is then added to 
increase the pH, whereupon a precipitate forms which can be removed by filtration 
and dried to give crude coca paste.8 The production of coca paste is usually 
performed on-site by the coca farmer, yielding a crude product which contains 
between 30 and 80 % cocaine, is of a gummy consistency and has a short shelf-life.2 
For this reason it is always immediately turned for processing into coke base. 
 
Coke base is purified from crude coca paste in small-scale clandestine laboratories. 
The process involves dissolving the coca paste in dilute sulfuric acid, then oxidising 
any residual impurities by titration against a concentrated solution of aqueous 
potassium permanganate. The resulting mixture is filtered to remove the manganese 
oxide precipitate, after which dilute aqueous ammonia is added to precipitate the 
cocaine free base.2 The resulting free base is filtered, dried, packaged and sold. It 
contains between 80 and 95 % cocaine and is commonly turned over to larger and 
more sophisticated clandestine laboratories which produce cocaine HCl on an 
industrial scale and to a higher standard than occurs in the previous two processes.2 
Alternatively, it can be sold as ‘crack cocaine’ which has a more granular texture than 
the salt form, is frequently in the form of nuggets or ‘rocks’ and has a slightly waxy 
appearance.9  
 
The procedures involved in the production of cocaine hydrochloride are varied and 
depend on the laboratory and the solvents that are locally available.2 In the classic 
methodology, coke base is dissolved in diethyl ether and filtered to remove any 
insoluble impurities that may be present. An equal volume of acetone containing a 
stoichiometric quantity of concentrated hydrochloric acid is then added to the filtrate 
and stirred. The hydrochloric acid immediately ion-pairs with the coke base, resulting 
in cocaine HCL salt which appears as a shiny white and flaky crystalline precipitate. 
The crystallisation process is allowed to continue for a further 3 to 6 hours after 
which the product is filtered, dried, pressed, packaged and distributed.2 The resulting 
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cocaine HCL typically contains between 80 and 97 % cocaine, as well as numerous 
impurities which can be detected and traced for forensic purposes.7 
 
 
1.1.2 Trade, use and social consequences 
The coca plant is native to the central and Northern Andean Ridge of South America 
and this remains the region of the world where the cultivation of coca for illicit sale 
takes place. The majority of this cultivation zone (approximately 60 %) is in Peru, 
30 % is in Bolivia and the remainder is distributed throughout Colombia, Ecuador, 
Venezuala, Brazil, Argentina and Panama.2,9 As discussed in Section 1.1.1, the 
production of coca paste normally occurs at the site of cultivation, and due to its short 
shelf life the processing of paste into coke base is also performed in the local area. 
As a result, over 99 % of coca processing laboratories are located in the three main 
cultivating countries; Bolivia, Colombia and Peru, although additional laboratories for 
the production of cocaine HCL from coke base have also been reported in other 
countries in South America and occasionally in Europe.10    
 
The main markets for cocaine are North America and Western Europe, with each 
accounting for over 40 % and 25 % of global cocaine consumption (at an estimated 
470 tonnes), respectively.10 The two regions combined account for more than 80 % 
of the global cocaine market, which was estimated at US$88 billion in 2008.10 From 
its origins in South America, cocaine is shipped worldwide via two main trafficking 
routes, a schematic of which is shown in Figure 1.2. The first route bound for North 
America travels from Colombia to Mexico or Central America by sea before 
continuing overland to the US and Canada, while the second bound for Europe 
travels directly from Colombia or Peru via maritime routes, typically in container 
shipments.10   
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Figure 1.2.  Major trading routes for the trafficking of cocaine worldwide (image obtained 
from the UNODC World Drug Report, 2010).10  
 
The annual prevalence of cocaine use in Western and Central Europe has seen a 
marked increase over the past decade, and has recently plateaued at nearly three 
times the global average (1.2 %).11 Cocaine use in the UK is the most abundant out 
of all of the EU countries at 2.4 %.10 Cocaine is sold illicitly to ‘recreational’ users by 
local dealers in two forms; as cocaine HCl, which is taken by inhalation through the 
nasal passage (snorting), and ‘crack’ cocaine or coke base which is typically 
smoked.9 At ‘street’ level, cocaine HCl is supplied as 1 g units wrapped in paper or 
cling-film wrappers, plastic bags or heat sealed wraps.9 It is then divided by the user 
into ‘lines’ of between 50 and 200 mg of cocaine, which can be inhaled through the 
nasal passage via rolled paper or a straw.12 Street cocaine is sold in the UK at 
purities of 40 % to 80 %, and is commonly diluted or ‘cut’ with additional substances 
including sugars such as glucose and lactose, analgesics such as procaine or 
lidocaine which mimic the analgesic properties of cocaine, caffeine which acts to 
increase stimulant properties as well as mask a reduced drug content, and over-the-
counter bulking agents such as baking soda or multi-vitamins.9,13 Crack cocaine is 
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commonly sold as 0.2 g ‘rocks’ which can be adulterated with other substances of a 
similar appearance; the occasional inclusion of toxic substances such as levamisole 
for this purpose has been documented.13 Crack cocaine vaporises at 90 °C which 
enables it to be smoked via short pipes made of glass or metal.14   
 
Cocaine is a local anaesthetic, a vasoconstrictor and a powerful stimulant, the latter 
of which gives rise to its psychologically addictive properties which can lead to abuse 
of the drug.9 Cocaine administered by insufflation or inhalation is rapidly absorbed 
through the bloodstream into the central nervous system where it acts upon the 
dopamine reuptake receptors of neurons.4 The binding of cocaine to these receptors 
prevents the clearance of dopamine from the synapses, which in turn results in 
increased concentrations of dopamine and norepinephrine being present.4,9 The 
resulting overstimulation of the dopamine ‘reward’ pathway of the body and brain 
leads to feelings of well-being and euphoria, competence and a heightened sense of 
energy and pleasure.4,9 The effect of the drug is short-lasting (from 30 min to 1 h) 
and is frequently followed by anxiety, paranoia and restlessness.9 Although physical 
dependence to cocaine is uncommon, the drive to re-experience initial euphoric and 
pleasant sensations can cause users to over-indulge in the drug, particularly due to 
the increased dosage that is required to obtain the same response after repeated 
use.14  
 
Excessive doses of cocaine can result in numerous long and short-term health 
problems including tremors and convulsions, hallucinations, agitation and 
hyperthermia, the latter of which can be particularly acute and dangerous.15 Severe 
cardiac adverse events, particularly sudden cardiac death, also become a serious 
risk at high doses due to cocaine's blocking effect on cardiac sodium channels which 
can lead to increased blood pressure and life-threatening arrhythmia.4 Such cardiac 
conditions can develop as a result of chronic cocaine use along with other numerous 
adverse effects including neurotoxicity, respiratory conditions, hyperpyrexia and 
degradation of the septum.4,14,15 The smoking of crack cocaine, which generates 
higher blood cocaine concentrations than the snorting of powder cocaine HCl, is 
 8 
 
particularly harmful and is commonly associated with psychological dependence.14 
Although the number of cocaine-related deaths each year is relatively low compared 
to other class A drugs, ‘polydrug’ use, where cocaine is combined with other drugs 
such as heroin and alcohol, accounts for significant fatalities.12    
 
The social ramifications of cocaine use, as well as the implications of trafficking and 
trade are widespread and significant.11 The use of cocaine can lead to 
unemployment, poverty, crime as a means of drug acquisition, malnutrition, rapidly 
developing ill health and sometimes death.14,16 These adverse effects of cocaine use 
are not restricted to an individual but will spread to families and communities around 
them; this in turn leads to increases in health problems, violence and crime.17 At the 
other end of the scale, the growth of coca plants and the subsequent production of 
cocaine in clandestine laboratories presents health risks for workers, causes an 
uptake in cocaine use among members of the local community and this in turn 
disrupts local economies and social networks.14,17 Overall the social and economic 
effects caused by the production or trafficking of cocaine can span entire countries or 
regions and include lowered productivity, drug-associated turmoil, wide-scale 
corruption, and skewed economies toward cocaine production and money 
laundering.11,17       
 
 
1.1.3 UK law enforcement 
As stated in Section 1.1.1, the supply and production of cocaine for non-medicinal 
purposes is internationally prohibited by the Single Convention on Narcotic Drugs, as 
well as the Convention on Psychotropic Substances and the United Nations 
Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic substances.6,18,19 
Substances prohibited and penalties for their sale and possession in accordance with 
the aforementioned treaties are enacted in the UK via The Misuse of Drugs Act 1971, 
in which cocaine is listed as a Class A substance.20 Implementation of the Act by 
police and law enforcement agencies is in line with the European Monitoring Centre 
for Drugs and Drug Addiction (EMCDDA) recommendation for an emphasis on harm 
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minimization.12,21 This has led to a de-emphasis on the persecution of simple 
possession in favour of the implementation of public health, social and policing 
measures for the reduction of small-scale street dealing and acquisitive crimes in the 
interest of public health and safety.21 The focus of enforcement agencies is instead 
on organised crime and cocaine trafficking at higher levels, particularly the groups 
involved in trafficking and the ways in which they operate.12,21  
 
Cocaine is smuggled into the UK through Western Europe, where British organised 
crime groups based in Spain and the Netherlands dominate the supply chain.12 Entry 
of cocaine into the UK occurs via four primary modes of transport; by air freight using 
drug couriers or ‘mules’ who swallow or conceal cocaine internally; by maritime ports, 
particularly concealed within domestic or Heavy Goods Vehicles (HGVs) or by small 
unauthorized vessels; by rail via the two international rail links, and finally by parcel 
post. At the majority of these entry routes, the detection of illicit drugs like cocaine is 
performed by customs officers of the UK Border Agency, who subsequently seize 
cocaine and detain the persons caught transporting it as they attempt to cross the 
border. This is a means of interrupting both the entry and supply chains involved in 
the trafficking of cocaine. The spectrum of analytical methods for the detection and 
identification of cocaine currently performed at Heathrow airport, for example, is one 
of the most comprehensive of its type involving sniffer dogs, X-ray body scanners, 
heat detectors which show concealed and internalised cocaine as black areas, and 
trace detection devices such as portable ion-mobility spectrometers for the 
identification of cocaine on luggage and clothing material.12  
 
 
1.2 The detection of cocaine for forensic evidence 
 
1.2.1 Cocaine detection in non-biological samples 
Laboratory procedures for the routine identification of seized cocaine include, but are 
not limited to; colorimetric indicator tests, immunoassays, high performance liquid 
chromatography (HPLC), capillary zone electrophoresis (CZE), ultraviolet-visible 
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(UV-Vis) spectrophotometry, Fourier transform infrared (FTIR) spectroscopy, powder 
X-ray diffraction, gas or liquid chromatography coupled with mass spectrometry (GC-
MS or LC-MS), tandem MS (MS2) and nuclear magnetic resonance (NMR).1,9,22 Of 
these, chromatography methods coupled with MS detection such as LC-MS and 
particularly GC-MS remain the most commonly used. Hyphenated techniques of this 
kind are based on the initial chromatographic separation of the constituent 
components of the sample based on their respective retention times, after which 
identification and the counting of relevant components is performed by MS.23 
Analysis by MS is sensitive, specific and can provide a wealth of forensic information 
in terms of drug molecule identification and impurity profiling from a single 
measurement.1,23  
 
Recent research in the area of forensic substance identification has become more 
focussed on the development of portable instruments which enable the rapid, 
sensitive, and non-destructive analysis of both bulk and microscopic material without 
the need for any sample preparation.24 Methods of this nature enable drugs like 
cocaine to be identified on-site and in a matter of seconds, rather than the hours or 
days required for external laboratory testing.1 As discussed in Section 1.1.3, this is 
particularly important in the context of border security as it enables the immediate 
seizure of known illicit drug substances, as well as the timely charge or release of 
suspected drug smugglers depending on the results of the test. Advances in 
techniques such as ion mobility spectrometry (IMS) and Raman spectroscopy have 
enabled the development of miniaturised instrumentation, resulting in portable or 
handheld devices which are highly practical in a forensic setting.25,26        
 
Raman spectroscopy, for example, is a technique based on the detection of Raman 
scattering, a term which describes the small fraction of inelastic scattered light that 
occurs when monochromatic light is applied to a sample.26 The difference in 
wavelength between the scattered and the incident light corresponds to an energy 
shift which in turn relates to the vibrational modes of the target molecule. These 
vibrational modes are unique and can therefore be used to identify the molecules 
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that are present.1 Ryder et al. have reported the use of Raman for the quantitation of 
cocaine in mixed solids containing glucose and caffeine to represent typical cutting 
agents.24 The spectrum from cocaine was easily distinguishable from those of other 
sample constituents, although it was noted that the quantitative accuracy was limited 
due to a lack of reference spectra.24 Because of such limitations, Raman 
spectroscopy is more commonly used for initial substance identification for which it is 
highly suited; it can for instance be applied for the examination of surfaces, and can 
analyse through packaging such as glass bottles and plastic bags.27 This in 
combination with its recent miniaturisation and the development of enhancement 
techniques which intensify the relatively weak Raman signal for increased sensitivity, 
has proven Raman spectroscopy to be highly applicable for the on-site detection of 
cocaine.26 The suitability of Raman spectroscopy for on-site analysis was proven by 
the success of trial studies performed in border control settings such as at an airport, 
and on seized street samples in different containers.22,27   
 
 
1.2.2 Cocaine detection in biological samples 
The chronic or abusive use of drugs like cocaine can lead to serious health, social 
and economic consequences for the both the user and those around them, as 
discussed in Section 1.1.2. The testing for cocaine in biosamples occurs in two main 
contexts; the first is therapeutic, for example during emergency medical intervention 
or as part of a monitored drug treatment program, and the second is forensic, where 
detection is required to demonstrate the use or presence of cocaine in association 
with illegal activity.9 Cocaine testing can also be performed by an employer to ensure 
the compliance of employees with drug-related safety regulations. In a forensic 
setting, the results from toxicological analyses can provide the court with evidence 
that an individual was under the influence of cocaine during a particular event (such 
as a robbery, rape, or traffic accident); identification of cocaine and its metabolites in 
biological specimens therefore needs to be objective and reliable.9,28  
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As mentioned in Section 1.1.2, the effects of cocaine are short-lasting even when 
taken in high dosages. Cocaine has a half-life of only 1 hour due to its rapid 
metabolism in the bloodstream which occurs via the four pathways shown in Figure 
1.3.29 The primary route for cocaine metabolism is by spontaneous hydrolysis, which 
accounts for 80 to 90 % of total elimination and can occur in one of two ways; either 
non-enzymatically to the primary cocaine metabolite benzoylecgonine, or 
enzymatically to methylecgonine by the action of esterase enzymes present in blood 
and tissue.30 Alternatively, metabolism of cocaine via oxidation by mixed function 
oxidase enzymes can occur, the process of which takes place predominantly in the 
liver.30 Recent cocaine use by an individual is normally demonstrated using 
benzoylecgonine rather than cocaine as an analyte. This is due to the shorter half-life 
of cocaine itself in blood and urine samples (the detection time for cocaine is typically 
between 1 and 2 days in blood after a single dose),29 and its low concentrations in 
urine where it is present for only a brief period.1 Benzoylecgonine, on the other hand, 
is present at high concentrations in urine and can be detected up to 3 days following 
use.30 Ecgonine methyl ester has been reported as detectable for up to 7 days after a 
single dose of cocaine in urine.29   
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Figure 1.3.  The metabolic processing of cocaine in blood.30 
 
 
Various analytical techniques have been used for the detection of cocaine 
individually, or alongside other illicit substances in a number of different biological 
matrices.31 Urine has traditionally been the most common biological specimen 
however advances in sample preparation methods, chromatography-based 
separation and detection techniques have nowadays made blood an equally 
accessible matrix.1 Due to difficulties in describing recent or current exposure to 
cocaine, various biological specimens have been incorporated into analytical 
techniques, including but not limited to hair, sweat, oral fluid, nails, teeth, amniotic 
fluid, meconium and inner organs.28 In oral fluid samples, for example, both cocaine 
and benzoylecgonine are detectable following a single dose of cocaine for up to 12 
and 24 hours after use, respectively.29 
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Due to the complexity of biological specimens, sample preparation steps are often 
required to pre-concentrate the target compound and remove it from potential 
interferents in the matrix prior to analysis.28 This is particularly important for post-
mortem specimens where by-products of degradation which can interfere with 
analytical techniques causing false-positive or false-negative results are commonly 
present.30 With the exceptions of urine and oral fluid which may require little or no 
sample preparation, the majority of liquid samples are pre-concentrated by solid-
phase or liquid-liquid extraction (SPE and LLE, respectively).28 Of the two 
techniques, SPE is the most common due to the flexibility enabled by the range of 
different cartridges with different properties available. Solid samples such as teeth 
and tissue specimens need to be pulverised and dissolved, or homogenised prior to 
extraction.28 Of all the common matrix types, hair is the most complicated and 
requires multiple digestion steps prior to extraction; in addition to LLE and SPE, the 
application of solid-phase micro-extraction (SPME) or ultrasound extraction for this 
matrix type is common.32  
 
Following sample preparation, the identification and quantitation of cocaine by 
toxicological analysis is performed in two stages: screening and confirmation.1 
Different groups of analytical techniques are applied in each step. The purpose of 
screening is to identify samples where cocaine is present at quantities of forensic 
significance prior to further analysis.33 For example, the presence of negligible 
concentrations of cocaine (<0.1 ng mL-1) is unlikely to stand up in court as evidence; 
higher concentrations (e.g. >50 ng mL-1), however, provide evidence of recent drug 
use and could therefore be relevant to a criminal trial.1 Distinguishing negative from 
positive samples at the beginning of the analytical process avoids the need to 
perform costly, sophisticated and labour intensive analyses on an unnecessarily high 
number of samples. In order to distinguish negative from positive samples, a 
quantitative analytical method with a ‘cut-off’ concentration (CO), above which the 
sample is positive and requires further confirmatory analysis, and below which it is 
considered negative, is applied.28 Rapid, specific, sensitive, inexpensive and easy to 
perform techniques such as thin layer chromatography (TLC) and immunoassays are 
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commonly used as screening methods.1 The accuracy of the technique at 
determining whether a sample falls below the cut-off concentration is crucial for 
avoiding false negative results, as this will prematurely end the toxicological 
analysis.28 
 
The majority of the immunoassays used for forensic screening purposes target 
benzoylecgonine as the primary cocaine metabolite, typically alongside other illicit 
substances or metabolites.1 Enzyme immunoassays such as the enzyme multiplied 
immunoassay technique (EMIT) and the enzyme-linked immunosorbent assay 
(ELISA) are widely used, although immunoassays with different labelling systems 
such as fluorescence polarization immunoassays (FPIA) and radioimmunoassays 
(RIA) are also frequently applied.28 All immunoassays harness the analyte (known as 
an antigen)-binding capacity of antibodies for their target specificity, the process of 
which is explained in more detail in Chapter 3.1.2. Due to the specificity of the 
antibody-antigen binding process even in the presence of potential matrix 
interferents, assays of this nature are highly suited to the detection of trace drug 
compounds in complex biological samples with only minimal sample preparation.34 
The limit of detection (LOD) of immunoassays, which are typically around 
0.1 ng mL⁻1, fall well below the typical cut-off concentrations of 50 to 300 ng mL-1 (for 
blood and urine) used in forensic analysis.28 This is illustrated in Table 1.1, in which 
the details of a number of recent studies where immunoassays have been applied for 
the screening of toxicological specimens are listed alongside their respective cut-off 
concentrations.33,35-44 The assay procedure can be readily automated for high-
throughput analysis, and the present-day mass manufacturing of drug-targeting 
assays for forensic purposes enables inexpensive screening particularly compared to 
sophisticated detection methods such as mass spectrometry (MS).28         
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The confirmatory analysis that follows screening is performed on samples in which 
the concentration of cocaine is determined as being above the cut-off concentration 
by the screening method. Confirmation is performed using methods which enable 
quantitation of drug compounds to high levels of accuracy and specificity. In the 
same way as for the detection of cocaine in non-biological sample matrices 
described in Section 1.2.1, chromatography separation coupled with mass 
spectrometry detection techniques remain the gold standard when it comes to the 
detection of illicit drug compounds in a toxicological setting.23 As shown in Table 1.1, 
GC-MS is the most frequently applied method for the confirmation of cocaine in a 
range of biological matrices in the studies shown, however advances in the 
sensitivity of LC-MS2 have also increased the number of studies performed using this 
method.45-47 The use of HPLC coupled with alternative detection methods such as 
ultraviolet (UV) and fluorescence (FL), as well as capillary electrophoresis (CE)-
based techniques for the quantitative detection of cocaine has also been reported.28  
 
Recent research into alternative biological specimens for illicit drug testing beyond 
traditionally used samples such as blood and urine has led to the development of 
methods for the analysis of sweat and oral fluid specimens, among others.39,48,49 
Drug compounds such as cocaine are transported by epithelial cells from blood 
plasma into sweat either by diffusion or via the process of active transport 
(secretion).50 The presence of cocaine and benzoylecgonine in sweat from regular 
cocaine users was investigated by Kidwell et al. using sweat collection patches 
analysed by GC-MS.48,50 Concentrations ranging from 250 to 22,000, and 30 to 
2,200 ng per patch were obtained for cocaine and benzoylecgonine, respectively; 
this notably showed that cocaine was present at higher concentrations than its 
principle metabolite.48,50 This phenomenon is thought to occur due to the lipophilic 
nature of cocaine, which enables it to be more easily transported by the lipid 
membrane of epithelial cells and thereby causing it to be more readily excreted into 
sweat than its hydrophilic metabolic counterpart.48 A study performed by Huestis et 
al. established that cocaine was present in predominance over benzoylecgonine in 
sweat sampled from volunteer subjects using sweat patches, and was detectable by 
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GC-MS for up to 48 hours after the drug was administered.51 The metabolite 
ecgonine methyl ester was also detected in sweat during this study, at 
concentrations comparable to those of the benzoylecgonine present in the same 
samples.51 The existence of a time lag between the taking of cocaine and its 
excretion in sweat suggests that detection will not only be indicative of drug use, but 
also provide a potential window of time during which the drug was taken. This could 
be important in circumstances where an issue has been raised as to whether or not 
an individual is in a fit state to, for example, operate machinery or drive a vehicle.    
 
Interest has also grown in recent years in gaining information from latent fingerprints 
beyond suspect identification via the unique ridge pattern that forms the print. 
Additional circumstantial information in a forensic context, such as the use by or 
recent exposure of an individual to illicit drugs, could provide a greater link between a 
fingerprint and a suspect.52 The mechanism of drug and metabolite compounds in 
sweat has been harnessed for the detection of cocaine in latent fingerprints using a 
number of different analytical approaches, and is particularly well-described for prints 
artificially doped with compounds of interest.53-56 However, recent advances by 
Leggett et al. using fluorescently labelled, antibody-functionalised magnetic particles 
have also demonstrated the detection of drug metabolites endogenously produced in 
the latent fingerprints of drug users.57-59  
 
In addition, Rowell et al. were able to show isolated patches of cocaine 
contamination in a fingerprint obtained from an individual being treated at a drug 
addiction centre using surface assisted laser desorption/ionisation time-of-flight mass 
spectrometry (SALDI-TOF-MS).55 The non-homogenous pattern of cocaine 
contamination in the print was thought to be the result of the subject’s fingertip 
coming into contact with the drug prior to the time of sampling.55 Analytical methods 
for the detection of these types of cocaine residues in latent fingerprints could be 
used in a forensic context, as their presence would provide further evidence of a 
suspect’s involvement in drug use or trade. 
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1.3 Cocaine on paper currency 
 
1.3.1 Banknotes as forensic evidence 
Over the past two decades, interest has grown in the detection of illicit drugs such as 
cocaine on paper currency. The number of scientific publications relating to the 
subject rose four-fold in the previous decade, from 1.8 papers per year in 1994 -
 2003 to 4.5 papers per year in 2005 - 2007.60 The presence of background levels of 
cocaine contamination on the majority of banknotes, discovered using newly 
developed analytical methods, coincided with an increase in popularity of the drug 
worldwide and generated a surge of public interest in the matter.60 Headlines like 
those shown in Figure 1.4 featured widely in news reports by the UK media in 2010 - 
2011, fuelling this public interest and resulting in further studies into the presence 
and detection of cocaine on banknotes.  
 
 
 
 
 
Figure 1.4.  Typical examples of the headlines from UK media reporting on the 
widespread contamination of paper currency with background levels of 
cocaine, published in 2010 and 2011.61-65 
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The presence of cocaine on banknotes is unsurprising since the notes can be 
involved in both the use and trade of the drug. For example, a common route of oral 
self-administration is by insufflation, which can be performed using a rolled banknote. 
The exchange of cocaine for cash monies by traders is the main route by which 
contamination occurs, either via the handling of banknotes with contaminated fingers, 
or by placing of banknotes onto a surface on which cocaine was previously present. 
The latter is described by Ebejer et al. as particularly common, as bulk cocaine 
received by a trader will first be weighed and packaged into smaller portions to be 
sold, a process performed on a flat surface (such as a table) which is most often the 
same surface where cash is counted or placed during a sale.66  
 
A number of possible mechanisms have been suggested for the adherence of 
cocaine to banknotes including dissolution in surface inks or grease, or chemical 
binding.67,68 The most probable of these adherence mechanisms involves the 
physical entrapment of small particles in the interstices between the fibres that form a 
banknote.69 UK Sterling banknotes, for example, are printed on a blend of cotton and 
linen rag.66,67 After a period of use the characteristics of the banknote fibres can 
change, resulting in a loosening of the meshwork of fibres and the subsequent 
formation of cavities within the weave of the note.70 As described in Section 1.1.2, 
cocaine HCl is most commonly traded as a solid, impure crystalline powder. 
Crystalline cocaine of this nature can become entrapped and retained in the cavities 
produced by the loosening of banknote fibres over time, illustrated by the improved 
adhesion of the drug to older banknotes as previously demonstrated.70-72 The images 
obtained using a scanning electron microscope (SEM) by Anglada et al. and by 
Roberts et al. visually demonstrate the entrapment of cocaine crystals within a 
meshwork of banknote fibres (Figure 1.5).72,73  
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Figure 1.5.  SEM images of cocaine crystals in the interstices between the fibres of a 
banknote; images (A) and (B) were obtained from Anglada et al. and 
Roberts et al., respectively.72,73  
 
 
The low or ‘background’ levels (ca. 1 µg note-1, for example) of cocaine 
contamination found on the majority of banknotes in general circulation is caused by 
the indirect transfer of drug crystals from notes which have been in direct contact 
with the drug via the mechanisms described in the previous paragraph. Transfer of 
this type is known to occur via two main routes; physical contact between a 
contaminated note with other banknotes around it, and by the workings of bank 
sorting machines. The former is known to occur to a much lesser extent than the 
latter, which is the route by which the majority of cross-contamination takes place. 
Transfer from one contaminated note to others within a bundle of banknotes was 
experimentally demonstrated by Carter et al. using the drug diamorphine as a model 
substance.66 The study showed that transfer from a single note to its nearest 
neighbours did not happen readily, was limited to only a small proportion of the total 
contamination (less than 6 %) and did not spread beyond more than two adjacent 
banknotes.66  
 
In a separate study by the same research group, Carter et al. also report the 
widespread contamination of mock banknotes (made of cotton paper) with illicit 
substances including cocaine after processing by bank sorting machines.67 The mock 
banknotes were sent to a number of different domestic bank branches within the UK 
for counting in the usual way, after which 60 % were found to be contaminated with 
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cocaine.67 The authors noted a diminishing concentration of cocaine throughout a 
bundle of notes which coincided with the order in which they had passed through the 
machine. The presence of crystalline material on one of the notes also coincided with 
the location of black marks on the surface of the note thought to originate from 
components of the sorting mechanism.67 These results confirm the presence of 
cocaine in dust samples obtained from counting machines at a bank in Switzerland 
as indicative of the cause of cross-contamination.74  
 
The presence of illicit substances including cocaine on paper currency is frequently 
used by police as circumstantial evidence of an individual’s involvement in illegal 
activities such drug trafficking or trade.66 Where activities of this type are suspected, 
the results of an analysis of banknotes obtained from the suspect indicating the 
presence of cocaine can be incriminating.69 However, presenting cocaine on 
banknotes as evidence requires the concentrations of cocaine on the confiscated 
banknotes to be distinguishable from those present in general circulation. The 
development of analytical methods for the quantitative analysis of cocaine on 
banknotes has led to efforts being made towards the identification of different 
degrees of contamination. This in turn would enable ‘dirty money’, which has recently 
been in contact with drugs, to be distinguishable from ‘background money’ which has 
become inadvertently contaminated by general circulation.70  
 
The simplest way to distinguish dirty from background banknotes would be to 
establish a cut-off concentration in a similar way to the screening methods performed 
on biological samples, or to set cut-off ranges for quantitative analysis. Cocaine 
levels below the cut-off would fall within the range of ‘background’ concentrations, 
whereas concentrations beyond that range could be associated with direct contact 
with cocaine. In a study by Dixon et al., 11,983 GB£ banknotes were analysed for 
cocaine by thermal desorption followed by MS2 detection.75 The notes were divided 
into two groups based on origin; 4826 were case notes seized from alleged drug 
dealers, and 7157 were from general circulation obtained from banks around the UK. 
The cocaine contamination was determined based on peak intensity rather than 
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concentration, as the MS2 method could not be applied quantitatively due to 
difficulties in comparing the responses from standard solutions with those of cocaine 
within banknote matrices. The peak intensity obtained from the banknote samples 
was subsequently compared using pattern recognition techniques to determine if the 
distribution of the seized notes was higher than that of the notes from general 
circulation.75 The analysis showed a clear difference between the distributions of the 
two groups of banknotes, where the peak intensity of the case notes was significantly 
higher than the circulation notes with a few exceptions.75 The results indicate that the 
quantitative analysis of cocaine on banknotes is a viable means by which to 
distinguish the route by which the contamination, whether by direct contact with 
drugs or via general circulation, could have occurred.  
 
Due to variation in the levels of background contamination of cocaine in different 
countries, further studies of this kind would be needed if a firmer set of cut-off ranges 
is to be established. This is illustrated in Table 1.2, where a summary of the different 
concentrations of cocaine detected on banknotes from different currencies and 
countries is shown alongside the methods used for analysis. A difference in the 
cocaine concentrations from different denominations of the same currency was 
observed by Zuo et al., who noted that sampled notes of higher denominations such 
as US$5 and US$10 also had higher concentrations of cocaine on them when 
compared with US$1 bills. This trend, however, was not observed in other studies of 
US currency.76-78 Variation was also observed between banknotes obtained in 
different cities in a case study performed by Di Donato et al. in Brazil, and amongst 
those from different states in a study by Jourdan et al. performed in the US.78,79   
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Table 1.2.  A summary of the quantities of cocaine previously detected on banknotes of 
different currencies, and the methods used for analysis.  
 
 
Year Currency Method Denomination 
Average [cocaine]/ 
ng note-1 
[Cocaine] range/ 
ng note-1 Ref. 
1996 US$ GC-MS $1 (n = 136) 22,300 0 – 1,327,000 68 
1998 US$ GC-MS 
$1 (n = 4) 
$20 (n = 10) 
2,860 
830 
140 – 10,020 
0 – 2,990 
77 
2001 US$ GC-MS $1 (n = 40) 28,750 0 – 922,720 76 
2005 
Spanish 
€ 
GC-
MS/MS 
€5 (n = 3) 
€10 (n = 7) 
€20 (n = 4) 
€50 (n = 2) 
82,200 
281,900 
36,900 
57,400 
1,250 – 234,000 
26,800 – 889,000 
27,200 – 76,700 
47,000 – 67,800 
80 
2007 Irish € 
LC-
MS/MS 
€5 (n = 20) 
€10 (n = 10) 
€20 (n = 10) 
€50 (n = 5) 
18.76 
5.07 
66.64 
14.34 
0.09 – 286.66 
0.07 – 19.17 
0.7 – 576.14 
0.25 – 32.47 
81 
2007 R$ GC-MS R$1 (n = 46) 51,150 0 – 275,100 79 
2008 US$ 
GC-
FID/MS 
$1 (n = 5) 
$5 (n = 5) 
$10 (n = 7) 
$20 (n = 6) 
$50 (n = 4) 
$100 (n = 4) 
0 
19,200 
10,300 
4,200 
13,400 
2,220 
– 
4,650 – 49,400 
0 – 46,200 
0 – 9,210 
3,820 – 19,600 
0 – 8,870 
82 
2011 
Canary 
Isl. € 
LC-
MS/MS 
Mixed 
(n = 120) 
Median = 188.48 0.00 - 15,023.1 83 
2011 
Luxem-
bourgish 
€ 
LC-
MS/MS 
Mixed (n = 64) Median = 106 ≤ 2 - 141 
 
70 
2013 US$ 
GC-MS, 
LC-MS 
and LC-
MS/MS 
$1 (n = 630) 
$5 (n = 628) 
$10 (n = 678) 
$20 (n = 870) 
$50 (n = 688) 
$100 (n = 680) 
2.15 
3.62 
3.18 
1.61 
2.26 
1.49 
0.09 – 20.6 
0.08 – 94.7 
0.05 – 37.5 
0.06 – 12.2 
0.06 – 29.0 
0.05 – 29.6 
78 
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1.3.2 Methods of analysis 
Analytical methods for the detection of cocaine on banknotes, like other forensic 
analytical methods require a high level of sensitivity, accuracy and robustness in 
order to detect trace levels of cocaine in the presence of potential interferences in the 
sample matrix. The level of sensitivity required is illustrated by the low concentrations 
of cocaine, in the ng to µg range, detected on banknotes as reported by the studies 
shown in Table 1.2. In addition to the low analyte concentration, the analytical 
method requires a level of specificity that is suitable for the detection of trace levels 
of cocaine in a complex sample matrix brought about by the nature and function of 
banknotes.  
 
As detailed in Section 1.3.1, Sterling banknotes comprise of cotton and linen rag 
which is treated with preservatives prior to printing to strengthen the material and 
minimize degradation.83 In addition to preservatives, the way in which paper currency 
is handled and transferred means environmental pollutants such as dust, soil, food 
particles, sweat, inks, oils, cosmetics and resulting micro-organisms can all be found 
on the fibres of a banknote.25 The presence of pharmaceutical substances or 
compounds deriving from food sources on banknotes is known; of these, caffeine is 
the most predominant but nicotine, codeine and paracetamol have also been 
reported at trace levels.80 In terms of illicit or controlled substances of forensic 
relevance, the primary cocaine metabolite benzoylecgonine, as well as other drug 
compounds including 6-monoacetylmorphine (6-AM), tetrahydrocannabinol (THC), 
morphine, 3,4-methylenedioxymethamphetamine, methamphetamine, heroin, 
ketamine, and phencyclidine (PCP) have been found on paper currency.81,84 Along 
with cocaine as the most prevalent drug on banknotes, heroin and ecstacy have also 
reportedly been detected on a number of notes at particularly high concentrations, 
raising concerns about health risks relating to exposure.85 
 
In the presence of the potential interferents listed in the previous paragraph within 
the sample matrix, it is imperative that the analytical technique used for the detection 
of cocaine is sufficiently specific and robust to ensure its accuracy. GC-MS was in 
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1989 the first reported method employed for the detection of cocaine on banknotes.86 
A two- or three-step process was a common method for analysis in the reports that 
followed; in the first step the cocaine is extracted from the banknote using an organic 
solvent such as methanol, after which the extract is further purified by solid-phase 
extraction (SPE) before analysis by GC or LC coupled with MS.68,77 Sample 
preparation procedures of this kind enable the cocaine to be separated from potential 
interferents on the banknote, thereby facilitating further specific analysis enabled by 
the sensitivity of the MS. As demonstrated by the summary of analytical methods 
shown in Table 1.3, methanol remains the most commonly used solvent for cocaine 
extraction, although the advancement of GC and LC-MS technologies has meant that 
SPE is sometimes no longer necessary. The advent of chromatography-coupled MS2 
techniques in particular has improved the sensitivity, selectivity and repeatability of 
analytical methods in this field, thereby enabling quantitative detection of cocaine on 
banknotes at extremely low levels.23 
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Table 1.3.  A summary of recently reported analytical methods for the detection of 
cocaine on banknotes. Abbreviated terms are as follows; LOD, limit of 
detection; RSD, relative standard deviation; GC-MS, gas chromatography-
mass spectrometry; HPLC, high pressure liquid chromatography; TD-APCI-
MS, thermal desorption-atmospheric pressure chemical ionisation-mass 
spectrometry; IMS, ion-mobility spectrometry; GC-FID/MS, gas 
chromatography-flame ionisation detection/mass spectrometry, ECL, 
electrochemiluminescence; LC-MS, liquid chromatography-mass 
spectrometry, LC-MS/ESI, liquid chromatography-mass 
spectrometry/electrospray ionisation; extract., extraction; SPE, solid-phase 
extraction; TD, thermal desorption; ACN, acetonitrile; MeOH, methanol.  
 
 
Year Method Sample treatment 
LOD / 
ng note-1 
% 
RSD Recovery / % Ref. 
1996 GC-MS MeOH extract. // SPE > 90   68 
1997 
GC-MS 
TD-APCI-MS 
Immunoassay 
HCl extract. // SPE 
Vacuum // TD 
None 
1.0 
 
 
 
Semi-quantitative 
Semi-quantitative 
77 
72 
87 
2001 GC-MS ACN extract. // SPE 1.0 ng mL-1   76 
2003 TD-APCI-MS None   Semi-quantitative 67 
2004 Raman None   Semi-quantitative 88 
2005 GC-MS2 MeOH extract. 0.15 6 101 - 98 80 
2006 
 
LC-MS2 
TD-APCI-MS2 
MeOH extract. 
None 
0.004 3.69 
87 
Semi-quantitative 
81 
75 
2007 
 
GC-MS 
TD-APCI-MS 
Aq. extract. 
None 
 
 
 
 
Semi-quantitative 
79 
66,89 
2008 
GC-FID/MS 
IMS 
Ultrasonic aq. extract. 
Vacuum 
1 
0.2 ng 
< 2 
95 
 
82 
25 
2011 
LC-MS2 
LC-MS2 
ECL biosensor 
ACN extract. 
MeOH extract. 
Acetic acid extract. 
0.003 
0.004 
3.7 pmol L-1 
< 5 
7.2 
5.2 
 
65 
92 
83 
70 
82 
2013 
GC-MS 
LC-MS/ESI 
LC-MS2 
MeOH extract. 
0.1 
0.1 
0.05 
  78 
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Although the methods developed using GC-MS and LC-MS for the detection of 
cocaine on banknotes provide undisputed levels of sensitivity, the disadvantages of 
using these techniques include the time needed for analysis and the destruction of 
the banknotes via solvent-based extraction systems.1 These disadvantages have led 
to the development of alternative methodologies including IMS and TD-MS which 
enable non-destructive sampling followed by rapid and sensitive detection allowing 
50 banknotes to be analysed in a 4 min period.60 The bulk of the reported studies into 
the development of MS2 based techniques for the detection of cocaine on banknotes 
have been performed by researchers at Mass Spec Analytical Ltd., who developed a 
series of methods based on the use of thermal desorption and APCI as sampling 
techniques.66,67,69,72,75,89,90 In these methods, cocaine is obtained from the banknotes 
either by trapping dust from the notes in a vacuum filter, or by desorbing the cocaine 
directly from the note itself into the source of the MS.69 Cocaine from the vacuum 
filters yields characteristically protonated molecular ions at m/z 304, whereas specific 
gas-phase ion transitions can be monitored for cocaine at m/z 304 to m/z 182, and 
m/z 304 to m/z 105 from the directly desorbed banknote material.60 The LOD for this 
type of technique is dependent on the amount of desorbed material, but is typically 
around 1 ng and therefore comparative to the sensitivity achieved by 
chromatography-MS based methods.72 However, due to the difficulties in comparing 
the responses from standard solutions with those of particulate materials trapped 
within banknote matrices, the developed MS2-based methods cannot be used 
quantitatively for applications of this nature.60 Instead, recent studies have focussed 
on the use of statistical analysis via which ‘drug money’ and banknotes from general 
circulation can be discriminated based on their respective peak intensities rather than 
cocaine concentration.75,90   
 
IMS, like TD-MS2, is a highly sensitive technique for the non-destructive and rapid 
detection of cocaine on banknotes. Samples containing trace compounds for IMS 
detection are typically applied to filter paper which is then heated to vaporization and 
ionised by electrons emitted by a 63Ni source. The time required for the resulting ions 
to drift through an electric field before meeting with a detector, known as ‘drift time’, 
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is substance-specific and therefore enables the presence of compounds in the 
sample to be identified.60 The method facilitates the detection of cocaine on bulk 
quantities of banknotes via vacuum sampling, which is typically performed by running 
the sampler down two specific ‘lanes’ down one side of the banknote prior to 
analysis.25 The detection of cocaine can alternatively be performed on individual 
banknotes by collecting surface swabs or by introducing the banknote directly into 
the vaporizer unit of the IMS.25 The latter, performed by Briellmann et al. using a 
specifically modified vaporizer unit, obtained a 1000-fold increase in sensitivity when 
compared with analysis by vacuum sampling.74 IMS is a sophisticated method 
capable of detecting ng quantities of cocaine, however it suffers from the same 
drawbacks as TD-MS2 in that due to the nature of desorption sampling techniques it 
cannot be applied for quantitative measurement.60,91 Nevertheless due to its inherent 
versatility, portability and low maintenance requirements it is widely used in security 
and law enforcement settings and remains the technique of choice for the detection 
of cocaine on banknotes by UK law enforcement agencies.12,25,60  
 
Despite the prevalence of immunoassay-based methods for the detection of cocaine 
and its primary metabolite benzoylecgonine in biological samples (as described in 
Section 1.2.1), the gold-labelled optically-read rapid immunoassay (GLORIA) is at 
present one of few immunoassays which have been successfully applied for the 
detection of cocaine on banknotes.87 The assay design is based on a lateral flow-
style set-up in which the detection of cocaine is facilitated by anti-cocaine antibody-
functionalised gold nanoparticles (AuNP). Cocaine on a banknote is sampled by 
swabbing using the ‘collection fleece’ part of the device; the fleece is then dipped in 
water, which immobilises the sample material and transports it toward the detection 
zone. Cocaine present in a sample will bind to immobilised anti-cocaine antibody in 
the detection zone, and is subsequently labelled by the addition of the anti-cocaine 
AuNP which produces a visible white to pink colour change when cocaine is 
present.87 The assay consists of a transportable device which enables the detection 
of ng quantities of cocaine in less than 3 min, although concerns have been raised 
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over its efficacy and specificity due to reports of false positive results in the presence 
of cocaine metabolites, pharmaceutical compounds and food additives.60  
 
As described in Section 1.2.1, immunoassays and particularly enzyme 
immunoassays are widely used by forensic toxicologists for the screening of illicit 
substances such as cocaine in biological specimens. The screening process requires 
quantitative accuracy in order to establish whether a sample is below the cut-off 
concentration, which is typically in the order of ng mL-1 concentrations. The 
successful applications for assays of this type for analysing complex forensic 
samples such as postmortem blood, or homogenised tissue demonstrates their 
efficacy for the detection of trace drug compounds in complex sample matrices. 
Banknotes, like biological samples, harbour trace levels of cocaine and present a 
challenging matrix for forensic analysis; however, the application of enzyme 
immunoassays for the detection of cocaine on banknotes is limited and does not 
allow for quantitative analysis. The widespread use of immunoassays for 
toxicological analysis is due to the fact that they are operator friendly, economical, 
rapid, sensitive and accurate alternatives to the more sophisticated and expensive 
hyphenated MS-based methods which dominate the types of analyses currently 
performed on banknotes. Based on this, the development and application of a 
quantitative enzyme immunoassay for cocaine extracted from banknotes, as well as 
the location-specific immunostaining of cocaine on the surface of banknotes will be 
demonstrated in this study.   
 
 
1.4 Thesis outline 
This thesis describes the development of two novel immunological methods for the 
quantitative and location-specific detection of cocaine on paper currency. The 
application of a technique for the detection of cocaine in latent fingerprints, and a 
comparison of different functionalisation strategies for the synthesis of antibody-gold 
nanoparticles for the detection of cocaine are also described.   
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A detailed description of the materials, reagents, instrumentation and experimental 
procedures used in this study are detailed in Chapter 2. The development of a 
competitive enzyme immunoassay for the detection of cocaine on paper currency, 
and its application for the analysis of cocaine extracted from both banknotes and 
latent fingerprints are described in Chapter 3. The preliminary efficacy of the assay is 
assessed based on the analysis of ten Bank of Scotland (UK) banknotes obtained 
from general circulation and the results of which are then compared to those of a 
parallel LC-MS analysis. The assay is also applied to the detection of cocaine in ten 
latent fingerprints obtained from five test subjects being treated for the habitual use 
of drugs, including cocaine, at a methadone treatment clinic; the resulting 
concentrations are then compared with the cocaine concentrations of corresponding 
oral fluid samples obtained by GC-MS analysis. 
 
Chapter 4 describes the development of an immunodetection method for the 
immobilisation and subsequent localised staining of cocaine on banknotes, using an 
enzyme-labelled anti-cocaine antibody and an acrylamide gel matrix. A comparative 
study of different semi-permeable hydrogel matrices for the immobilisation of cocaine 
is initially performed. Optimisation of the in-gel immunodetection method is then 
carried out using polyacrylamide gel electrophoresis gels, and cotton paper samples 
as a representation of the banknote sample matrix. The labelling of anti-cocaine 
antibody with the enzyme horseradish peroxidase is also described. The final 
optimised method is applied to control samples consisting of newly minted banknotes 
spiked with ‘street’ cocaine, after which banknotes obtained from general circulation 
are analysed.   
 
A comparative study of four strategies for the synthesis of antibody-functionalised 
gold nanoparticles for the detection of cocaine is detailed in Chapter 5. 
Characterisation of the functionalised particles is performed using transmission 
electron microscopy, ultraviolet visible spectrophotometry, and gel electrophoresis 
methods. The cocaine binding efficacy of the resulting nanoparticles, and their 
suitability for the detection of cocaine in forensic specimens is then determined by 
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enzyme labelling using a cocaine-horseradish peroxidase conjugate, and by the 
application of a plate-based immunoassay in which the immobilisation of cocaine is 
facilitated by a bovine serum albumin protein intermediate.  
 
Finally, conclusions of the findings for all the experiments presented in the thesis are 
provided in Chapter 6, along with detailed suggestions for future experiments.   
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CHAPTER 2 
 
Experiment al 
 
This chapter provides details of the materials and methods used to perform the 
experiments described in this thesis. 
 
2.1 Materials and instruments 
 
2.1.1 Starting materials and solvents 
All reagents were of analytical grade, purchased from Sigma-Aldrich (UK) and used 
as received unless otherwise stated. This included gold(III) chloride trihydrate, with a 
molecular mass of 393.83 g mol-1, and Protein A/G with a molecular weight of 
66 kDa. Analytical grade deionised water (dH2O), methanol (MeOH), hydrochloric 
acid 32 % (HCl (aq)), sodium dihydrogen orthophosphate dihydrate 
(NaH2PO4·2H2O), di-sodium hydrogen orthophosphate anhydrous (Na2HPO4), 
sodium hydrogen carbonate (NaHCO3), sodium chloride (NaCl), glycerol, dimethyl 
sulfoxide (DMSO), tri-sodium citrate (Na3H5C6O7), 50 mL centrifuge tubes, 25G 
0.5 mm sterile needles, Swann-Morton disposable scalpels and Eppendorf 
microcentrifuge tubes (1.5 and 2 mL) were all purchased from Fisher Scientific (UK). 
Dithiothreitol (DTT) and sodium dodecyl sulfate (SDS) were purchased from 
Pharmacia Biotech (UK). Rabbit polyclonal anti-cocaine antibody was purchased in 
1 mL units of serum from Europa Bioproducts (UK) and purified as reported in 
Section 2.2.1. Sheep polyclonal anti-cocaine antibody and horseradish peroxidase 
(HRP)-labelled mouse monoclonal anti-sheep IgG were purchased from Abcam (UK) 
and Jackson ImmunoResearch laboratories (USA), respectively. Cocaine-
horseradish peroxidase (cocaine-HRP) and cocaine-bovine serum albumin (cocaine-
BSA) haptens were purchased from Randox (UK) and Europa Bioproducts (UK), 
respectively. 
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Sephadex PD-10 desalting columns were purchased from GE Life Sciences (UK). 
‘Slide-A-Lyzer’ mini dialysis units (10,000 MWCO), ‘NAb Protein A plus’ spin 
columns, Coomassie brilliant blue R250, bromophenol blue sodium salt, ammonium 
persulfate (APS), 10 MWCO dialysis tubing, sulfo-N-hydroxysuccinimide sodium salt 
(sulfo-NHS), ethylene dichloride (EDC), N-succinimidyl 3-(2-pyridyldithio)-propionate 
(SPDP), 96-well Nunc C8 Maxisorp microtiter plates, 3,3',5,5' tetramethylbenzidine 
(TMB) substrate solution, and horseradish peroxidase (HRP) were all purchased 
from Thermo Scientific (UK). α-thio-ω-carboxy polyethylene glycol (PEGCOOH, MW 
3317 Da) and  α-Mercapto-ω-amino polyethylene glycol hydrochloride (PEGNH2, 
MW 3163 Da) were purchased from Iris Biotech GMBH (Germany). Ultrapure 
agarose, Novex Sharp unstained protein standard (molecular weight marker), Gibco 
rat tail collagen I, Novex enhanced chemiluminscence (ECL) substrate reagent and 
stable 3,3´-diaminobenzidine (DAB) were all purchased from Invitrogen (UK). 
18 x 16 cm glass plates, and 16 cm x 8 cm x 1.5 mm gel spacers were purchased 
from Web Scientific (UK). 
 
N,N,N’-tetramethylethylenediamine (TEMED) was purchased from Bio Rad (UK). 
Cerilliant Cocaine standard (1 mg mL-1 in acetonitrile) was purchased from LGC 
Standards (UK). Nitrocellulose membrane and Millex GP syringe driven filter units 
(0.22 µm) were purchased from Millipore (UK and USA, respectively). 15 mL 
centrifuge tubes were purchased from Corning B. V. Life Sciences (The 
Netherlands). Vivaspin20 (30,000 MWCO) and Vivaspin500 (100,000 MWCO) 
centrifuge tubes were purchased from Sartorius Stedim Biotech (UK). Holey carbon 
film 300 mesh copper grids were purchased from Agar Scientific (UK). Everyday 
Value dried skimmed milk powder was purchased from a local grocery store (Tesco, 
UK), and Dow Corning food grade RTV silicon was purchased from MB Fibreglass 
(UK). Fabriano Roma 100 % cotton ivory illustration paper was purchased from 
Atlantis Art, London (UK). 
 
Benzoylecgonine standard (Cerilliant; 1 mg mL-1 in MeOH) was kindly donated by 
Simon Hudson of HFL Sports Science, LGC Health Sciences (Fordham, UK). 
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Scottish banknotes of both £10 and £20 denominations from general circulation were 
kindly provided by the Scottish Crime and Drug Enforcement Agency (SCDEA). Ten 
fingerprint samples on glass microscope slides obtained from five volunteers at a 
methadone treatment clinic were kindly donated by Intelligent Fingerprinting Ltd. 
(Norwich, UK). Five newly minted £20 GBP banknotes, along with five £20 and ten 
£10 GBP banknotes from general circulation were kindly provided by Kevin Wills on 
behalf of the Bank of England (Notes Division, Banking Services; Loughton, UK). 
Approximately 1 g of seized ‘street’ cocaine (of unknown purity) was kindly provided 
by Steven Hamilton of the Norfolk Constabulary (Serious and Organised Crime 
Directorate, Wymondham, UK).   
 
 
2.1.2 Gel electrophoresis buffers and solutions 
The analysis of proteins and the coating of banknote samples were performed using 
polyacrylamide gels and gel electrophoresis. The buffers and gel solutions applied 
for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), non-
denaturing polyacrylamide gel electrophoresis (native-PAGE) and agarose gel 
electrophoresis are described in this chapter. The components of the buffers used for 
SDS-PAGE and native-PAGE, and of the SDS-PAGE gels are listed in Tables 2.1 
and 2.2, respectively. 1 L of protein stain for SDS-PAGE was prepared by firstly 
dissolving 1.0 g Coomassie brilliant blue R250 in 500 mL MeOH and 400 mL dH2O, 
then adding 100 mL glacial acetic acid. 1 L of de-stain for SDS-PAGE was prepared 
by adding 70 mL glacial acetic acid to 100 mL of MeOH, and making the volume up 
to 1 L with dH2O. For native-PAGE, the protein stain was prepared by firstly 
dissolving 0.25 g Coomassie brilliant blue R250 in 125 mL methanol and 100 mL 
dH2O, and then adding 25 mL glacial acetic acid. The de-stain solution used for 
native-PAGE was the same as that used for SDS PAGE.   
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Table 2.1.  The components of the buffers used for SDS PAGE and native-PAGE in this 
study, prepared based on the original Laemmli buffer system.1  
 
 Sample buffer Electrophoresis buffer 
SDS PAGE 5 mL 0.6 M Tris buffer, pH 6.8 
0.5 g SDS 
5.0 g sucrose 
250 µL β-mercaptoethanol 
5 mL 0.5 % w/v bromophenol blue 
(made up to 50 mL with dH2O)  
6.0 g Tris 
28.8 g glycine 
1.0 g SDS 
(made up to 1 L with dH2O) 
Native-PAGE 15.5 mL 1 M Tris buffer, pH 6.8 
2.5 mL 1 % w/v bromophenol blue 
7 mL dH2O 
25 mL glycerol 
(diluted 1:5 before use) 
3.0 g Tris 
14.4 g glycine 
(made up to 1 L with dH2O, 
adjusted pH to 8.3)  
 
 
Table 2.2.  The components used for the preparation of a 15 % polyacrylamide gel for 
SDS PAGE.2  
 
Resolving gel Stacking gel 
2 mL 1.875 M Tris buffer (pH 8.8) 
2.85 mL dH2O 
5 mL 30 % acrylamide/bis-acrylamide 
100 µL 10 % w/v SDS 
50 µL 10 % w/v APS 
25 µL TEMED 
1 mL 0.6 M Tris buffer (pH 6.8) 
7.5 mL dH2O 
1.35 mL 30 % acrylamide/bis-acrylamide 
100 µL 10 % w/v SDS 
50 µL 10 % w/v APS 
25 µL TEMED 
 
 
1 L of 5 x Tris-borate EDTA (TBE) buffer stock was prepared for agarose gel 
electrophoresis by dissolving 54 g of Tris and 27.5 g of boric acid with 20 mL of 
0.5 M EDTA (pH 8.0). The solution was then made up to a final volume 1 L with 
dH2O. 0.5 x TBE electrophoresis buffer was prepared by diluting the 5 x TBE buffer 
stock to 1:10 in dH2O. 200 mL 0.2 % w/v agarose gel mix was prepared by 
combining 0.4 g of ultrapure agarose with 100 mL of dH2O and heating to 85 °C to 
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melt the agarose. The mixture was cooled to 60 °C and 100 mL of 1 x TBE buffer (pH 
8.0) was added. The solution was immediately poured into a 15 x 15 cm gel tray and 
set at room temperature (RT).   
 
 
2.1.3 Instrumental techniques 
Centrifugation of large (20 - 50 mL) tubes was performed using an Avanti J-25 
centrifuge. Centrifugation of small (1.5 – 2.0 mL) tubes and Protein A spin columns 
were performed using a Beckman Coulter Allegra X-22R and an MSE Micro Centaur 
Pluse centrifuge, respectively. Samples for SDS PAGE analysis were heated to 
100 °C using a Grant-Bio PHMT Thermoshaker (at 0 rpm). 8 x 10 cm2 SDS-PAGE 
and native-PAGE gels were cast in a Hoefer S245 dual gel cassette, and performed 
using a Hoefer Mighty Small II vertical electrophoresis system. 16 x 18 cm2 native-
PAGE gels were cast using a Hoefer SE600 dual cassette. 15 x 15 cm2 agarose gels 
were prepared and run using a Scie-Plas HU-15 standard horizontal electrophoresis 
gel unit. Both SDS-PAGE and agarose gel electrophoresis were performed using an 
Amersham Pharmacia Biotech EPS 601 power supply. Colorimetric imaging of SDS-
PAGE and native-PAGE gels was performed using an HP photosmart C4580 
scanner. Chemiluminescent imaging was performed using a Fuji LAS-3000 imaging 
system; images were obtained at 30 s intervals in chemiluminescent increment mode 
and at high sensitivity, for a total exposure time of 5 min. Photographic images of 
gels were made using a Canon IXUS 115HS handheld digital camera.   
 
UV-Vis absorption spectra were recorded on a Hitachi U-3000 spectrophotometer at 
RT. Quartz cuvettes with a 1 cm path length were used. Microtiter plate absorbance 
intensity readings were recorded using a Perkin Elmer Wallac Envision 2103 
multilabel microplate reader. HRP-labelled anti-cocaine antibody was separated from 
unconjugated HRP by gel filtration with a 350 mL of GE Health Life Sciences 
Superdex 200 column using an Amersham Pharmacia Biotech AKTA Explorer. 
20 mM phosphate buffered saline with 150 mM NaCl (pH 7.2) was used as a running 
buffer. Absorbance intensity of the fractions was measured at 280 nm.   
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Transmission electron microscope (TEM) images were obtained using a Joel 
2000EX TEM operating at 200 kV. Imaging was performed by Dr Colin McDonald 
(School of Chemistry, University of East Anglia, Norwich, UK). LC-MS confirmation 
analysis of cocaine in extracted fingerprint samples was performed using a Thermo 
LTQ Orbitrap Discovery high resolution accurate mass LC-MS running in full scan 
positive ion electrospray mode. The orbitrap was operating at a mass resolution of 
30,000 FWHM at m/z 400. The analysis was performed by Simon Hudson at HFL 
Sports Science, LGC Health Sciences, Fordham, UK. Confirmation analysis of 
cocaine in oral fluid samples was performed using a GC-MS2 by Michalakis Michael 
at LGC Ltd. (Teddington, UK). 
 
 
2.2 Developing a competitive enzyme-immunoassay (cEIA) 
for the quantitation of cocaine on banknotes 
 
2.2.1 Anti-cocaine antibody purification 
Polyclonal anti-cocaine antibody was isolated from the supplied rabbit serum 
samples by immunoprecipitation using ammonium sulfate,3 followed by Protein A 
chromatography. A saturated solution of ammonium sulfate in dH2O was prepared by 
adding 190 g of (NH4)2SO4 to 200 mL of dH2O and stirring overnight at RT. The 
solution was made 24 h in advance and stored at 4 °C before use. The 1 mL aliquots 
of purchased serum were centrifuged at 10,000 xg for 30 min at 4 °C. The resulting 
supernatant was removed by pipette and the pellet discarded. The serum was then 
cooled to 4 °C in an iced waterbath. 400 µL of the pre-prepared saturated ammonium 
sulphate solution was added dropwise for every 1 mL of serum. The solution was 
then gently stirred for 3 h at 4 °C before being transferred to 1.5 mL Eppendorf tubes. 
Centrifugation was performed at 4000 xg for 10 min at 4 °C, after which the 
supernatant was discarded and the pellet drained by inverting the sample tube gently 
over tissue paper. The pelleted material was resuspended in 200 µL of 10 mM 
phosphate buffer (pH 7.4; PB) by drawing repeatedly into a wide-gauge Pasteur 
pipette. The final volume of the IgG solution was then made up to 500 µL with PB, 
 44 
 
and the IgG solution transferred in aliquots of 200 µL into mini dialysis units. Dialysis 
was performed against 2 L of 10 mM PB (pH 7.4) for 2 h at 4 °C, after which the 
solution was transferred to 1.5 mL Eppendorf tubes and stored at 4 °C overnight. 
 
Immunochromatography was performed using Protein A spin columns, with a sample 
capacity of ≤ 500 µL, in accordance with the manufacturer’s instructions. Three 
columns were used to accommodate the 900 µL of solution to be purified. Briefly, the 
columns were equilibrated before use by washing twice with 400 µL of 10 mM PBS 
(150 mM NaCl, pH 7.2). Wash solutions were removed from the columns by 
centrifugation for 1 min at 4,000 xg. The solution containing the antibody was added 
at 300 µL per column, and the columns were incubated at room temperature on a 
rotary mixer for 10 min. The columns containing bound antibody were then washed 
three times with 400 µL of 10 mM PBS (pH 7.2). The antibody was eluted from the 
columns using three 400 µL additions of 0.1 M glycine (pH 2.0). Each of the resulting 
three fractions was neutralised with 40 µL of 1.0 M Tris buffer (pH 8.5). The presence 
of antibody in the first and second fractions was determined by recording the 
absorbance intensity at 280 nm, measured using a UV-Vis spectrophotometer as 
described in Section 2.1.3. Confirmation was performed by SDS-PAGE.2 For this, 
10 µL of each fraction was diluted in an equal volume of sample buffer and heated to 
100 °C for 5 min. 15 µL of each sample was then loaded onto a 15 % SDS-
polyacrylamide gel alongside a molecular weight marker and run at a constant 
voltage of 180 V for 60 min. The Laemmli sample and electrophoresis buffers, gel 
mixes and staining solutions used were all prepared as described in Section 2.1.2. 
The resulting gels were imaged by scanning as described in Section 2.1.3. After the 
presence of antibody was confirmed, the two fractions were combined and dialysed 
in mini-dialysis units for 2 h against 2 L of 10 mM PB (pH 7.4). The solutions were 
then aliquoted and stored at -20 °C for up to six months. 
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2.2.2 Extraction of cocaine from banknote and latent fingerprint 
samples 
Cocaine was extracted from banknote samples using a modified version of the 
method described by Esteve-Turrillas et al..4 Each banknote was rolled and placed in 
a 20 mL glass test tube with 15 mL of MeOH. The tube was sealed and vortex-mixed 
for 5 min. The banknote was then removed from the tube and rinsed with a further 
5 mL of methanol. The two extract volumes (15 and 5 mL) were combined to make 
up the 20 mL final volume. The solvent was evaporated under reduced pressure at 
40 °C and the extract reconstituted in 0.5 mL of MeOH. The reconstituted extract was 
centrifuged at 14,000 rpm for 7 min at 4 °C to remove any solids, and the 
supernatant retained. Each extract was then divided into two halves; one half for 
cEIA and the other half for confirmation analysis by LC-MS. Extract portions set 
aside for LC-MS confirmation were kept in MeOH and stored at 4 °C. For the 
immunoassay, 50 µL of the extract was taken and the solvent was removed by drying 
under a gentle stream of argon. The extracts were then reconstituted in 50 µL of 
10 mM PB (pH 7.4) containing 2 % v/v MeOH and stored at 4 °C overnight until 
analysed. 
 
Fingerprint samples obtained from volunteer subjects known to be taking illicit drugs 
were provided by Intelligent Fingerprinting Ltd. The samples were taken by 
deposition of a fingerprint onto a clean glass microscope slide. Oral fluid samples 
were collected from the volunteers at the same time and analysed by GC-MS2, as 
described in Section 2.1.3. Fingerprints from drug-free volunteers were taken in the 
same manner as for the test subjects and used as negative controls. Cocaine was 
extracted from each fingerprint separately using a similar method as described 
previously for the banknote samples. Specifically, the microscope slide with the 
fingerprint was inserted into a 50 mL centrifuge tube and 20 mL of MeOH was added. 
The tube was sealed and vortex-mixed for 5 min. The solvent was evaporated under 
reduced pressure at 40 °C and the extract reconstituted in 0.5 mL of 10 mM PB 
(pH 7.4) containing 2 % v/v MeOH. The samples were stored at 4 °C overnight until 
analysed.   
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2.2.3 Preparation of standard and sample solutions 
A cocaine standard stock solution (1 mg mL-1) was prepared in advance of analysis 
as follows. A 50 µL aliquot of cocaine standard was taken and the acetonitrile 
removed by evaporation under a gentle stream of argon. The standard was then 
reconstituted in 50 µL of 10 mM PB (pH 7.4) containing 2 % v/v acetonitrile. A 
standard curve was prepared on the day of analysis by diluting the stock solution to 
known concentrations in 10 mM PB (pH 7.4). The concentrations of cocaine for each 
curve was as follows; 0.78, 1.56, 3.125, 6.25 12.5, 25, 50 and 100 ng mL-1 for the 
analysis of banknote extracts, and 0.195, 0.39, 0.78, 1.56, 3.125, 6.25 12.5, and 
25 ng mL-1 for the analysis of fingerprint extracts.  
 
Banknote extracts were diluted to 1:500 by adding 1.0 µL of sample to 499 µL of 
10 mM PB (pH 7.4), or to 1:1000 by adding 1.0 µL of sample to 999 µL of PB 
immediately prior to analysis. Fingerprint extracts were not diluted prior to analysis.  
 
 
2.2.4 Anti-cocaine cEIA method 
A schematic overview of the developed cEIA method is shown in Figure 2.1. The 
assay involved the adsorption of the purified anti-cocaine antibody (1 µg mL-1) to a 
microtiter plate at 100 µL/well in 100 mM carbonate buffer, pH 9.5 (optimised as 
described in Section 2.2.5). The plate was incubated overnight (18 h) at 4 °C and 
then washed three times with 10 mM PBS containing  0.05 % v/v Tween-20 (150 mM 
NaCl, pH 7.4; PBS/T). Blocking buffer, PBS containing 1 % w/v bovine serum 
albumin (PBS/BSA), was added at 200 µL/well and incubated at RT for 2 h. The plate 
was then washed a further three times with PBS/T before the addition of pre-diluted 
standards and banknote extracts (in PB) at 50 µL/well. The plate was incubated for a 
further 2 h at RT after which 50 µL of the cocaine-HRP conjugate (1:20 in sample 
buffer (blocking buffer with 0.05 % v/v Tween-20), optimised as described in Section 
2.2.5), was added to each well. The solutions were mixed by gently tapping the side 
of the plate several times and then incubated for 2 h at room temperature. The plate 
was then washed four times with PBS/T. TMB substrate solution was added at 
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100 µL/well followed by a 20 min incubation at RT in the absence of light. Sulfuric 
acid (0.5 M in dH2O) was added at 100 µL/well to stop the enzymatic reaction, after 
which the absorbance of each well was measured at A450 using a multi-label plate 
reader as described in Section 2.1.3. Wells without antibody were used as a blank. 
The intensity of the absorbance measured was inversely proportional to the quantity 
of cocaine in the banknote extract.  
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Figure 2.1.  A schematic representation of the cEIA for the detection of cocaine in 
extracts taken from banknotes or latent fingerprints. 
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Absorbance intensities were corrected for cocaine-HRP binding in the absence of 
cocaine as shown in Equation 2.1.  The standard curve was generated by plotting the 
cocaine concentration (on a logarithmic scale) against the logit of the corrected 
absorbance intensity (Logit (B/B0)).5 For this, Equation 2.2 was applied.6  
 
  (2.1) 
 
 (2.2) 
 
In Equations 2.1 and 2.2: B is the absorbance intensity of the sample or standard 
solution, and B0 is the absorbance intensity produced by the 0 ng mL-1 cocaine 
standard solution.  
 
 
2.2.5 cEIA method optimisation 
Anti-cocaine antibody (1 µg mL-1, 100 µL/well) was adsorbed onto a micro-titer plate 
by overnight incubation (18 h) at 4 °C as described in Section 2.2.4. Initially, the 
antibody was diluted in either 100 mM carbonate buffer (pH 9.5), or 10 mM PB 
(pH 7.4) prior to addition to the wells. The resulting relative concentration of antibody 
immobilised onto the plate was then estimated using an enzyme-labelled molecule of 
antigen, in this case HRP-labelled cocaine (cocaine-HRP), as follows. 50 µL of 
cocaine-HRP (1:20 in blocking buffer) was applied to each well. Unbound hapten 
was removed by washing three times with PBS/T. TMB substrate solution was added 
at 100 µL/well followed by a 20 min incubation at RT in the absence of light. Sulfuric 
acid (0.5 M in dH2O) was added at 100 µL/well to stop the enzymatic reaction, after 
which the absorbance of each well was measured at A450 using a multi-label plate 
reader as described in Section 2.1.3. Wells without antibody were used as a blank. 
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The concentration of cocaine-HRP bound, as indicated by the intensity of the 
coloured product, was proportional to the amount of antibody bound to the plate. 
 
The optimal dilution factor for the cocaine-HRP was similarly determined based on 
the coloured product produced by the bound enzyme. The cocaine-HRP was 
subjected to a series of dilution factors from 1:20 – 1:160 in blocking buffer, and 
applied to a microtiter plate containing anti-cocaine antibody bound at a 
concentration of 1 µg mL-1 as described previously. Wells with BSA bound at 
100 ng mL-1 in place of the antibody were used as negative controls. Unbound 
hapten was removed by washing three times with PBS/T, and the presence of 
enzyme detected using TMB substrate solution as described for the labelling of 
bound antibody in the previous paragraph.  
 
The addition of Tween-20 to the blocking buffer as a means of preventing non-
specific binding of cocaine-HRP was investigated using a preliminary set of cocaine 
standards. Wells containing anti-cocaine antibody, and negative control wells with 
BSA were prepared as previously described. Blocking buffer was then added at 
200 µL/well and incubated at RT for 2 h. The plate was washed three times with 
PBS/T before the addition of four pre-diluted cocaine standards (in PB) at 50 µL/well. 
The cocaine standards, at the concentrations 0, 100, 500 and 1000 ng mL-1, were 
prepared as described in Section 2.2.3. Cocaine-HRP, diluted to 1:20 in sample 
buffer, was then added at 50 µL/well. The solutions were mixed by gently tapping the 
side of the plate several times and then incubated for 2 h at RT. The plate was 
washed four times with PBS/T, and enzyme substrate added and measured as 
described as described for the labelling of bound antibody at the beginning of this 
section. 
 
 
2.2.6 Limit of detection (LOD), precision and specificity 
The detection limit of the cEIA was calculated from the average absorbance values 
from six replicate analyses of the blank minus three times the standard deviation of 
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the average. The resulting absorbance value was then extrapolated from the log-logit 
standard curve.  
 
The precision of the assay was estimated based on repeat measurements of 
calibration standard samples prepared in assay buffer (10 mM PB, pH 7.4). 
Standards at three different cocaine concentrations (6.25, 25 and 100 ng mL-1) were 
used. The intra-assay precision was determined using four replicates of each 
standard in a single analysis. Inter-assay precision was similarly assessed by 
analysing the same sample, as four repetitions, across three separate analyses 
undertaken on different days over a period of 30 days. 
 
The analytical specificity, or cross-reactivity, of the assay was tested for 
benzoylecgonine (BE), the cocaine analogue and main metabolite of cocaine found 
in urine. Three BE standard solutions (6.25, 25.0 and 100.0 ng mL-1) were prepared 
in assay buffer (10 mM PB, pH 7.4) using the same method applied for the 
preparation of cocaine standards in Section 2.2.3. The standards were analysed as 
four repeat measurements by cEIA as described in Section 2.2.4, alongside a 
complete set of cocaine standards. The % cross-reactivity of BE was calculated 
relative to the cocaine standard curve,7 as shown in Equation 2.3.  
 
   
  (2.3) 
 
 
In Equation 2.3: [Apparent cocaine] is the concentration of cocaine calculated from 
the standard curve based on the absorbance intensity, and [Added BE] indicates the 
actual concentration of BE from which the absorbance intensity was measured.  
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2.3 Location-specific immunodetection of cocaine on 
banknotes 
 
2.3.1 Comparing gel matrices for cocaine immobilisation 
In this study, a number of different gel matrices were initially tested in order to gauge 
their suitability for application onto banknotes. A summary of the gel types and the 
methods used to prepare them is provided in Table 2.3. The mechanical properties of 
the gels were established by preparing gels set to a ca. 2 mm thickness around small 
squares (ca. 2 x 3 cm2) of cotton paper. This was carried out by pouring the pre-
prepared gel mixes into custom moulds (ca. 5 x 7 x 0.5 cm3, cast out of food grade 
silicon in a mould prepared using small interlocking plastic building blocks) containing 
the cotton paper. The paper was submerged into the gel mix using tweezers, and the 
gels set as per the conditions specified in Table 2.3.  
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Table 2.3.  A summary of the different types of gel matrices compared in this study. The 
methods used to make the gels are provided alongside each gel type. 
 
 
Medium Content Method(s) used 
Gelatin 3, 5 and 
7 % w/v 
30 mL of 3, 5 or 7 % w/v porcine skin gelatin was prepared in dH2O. 
The solution was heated to 55 °C in a glycerol bath for 30 min,8 then 
poured into the mould and set at RT or 4 °C.  
Cross-
linked 
gelatin 
7 % w/v 7 % w/v gelatin gels were prepared and set as described above. For 
cross-linking, the gels were soaked for 2 h in 4 % PFA* in 0.1 M 
PBS (50 mM NaCl, pH 7.4) at RT.9  
Casein 7 % w/v 20 mL of 7 % w/v bovine casein was prepared in dH2O. The pH was 
adjusted to 10 by adding 1.0 M NaOH. The solution was then 
heated to 65 °C for 45 min in a glycerol bath with continuous stirring. 
The solution was filtered through one layer of muslin ‘butter cloth’ 
and cooled to RT before being poured into the mould and set at RT.  
Collagen 1.0  
mg mL-1 
Collagen (3 mg mL-1) in 0.2 % acetic acid (pH 3-4) was diluted 1:2 in 
2 mM PBS (100 mM NaCl, pH 7.4) and stored on ice to prevent 
gelation. The pH of the solution was adjusted to 7.4 with 1 M NaOH, 
before being warmed to RT for ca. 10 min. The solution was poured 
into moulds and set for 1-2 h at 37 °C.10 
Cross-
linked 
collagen 
1.8  
mg mL-1 
2.5 mL 2 mM PBS, 0.1 mL 1 M NaOH and 4 mL collagen 
(3 mg mL⁻1, as above) were placed on ice. The collagen was added 
dropwise to the PBS and the pH adjusted to 7.6 using the NaOH. 
The solution was warmed to RT, poured into moulds and set for ca. 
40 min at RT.10 The gels were removed from the mould, soaked in 
4 % PFA* for 30 min at RT and then washed in PBS with 0.05 % v/v 
Tween-20 for 10 min at RT. 
Agarose 0.2 % w/v A 0.2 % w/v solution of agarose was prepared by adding 12 mg of 
ultrapure agarose to 6 mL of 10 mM PB (pH 7.4). The solution was 
heated to 95 °C until the agarose dissolved. It was poured into the 
mould and set for ca. 1 h at RT.11 
LMP† 
agarose 
0.2, 0.5 
and 
1.0 % w/v 
0.2, 0.5 and 1.0 % w/v agarose solutions were prepared by adding 
0.04, 0.1 and 0.2 g of agarose to 20 mL of dH2O, respectively. The 
gels were further prepared and set as described above.       
*PFA = paraformaldehyde and †LMP = low melting point. 
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Permeability testing was performed using gels cast to a ca. 5 mm thickness on top of 
the glass wool at the base of a chromatography column. The glass wool was first 
lined with filter paper before the gel solutions (7 % w/v gelatin, 0.2 % w/v agarose, 
and 2 mg mL-1 collagen) were prepared and cast as described in Table 2.3. The set 
gels were washed by applying 20 mL of PBS/T (10 mM PBS/0.05 % Tween-20) 
above the gel layer. The solution was then left to flow through the gel for ca. 1.5 h at 
4 °C with the column tap set to ‘open’, after which the eluent was discarded. 20 mL of 
primary antibody solution (1:100 in PBS/T) was then applied on top of the gel and left 
to permeate for a further 1.5 h at 4 °C. The absorbance intensity of the antibody 
solution was measured at 280 nm as described in Section 2.1.3 before and after gel 
permeation.  
 
Cross-linking of the gel matrices was performed using a pre-prepared 4 % solution of 
paraformaldehyde (PFA) in 50 mM PBS (0.137 M NaCl, pH 7.4). 500 mL of this 
solution was prepared by first heating 400 mL of the PBS to 60 °C and stirring gently 
throughout. 20 g of PFA was then added. 1 M NaOH was added dropwise until the 
solution became clear. Once clear, the solution was cooled to RT and sterile-filtered 
using a 0.22 µm filter unit. The volume was made up to 500 mL with PBS, before 
being divided into 20 mL aliquots and stored at -20 °C.    
 
 
2.3.2 In-gel immunodetection method development for 
polyacrylamide gels 
Samples of cocaine-bovine serum albumin (cocaine-BSA) hapten, and control 
samples containing primary anti-cocaine or secondary HRP-labelled antibody were 
imbedded into a polyacrylamide gel using a modified version of the native-
polyacrylamide gel electrophoresis (native-PAGE) method described by Walker.12 
The gels were cast as homogenous Tris-HCl slab-gels, using a single separating gel 
mix rather than a layered stacking- and separating- gel approach. An 8 x 10 cm2 gel 
cassette was prepared using 0.75 or 1.5 mm spacers. Gel mixes were made using 
different acrylamide concentrations and cross-linker ratios, as listed in Table 2.4. The 
pre-prepared gel mix was added slowly to the cassette and allowed to set at RT. 
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10 µL of the molecular weight marker was loaded into the first well of the gel. 15 µL 
of sample, diluted 1:1 in 1x native-PAGE sample buffer (prepared as described in 
Section 2.1.2), was then added to each remaining well. Electrophoresis was 
performed at 120 V constant voltage for approximately 3 h in native-PAGE 
electrophoresis buffer, prepared as reported in Section 2.1.2. Gels which were not 
required for in-gel immunodetection were stained using the native-PAGE protein 
stain, prepared as described in Section 2.1.2. De-staining was performed using the 
SDS-PAGE de-stain solution described in the Section 2.1.2.     
 
 
Table 2.4.  Solutions for preparing Tris-HCL separating gels for native-PAGE; the 
different acrylamide concentrations and cross-linker ratios used in this study.  
 
 % Acrylamide 
Components (in mL): 5.0 % 7.5 % 8.0 % 8.5 % 10.0 % 
30 % acrylamide/bis-acrylamide 2.5 3.75 4.0 4.25 5.0 
dH2O 8.4 3.75 6.9 6.65 5.9 
Tris Buffer (1.5 M, pH 8.8) 3.8 7.425 3.8 3.8 3.8 
10 % APS 0.15 0.075 0.15 0.15 0.15 
TEMED 0.008 0.009 0.009 0.009 0.006 
 
 
In-gel immunodetection was performed on unstained gels using a modified version of 
the method described by Desai et al..13 Following electrophoresis, the gel was 
removed from the cassette and transferred to a gel box. The gel was then 
submerged in approximately 50 mL of 50 % isopropanol/water for 15 min at RT. This 
was followed by a 15 min wash step in approximately 50 mL of dH2O. The gel was 
then incubated for between 1 and 3 h (as listed in Table 2.5) at RT in a 20 mL 
solution of anti-cocaine primary antibody diluted in sample buffer. Two types of 
primary anti-cocaine antibody were used in this study; rabbit antibody (purified as 
reported in Section 2.2.1), and sheep antibody, which was diluted directly from the 
purchased stock solution. The conditions used for each of the antibody types are as 
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shown in Table 2.5. Following incubation with the primary antibody, the gel was 
washed three times for 10 min in approximately 50 mL of wash buffer (either 
PBS/0.05 v/v Tween-20 (PBS/Tween-20), or 1x Tris-buffered saline 
(TBS)/0.05 v/v Tween-20 (TBS/Tween-20), depending on the type of sample buffer 
used). 20 mL of an appropriately diluted solution of HRP-labelled secondary antibody 
in sample buffer was then added to the gel and incubated for 1 h at RT. Table 2.5 
lists the dilutions of secondary antibody alongside the type of sample buffer used. 
The gel was then washed a further three times as previously described. 
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The colorimetric substrate DAB was initially applied for the detection of HRP within 
the gels for experiments 1 – 5, as listed in Table 2.5. 20 mL of DAB substrate 
solution, pre-equilibrated to RT, was added to the gel after the final wash step. The 
gel was incubated in the DAB solution for 1 – 2 min, or until the coloured product 
became visible. The gel was then rinsed four times with wash buffer before being 
placed between acetate sheets and imaged. An enhanced chemiluminescence (ECL) 
substrate solution was also applied for the detection of HRP in gels, as shown for 
experiments 7 – 10 in Table 2.5. For this, 10 mL of the ECL substrate solution was 
prepared by mixing 5 mL of reagent A (stable peroxidase buffer) with 5 mL of reagent 
B (luminol enhancer). This was added to the gel immediately after the final wash 
step, and was followed by a 5 min incubation in the dark at RT. The ECL solution 
was removed after incubation, and the gel was briefly rinsed (for around 15 s) in 
dH2O to remove any excess. The gel was then placed between acetate sheets and 
imaged at 30 s intervals for a total exposure time of 5 min, as detailed in Section 
2.1.3. 
 
 
2.3.3 Detection of antibody interaction by ‘dot blot’-style assay 
Interaction between the primary and labelled secondary antibody was detected using 
a modified protocol based on the original method of Hawkes et al..14 A 1 mg mL-1 
solution of primary antibody in 10 mM PB (pH 7.4) was prepared, along with a 
1 mg mL-1 solution of BSA in PB as a negative control. A rectangle of nitrocellulose 
membrane was cut and pre-labelled with pencil in a grid pattern. 2 µL of anti-cocaine 
antibody stock solution (as purchased), or 2 µL of a control solution of BSA 
(5 mg mL-1 in PB) was slowly spotted onto the circle drawn in the centre of each grid 
using a micropipette and allowed to dry at RT. Once dry, the membrane was 
transferred to a 10 cm plastic Petri dish and submerged in approximately 20 mL of 
blocking buffer (5 % w/v BSA/TBS/0.05 % v/v Tween-20) for 45 min at RT. The 
membrane was then incubated for 30 min in 10 mL of secondary antibody solution 
(1:1000 in TBS/0.05 % v/vTween-20, TBS/T) at RT. The membrane was washed 
once in TBS/T for 15 min at RT, followed by two times in TBS/T for 5 min at RT, and 
 59 
 
a final time for 5 min in TBS at RT. 10 mL of ECL substrate solution, prepared by 
mixing 5 mL of reagent A with 5 mL of reagent B, was added to the membrane and 
incubated for 1 min in the dark and at RT. The membrane was then rinsed for 
approximately 15 s in dH2O, placed between acetate sheets and imaged at 30 s 
intervals for a total exposure time of 3 min, as detailed in Section 2.1.3. 
 
 
2.3.4 HRP labelling of sheep polyclonal anti-cocaine antibody 
Anti-cocaine IgG was labelled with HRP using the periodate-mediated method of 
conjugation as reported by Tijssen and Kurstak,15 and Wisdom.16 2 mg of HRP was 
dissolved in 500 µL of sterile-filtered dH2O. 100 µL of freshly prepared 0.1 M sodium 
periodate was added to the HRP solution and stirred for 20 min at RT, during which a 
colour change of orange to green was observed. The resulting solution was dialysed 
in mini-dialysis units overnight at 4 °C against 2 L of 1 mM sodium acetate buffer 
(pH 4.4). 50 µL of the anti-cocaine antibody was made up to 500 µL in 10 mM 
sodium carbonate buffer (pH 9.5). The pH of the dialysed enzyme was adjusted to 
9.0 – 9.5 by adding 10 µL of 0.2 M sodium carbonate buffer (pH 9.5), after which the 
solution containing the antibody was immediately added. The mixture was then 
stirred for 2 h at RT. 50 µL of freshly prepared sodium borohydride solution 
(4 mg mL-1 in dH2O) was added and the mixture was stirred for a further 2 h at RT. 
The antibody-HRP hapten was purified using a gel filtration column as described in 
Section 2.1.3. The fractions from the first peak at A280 were selected, and the 
presence of the hapten was confirmed by SDS-PAGE, performed as described in 
Section 2.2.1, and by UV-Vis spectrophotometry at A280 and A403. Fractions found to 
be containing the hapten were then concentrated to a 1 mL volume by centrifugation 
in a Vivaspin20 tube at 2,500 xg for 40 min at 4 °C. The purity of the labelled 
antibody, as indicated by the Rz value, was determined using the ratio of the 
absorbance intensity at A275:A403.17 The concentration of the labelled antibody was 
estimated based on the absorption of HRP at 403 nm using the extinction co-efficient 
102 mM-1 cm-1.18 5 mg of BSA was added to the labelled antibody to make a final 
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BSA concentration of 5 mg mL-1. The solution was divided into 1 mL aliquots and 
stored at -20 °C.    
 
 
2.3.5 Preparation of spiked cotton paper, partial banknote and 
whole banknote samples 
Cotton paper was cut into rectangular-shaped pieces of approximately 5 x 7 cm2 and 
pre-labelled with pencil in a grid pattern. Small circles (ca. 3 mm) were drawn in the 
centre of each grid to indicate the location of the spiked sample. The cocaine 
standard solution (1 mg mL-1 in MeOH), and a cocaine-BSA hapten at various 
concentrations in PB were used for spiking. BSA (5 mg mL-1 in PB), anti-cocaine 
antibody and HRP-labelled secondary antibody solutions were used as control 
samples. 2 - 10 µL of each standard or control solution was slowly spotted onto the 
centre of each circle using a micropipette. The paper was then allowed to dry for 2 -
3 h at RT before analysis by in-gel immunodetection. For the partial banknote 
samples, £5 GBP notes were cut width-wise into ca. 6 cm wide strips and then 
spiked in the same manner as the cotton paper samples.  
 
Whole or partial banknote samples were spiked with ‘street’ cocaine using the 
approach described by Ebejer et al..19 For the partial banknote samples, £5 GBP 
notes were first cut width-wise into ca. 4 cm wide strips before spiking. Newly minted 
£20 GBP notes were used as whole banknote samples. A flat glass plate was dusted 
with 25 mg of cocaine to represent a ‘contaminated surface.’ The banknote was then 
rubbed over the surface at random, in order to achieve sporadic but overall 
coverage. The same process was performed for both sides of the note. The 
contaminated glass plate was weighed before and after spiking to enable the quantity 
of cocaine adhered to the note to be estimated. 
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2.3.6 In-gel immunodetection of cocaine on spiked cotton paper, 
partial banknote and whole banknote samples 
In-gel immunodetection was performed using a method based on that developed for 
PAGE gels in Section 2.3.2. Figure 2.2 shows a schematic overview of the 
developed method for immunodetection on whole banknotes.  
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Figure 2.2.  A schematic representation of the in-gel immunodetection method for the 
detection of cocaine on banknotes. 
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An appropriately sized gel cassette, as indicated in Table 2.6, was assembled using 
either 0.75 or 1.5 mm spacers. A gel mix containing 7.5 % acrylamide was then 
prepared using the components listed in Table 2.4. The spiked cotton paper, partial 
banknote samples or whole banknote samples were prepared as described in 
Section 2.3.5. The cotton paper samples were initially coated in the pre-prepared gel 
mix using one of two different approaches. For the first method, the sample was 
placed inside the cassette and the gel mix slowly poured around it; in the second, the 
gel mix was added slowly to the cassette beforehand and the sample was slowly 
lowered into the solution using tweezers until completely immersed. All banknote 
samples were gel-coated using the second approach. For whole banknotes, the 
sample was gently lowered length-ways into the gel mix and pushed down with 
tweezers until completely immersed. Air bubbles in the gel mix were removed by 
gently tapping the cassette, or by sucking out the air through a narrow pipette tip. A 
thin layer of ethanol (ca. 3 mm) was floated on top of the gel before it was left to set 
for ca. 40 min at RT.    
 
Once set, the gel containing the sample was gently removed from the cassette and 
transferred to a gel box. For the whole banknote samples, excess gel (beyond ca. 
1.5 cm of the edge of the banknote) was removed using a scalpel prior to transfer to 
the gel box. Once transferred, the gel was then submerged in 50 % isopropanol in 
dH2O (using the volumes listed in Table 2.6) for 15 min at RT. This was followed by a 
15 min wash step in dH2O. The gel was then incubated for 2 h at RT in a solution of 
either rabbit or sheep polyclonal anti-cocaine antibody (diluted in 0.5 % w/v BSA/1x 
TBS/0.05 % v/v Tween-20 (pH 7.5, sample buffer)), as indicated in Table 2.6. HRP-
labelled sheep anti-cocaine antibody, prepared as described in Section 2.3.4, was 
used an alternative to the HRP-labelled secondary antibody in later experiments 
(Table 2.6). After incubation with the primary antibody, the gel was then washed 
three times for 10 min in TBS/T (1x TBS/0.05 v/v Tween-20, pH 7.5) using the 
volumes listed in Table 2.6. HRP-labelled goat anti-rabbit IgG, or HRP-labelled anti-
sheep IgG secondary antibody in sample buffer was then added to the gel and 
incubated for 1 h at RT. The gel was washed a further three times as described 
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previously. For gels treated with HRP-labelled primary antibody, the previous two 
steps involving the addition of the HRP-labelled secondary antibody and subsequent 
wash step were omitted. The ECL substrate solution, at the volumes indicated in 
Table 2.6, was prepared by performing a 1:1 dilution of reagent A with reagent B, as 
described in Section 2.3.2. The ECL solution was added to the gel and incubated for 
5 min at RT in the absence of light. The solution was then removed and the gel was 
briefly rinsed (around 15 s) in dH2O, before being placed between acetate sheets 
and imaged at 30 s intervals for a total exposure time of 5 min, as detailed in Section 
2.1.3. 
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2.4 Anti-cocaine antibody functionalisation of gold 
nanoparticles: a comparison between different 
techniques 
 
2.4.1 Synthesis of 16 nm citrate-stabilised gold nanoparticles 
16 nm citrate-stabilised gold nanoparticles (cAuNP) were synthesised according to 
the method of Turkevich et al..20 A 1.3 mM solution of aqueous tri-sodium citrate was 
prepared by dissolving 50 mg of tri-sodium citrate in 50 mL of dH2O. A 0.2 mM 
aqueous solution of gold (III) chloride trihydrate was similarly prepared by dissolving 
12.5 mg of the gold (III) chloride trihydrate in 100 mL of dH2O. Both solutions were 
heated to 60 °C, combined and immediately heated further to 85 °C while being 
stirred. The combined solution was then stirred for a further 2.5 h at 85 °C. The 
resulting burgundy-coloured solution was cooled to RT, filtered using a 0.22 µm filter 
and stored at 4 °C. The concentration of AuNP was calculated using the absorption 
at 520 nm and the extinction co-efficient 2.4 x 108 M-1 cm-1.21 
 
2.4.2 Synthesis of 40 nm cysteamine-stabilised gold nanoparticles 
Cysteamine stabilised AuNP were synthesised using a modified version of the 
method described by Niidome et al..22 The particles were prepared by sodium 
borohydride (NaBH4) reduction of gold (III) chloride trihydrate in the presence of the 
cystamine stabiliser, using a molar ratio of 56 Au:0.1 NaBH4:85 cysteamine. 400 µL 
of 213 mM cysteamine hydrochloride was added to 40 mL of 1.42 mM gold (III) 
chloride trihydrate and stirred for 20 min at RT. 10 µL of 10 mM sodium borohydride 
was added and the solution stirred vigorously in the dark and at RT. After 10 min, the 
speed of stirring was reduced and left overnight. The presence of AuNP was 
observed by the formation of a deep red colouration. The particles were purified by 
dialysis for 24 h against 4.5 L of dH2O at RT using 10 MWCO dialysis tubing. The 
concentration of AuNP was calculated using the absorption at 528 nm and the 
extinction co-efficient 4.7 x 109 M-1 cm-1.23  
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2.4.3 Gold nanoparticle characterisation by transmission electron 
microscopy (TEM) 
Transmission electron microscopy (TEM) was used to characterise the size and 
morphology of the AuNP. 10 µL of the AuNP in solution was placed onto a holey 
carbon film 300 mesh copper grid. Excess solvent was removed from the sample by 
touching the side of the grid with absorbent tissue paper. The grid was then allowed 
to dry overnight at RT before imaging. Imaging was performed as described in 
Section 2.1.3. 
 
 
2.4.4 Antibody functionalisation of 16 nm AuNP using a PEG-
carboxyl linker 
Antibody-functionalised AuNP were prepared using a modified version of the protocol 
described by Mason et al., whereby the PEG-carboxyl linker was self-assembled 
onto cAuNP, followed by the addition of the anti-cocaine antibody via the formation of 
an amide bond.24  A w/v ratio of 1 PEG:1 AuNP was self-assembled by adding 20 mg 
of α-thio-ω-carboxy polyethylene glycol (3,317 Da, PEGCOOH) to 20 mL of cAuNP 
prepared as described in Section 2.4.1. The mixture was then stirred overnight at RT. 
Unbound PEG was removed by centrifugation filtration in a Vivaspin20 tube at 
2,500 xg for 15 min at 4 °C. Following centrifugation, the AuNP-PEGCOOH were 
resuspended in 10 mL of 50 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer 
(pH 5.5) and stored at 4 °C.   
 
Addition of the anti-cocaine antibody to the terminal -COOH functional group on the 
PEG was performed using sulfo-NHS/EDC chemistry, in a similar manner to that 
described by Won and Sim.25 10 µL of an EDC/sulfo-NHS solution (0.1 M EDC and 
0.1 M sulfo-NHS in dH2O) was added to 1 mL of AuNP-PEGCOOH. Immediately, 
100 µL of anti-cocaine antibody (diluted to 10 µg mL-1 in 10 mM PB, pH 7.4) was 
added. The solution was then mixed thoroughly by drawing repeatedly into a wide-
mouthed pipette, before being stirred gently for 2 h at RT. Unbound antibody was 
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removed by centrifugation at 14,000 rpm for 15 min at 4 °C, after which the AuNP 
were resuspended in 1.0 mL of 10 mM PB (pH 7.4). The centrifugation step was 
repeated for a total of three times, yielding 1.0 mL of purified AuNP-PEGCOOH-
antibody. The antibody-functionalised particles were stored at 4 °C until needed. 
 
 
2.4.5 Antibody functionalisation of 16 nm AuNP using a PEG-amine 
linker 
cAuNP with a PEG-amine (PEGNH2) monolayer were synthesised in a similar 
manner to the AuNP-PEGCOOH described in Section 2.4.4. Briefly, a w/v ratio of 
1 PEG:1 AuNP was produced by adding 20 mg of α-mercapto-ω-amino poly(ethylene 
glycol) hydrochloride (MW 3163 Da) to 20 mL of cAuNP. The PEG was self-
assembled onto the gold surface by stirring overnight at RT. Unbound PEGNH2 was 
removed by centrifugation in a Vivaspin20 tube at 2,500 xg for 15 min at 4 °C. 
Following centrifugation, the AuNP-PEGNH2 were resuspended in 10 mL of 10 mM 
PB (pH 8.0) and stored at 4 °C until used the same day. 
 
Functionalisation of the AuNP-PEGNH2 was performed using the method reported by 
Puertas et al. for the addition of antibody to aminated magnetic particles.26 Anti-
cocaine antibody (purified as stated in Section 2.2.1) was diluted to 0.5 mg mL-1 in 
10 mM PB (pH 7.0). 50 µL of sodium periodate (100 mM in dH2O) was added to 
1.0 mL of the antibody solution and incubated for 2 h at 4 °C in the dark. Excess 
sodium periodate was removed using a PD-10 desalting column equilibrated by 
washing four times with 8.0 mL 10 mM PB (pH 8.0), as per the manufacturer’s 
instructions. The 1.0 mL of oxidised antibody was applied to the column, allowed to 
enter the packed column bed completely, and then made up to 2.5 mL with 1.5 mL of 
10 mM PB (pH 8.0). The column flow-through was discarded before the antibody was 
eluted from the column using 3.5 mL of 10 mM PB (pH 8.0). The 3.5 mL of oxidised 
antibody solution was added to 10 mL of AuNP-PEGNH2. The mixture was stirred 
gently for 1 h at RT, after which 2.5 mL of milk buffer (1 % w/v skimmed milk powder 
in 10 mM PB, pH 7.4) was added. The AuNP were then stirred for a further 1 h at RT.  
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The antibody-functionalised AuNP-PEGNH2 were purified by glycerol gradient using 
a modified version of the method described by Karthik et al..27 900 µL of 80 % v/v 
glycerol in dH2O (pH 7.8) was added to a 15 mL centrifuge tube. 1.3 mL of 30 % v/v 
glycerol in dH2O (pH 7.8) was layered on top. 5 mL of the AuNP-PEGNH2-antibody 
was then floated on top of the glycerol solutions, followed by centrifugation at 
2,500 xg for 2 h at 30 °C. After centrifugation, the AuNP-PEGNH2-antibody had 
moved from the top buffer layer to the 30 % glycerol layer lower down in the tube. 
The AuNP were extracted from this 30 % glycerol layer by piercing the side of the 
tube with a 25G needle and collecting the AuNP in a 10 mL syringe. The extracted 
volume (ca. 1.5 mL) was made up to 5 mL with 10 mM MES (pH 6.0). The glycerol 
was removed by centrifugation in a Vivaspin20 tube (30,000 MWCO), at 2,000 xg for 
15 min (4 °C), after which the AuNP-PEGNH2-antibody were resuspended in 5 mL of 
10 mM MES (pH 6.0). Centrifugation was repeated for a total of four wash steps. The 
AuNP-PEGNH2-antibody were resuspended in a final volume 2 mL of 10 mM MES 
(pH 6.0) after the last wash step. 2 mL of 0.25 M sodium cyanoborohydride in 10 mM 
PB (pH 8.0) was added to the 2 mL of AuNP-PEGNH2-antibody and stirred for 
30 min at RT. Excess reducing agent was removed by centrifugation in a Vivaspin20 
tube at 2,000 xg for 15 min at 4 °C. Centrifugation was repeated a total of three 
times. The AuNP-PEGHN2-antibody were resuspended in 4 mL of 10 mM PB 
(pH 7.4) after each centrifugation. Once purified, modification of the AuNP surface 
was measured by UV-Vis spectrophotometry at 520 nm. The functionalised AuNP 
were stored at 4 °C.   
 
 
2.4.6 Antibody functionalisation of 16 nm AuNP using a Protein-A/G 
intermediate  
Antibody immobilisation onto the surface of cAuNP via an SPDP-Protein A/G 
intermediate was performed using a modified version of the method described by 
Leggett et al..28 The Protein A/G was first modified by addition of the SPDP 
bifunctional linker. 60 µL of SPDP (10 mM in DMSO) was added to 2.5 mL of Protein 
A/G (5 µM in 100 mM PB, pH 7.8). The solution was stirred at RT for 30 min. 
 70 
 
Unbound SPDP was removed using a Sephadex PD-10 desalting column 
equilibrated with 10 mM PB (pH 7.4) as per the manufacturer’s instructions. Briefly, 
2.5 mL of the SPDP-Protein A/G solution was applied to the column, and the flow-
through discarded. The column was washed four times with a total of 8 mL of 10 mM 
PB (pH 7.4) and the SPDP-Protein A/G eluted in a further 3.5 mL of 10 mM PB 
(pH 7.4). The presence of SPDP in the elution was determined by adding 25 µL of 
DTT (100 mM in dH2O) to 1 mL of the SPDP-Protein A/G eluent. The mixture was 
then stirred for 30 min at RT. The presence of 2-thiopyridine in the resulting solution 
was measured by UV-Vis spectrophotometry at 343 nm, and its concentration 
subsequently determined based on the recorded absorption using the extinction co-
efficient 8.08 x 103 M⁻1 cm⁻1.29,30 This concentration was in turn used as the overall 
concentration of SPDP-Protein A/G, based on the finding that separated 2-
thiopyridine is equivalent to the 2-pyridyl disulfide content of the modified protein as 
reported by Stuchbury et al..29 
 
The SPDP-Protein A/G was adsorbed onto the surface of the AuNP by combining the 
two at a molar ratio of 100 SPDP-Protein A/G:1 AuNP, and stirring overnight at RT. 
Purification of the AuNP-Protein A/G was performed by centrifugation in Vivaspin500 
tubes at 2,500 xg for 12 min at 4 °C. 10 of the Vivaspin500 tubes were used to 
accommodate 5 mL of the AuNP in 500 µL aliquots. Each aliquot was resuspended 
in 500 µL of 10 mM PB (pH 7.4) following centrifugation. The wash step was 
repeated for a total of three times. The shift in absorption maximum that followed the 
addition of Protein A/G to the particle surface was measured by UV-Vis 
spectrophotometry at around 520 nm.   
 
Anti-cocaine antibody, purified as described in Section 2.2.1, was added to 10 mL of 
AuNP-Protein A/G to make a final concentration of 10 µg mL-1. The solution was 
stirred gently for 1 h at RT. After incubation, 2.5 mL of milk buffer (1 % w/v in 10 mM 
PB) was added and the AuNP stirred for a further 1 h at RT. The solution was divided 
into ten 1 mL aliquots and transferred to 1.5 mL Eppendorf tubes. Unbound antibody 
was removed by centrifugation at 8,000 rpm for 30 min at 4 °C, after which the AuNP 
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were resuspended in 1.0 mL of 10 mM PB (pH 7.4). The centrifugation step was 
repeated for a total of three times. After the final centrifugation, the AuNP were 
resuspended in 250 µL of 10 mM PB (pH 7.4) per aliquot. The aliquots were 
combined to make up a total of 2.5 mL of purified AuNP-Protein A/G-antibody. The 
functionalised particles were stored at 4 °C until needed. 
 
 
2.4.7 Antibody functionalisation of 40 nm cysteamine-stabilised 
AuNP 
Antibody functionalisation of the 40 nm cysteamine-stabilised AuNP, synthesised as 
stated in Section 2.4.2, was performed using the method of functionalisation 
described in Section 2.4.5.  
 
 
2.4.8   Detection of bound antibody by SDS PAGE 
A modified version of the SDS-PAGE method reported by Puertas et al. was used for 
the detection of antibody bound to the surface of the functionalised AuNP.26 500 µL 
of the functionalised AuNP were first concentrated by centrifugation in a Vivaspin500 
tube at 2,500 xg for 15 min at 4 °C. Following centrifugation, 10 µL of concentrated 
AuNP was taken from above the membrane and transferred to a 1.5 mL Eppendorf 
tube. 10 µL of a 40 % w/v SDS and 20 % v/v mercaptoethanol solution in dH2O was 
added and the solution incubated at 100 °C for 10 min. The aggregated AuNP cores 
were removed by centrifugation at 8,800 xg for 10 min, producing a small black 
pellet. The supernatant was transferred to a fresh tube and the pellet discarded. In a 
separate tube, 10 µL of the supernatant was added to 10 µL of SDS-PAGE sample 
buffer (prepared as described in Section 2.1.2) and incubated for 5 min at 100 °C. 
The solution was cooled for approximately 5 min before 10 µL was loaded onto a 
15 % SDS-polyacrylamide gel, prepared as described in Section 2.1.2. SDS-PAGE 
was performed as detailed in Section 2.2.1.  
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2.4.9 Visualisation of AuNP surface modification and size by agarose 
gel electrophoresis 
In this study, the method reported by Hanauer et al. was applied for the separation of 
AuNP on the basis of size.31 Antibody-functionalised AuNP were concentrated by 
centrifugation using a Vivaspin500 tube at 2,500 xg for 15 min at 4 °C. 20 µL of 
concentrated AuNP solution was then taken from above the membrane and loaded 
directly onto a 0.2 % w/v agarose gel prepared in 1 x TBE buffer (pH 8.0). The gels 
were run with a 15 cm electrode spacing at a constant voltage of 150 V for 60 min, 
using a 0.5 x TBE electrophoresis buffer (pH 8.0). The gel and buffer solutions were 
prepared as described in Section 2.1.2. Photographic images of the gels were 
obtained immediately after electrophoresis, as described in Section 2.1.3.  
 
 
2.4.10 Estimation of bound antibody concentration using enzyme 
labelled antigen 
In this study, HRP labelled cocaine (cocaine-HRP) was used as an indication of the 
presence of antibody on the surface of functionalised AuNP. An attempt was made to 
estimate the number of antibodies bound to each AuNP based on the intensity of the 
enzyme product generated by the bound labelled antigen. A schematic version of the 
developed method is shown in Figure 2.3.  
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Figure 2.3.  A schematic diagram of the detection of anti-cocaine antibody on the surface 
of functionalised AuNP using the HRP-labelled cocaine hapten. 
 
 
The concentration of the cocaine-HRP hapten was first calculated based on the 
absorption of HRP at 403 nm, as described in Section 2.3.4. A 1.0 µM cocaine-HRP 
stock solution was then prepared. Six 500 µL standard solutions of cocaine-HRP, 
 74 
 
ranging in concentration from 0 to 100 nM, were prepared by diluting the 1.0 µM 
stock in 10 mM PB (pH 7.4). 200 µL of TMB substrate solution was added to each 
standard followed by a 20 min incubation in the dark at RT. 200 µL of sulfuric acid 
(0.5 M in dH2O) was added. A 1:2 dilution of the resulting enzyme product solution 
was made in 10 mM PB (pH 7.4), before the absorbance intensity was measured at 
450 nm.  
 
For the detection of antibody bound to AuNP, a 1:20 dilution of the cocaine-HRP was 
made in 10 mM PB (pH 7.4). 2.0 µL of this solution was added to 1.0 mL of 
functionalised AuNP and stirred at room temperature for 30 min. Two 500 µL aliquots 
of the solution were placed into two Vivaspin500 tubes. Unbound cocaine-HRP was 
removed by centrifugation at 2,500 xg for 12 min at 4 °C, and the solutions 
resuspended in 500 µL of 10 mM PB (pH 7.4) per aliquot. Centrifugation was 
repeated for a total of four wash steps, or until the supernatant below the membrane 
remained colourless when TMB substrate solution was added. The concentration of 
AuNP was then determined by measuring the extinction at 520 nm and using the 
extinction co-efficient 2.4 x 108 M-1 cm-1.21 Each 500 µL aliquot was then transferred 
to a 1.5 mL Eppendorf tube, and the presence of HRP determined using the TMB 
substrate solution in the same way as for the cocaine-HRP standard solutions. The 
resulting solutions were centrifuged at 10,000 xg for 10 min at 4 °C to remove the 
aggregated AuNP, producing a small black pellet. 500 µL of the supernatant was 
taken and the remaining solution and pellet discarded. A 1:1 dilution of the 
supernatant was made in 10 mM PB (pH 7.4) and the absorbance intensity 
measured by UV-Vis spectrophotometry at 450 nm. 
 
The HRP concentration in the sample was determined based on the absorbance 
intensity of the sample at 450 nm, using a linear regression of the standard curve. A 
1:1 ratio of bound cocaine-HRP:antibody was assumed. The average molar ratio of 
AuNP:antibody was calculated for each type of functionalised particle based on the 
concentration of AuNP after the final wash step (measured as stated). The molar 
ratio was expressed as the number of antibody per particle. 
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2.4.11 Determination of antigen binding efficacy using a microtiter 
plate-based assay 
The efficacy with which the antibody-functionalised AuNP were able to bind cocaine 
was determined using a cocaine-BSA hapten, which was adsorbed onto micro-titer 
plates to form the basis of a simple immunoassay. A schematic overview of this 
method is shown in Figure 2.4. Cocaine-BSA (1 mg mL-1 in 10 mM PB, pH 7.4) was 
first diluted to 100 µg mL-1 in 100 mM carbonate buffer (pH 9.5). 100 µL of this 
cocaine-BSA solution was then added to each well of the plate (Figure 2.4A). BSA 
(100 µg mL-1 in 100 mM carbonate buffer, pH 9.5) was added to an equal number of 
wells on the plate and used as a negative control (Figure 2.4B). The plate was 
incubated overnight at 4 °C, then washed three times with PBS/T (10 mM PBS with 
100 mM NaCl/ 0.05 % v/v Tween-20, pH 7.4). 200 µL of blocking buffer (1.0 % w/v 
BSA/PBS) was added to each well and incubated for 2 h at RT. The plate was then 
washed a further three times with PBS/T before the addition of either antibody-
functionalised AuNP, or unbound antibody (100 µg mL-1 in 10 mM PB, pH 7.4) at 
100 µL/well. This was followed by 2 h of incubation at RT, after which the plate was 
washed three times with PBS/T. 100 µL of the HRP-labelled secondary antibody 
solution (1:5,000 in 10 mM PB, pH 7.4) was then added to each well, and the plate 
was incubated for a further 2 h at RT. The plate was washed a final four times with 
PBS/T. TMB substrate solution was added at 100 µL/well followed by a 20 min 
incubation at RT in the absence of light. Sulfuric acid (0.5 M in dH2O) was added at 
100 µL/well to stop the enzymatic reaction, after which the absorption of each well 
was measured at 450 nm using the multi-label plate reader as described in Section 
2.1.3. Wells without protein bound were used as control blanks. The intensity of the 
absorbance measured was proportional to the concentration of the antibody, or the 
functionalised AuNP bound to the adsorbed cocaine-BSA.  
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Figure 2.4.  A schematic diagram of the immunoassay-based method developed for 
determining the binding characteristics of the anti-cocaine AuNP-antibody in 
the (A) presence and (B) absence of a cocaine-BSA hapten bound to a 
microtiter plate. Detection of the antibody-functionalised AuNP was 
performed using an HRP-labelled secondary antibody, as shown. 
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CHAPTER 3 
 
Devel opment of a competitive enzyme 
immunoassay for the d  etection of cocaine on 
banknotes and in l atent fingerprints 
 
This chapter describes the development of a competitive enzyme immunoassay 
(cEIA) method for the quantification of cocaine in forensic samples, and its 
application for the detection of cocaine extracted from banknotes and latent 
fingerprints.  
 
 
3.1 Introduction 
 
3.1.1 Antibodies 
Antibodies, also known as immunoglobulins (Ig), are large immunological proteins 
that exhibit unique individual specificity for a broad range of target molecules.1 
Antibodies are synthesised by B lymphocytes and are used by the mammalian 
immune system to identify and neutralise invading foreign bodies.1-3 Initially, 
antibodies are present in a membrane-bound form on the surface of a B-cell and are 
referred to as B-cell receptors (BCR). The interaction of a BCR with its specific 
antigen facilitates activation of the B cell and subsequent differentiation into cells 
responsible for the synthesis of large quantities of antibody in a soluble, extracellular 
form.1 Exploitation of this immunisation process has enabled the production of 
specifically-targeted antibodies for a wide range of analytical applications. Antibodies 
can be produced via the direct immunisation of a mammalian host, such as a mouse, 
rabbit or sheep, with the target molecule.3 The resulting polyclonal antibodies 
obtained from the serum of the animal consist of a mixture of molecules of different 
epitope specificity and affinity.1-3 Purification of polyclonal antibodies is typically 
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performed in a series of steps based on antibody class and antigen binding affinity. 
Alternatively, monoclonal antibodies can be generated from a single activated B cell, 
which is fused with an immortalised cell line to form a hybridoma. These hybridoma 
cells produce antibodies with single antigen epitope specificity, and can be selected 
and cloned to produce antibodies with optimal binding affinity.2 
 
All monomeric antibodies are “Y”-shaped molecules constructed of paired heavy and 
light polypeptide chains tethered together by disulfide bonds.1-3 A typical structure is 
shown in Figure 3.1. At the N-terminal end the four chains combine to form two 
antigen binding fragments (FAb), the structure of which are variable and depend on 
the target antigen.1,4 At the C-terminal end the constant region (Fc), made up of the 
two heavy chains, is responsible for B-cell activation and exhibits little structural 
variation within each antibody class.1 Immunoglobulins have been divided into five 
different classes according to the structure of the Fc region; IgG, IgM, IgA, IgD and 
IgE.1,3 Of these, IgG is produced in the highest yield in response to immunisation and 
is used almost exclusively in immunoassays.3 Furthermore, IgG binds to its epitope 
with the highest affinity, remains stable throughout purification procedures and 
features several functional groups which enable chemical coupling with only minimal 
interference to antigen binding, making it highly suited to immunoassay-based 
applications.3    
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Figure 3.1.  A schematic representation of the structure of an antibody.1 The molecule is 
made up of paired heavy and light chains joined together by disulfide bonds. 
The antibody binding sites (Fab) are situated at the N-terminus, and the 
constant fragment (Fc) at the C-terminus.     
 
 
Small target molecules, such as drugs, are not large enough to produce an immune 
response in an animal host.3 The molecule must therefore be conjugated to a carrier 
protein to form a hapten prior to immunisation.5 Proteins such as bovine serum 
albumin (BSA) and keyhole limpit hemocyanin (KLH) are typically used for this 
purpose.3 Although this enables the production of antibodies for drugs like cocaine, it 
can also increase the ability of the antibody to detect compounds other than the 
antigen, a phenomenon known as cross-reactivity. Polyclonal antibodies produced 
using a hapten immunogen can be specific for the carrier protein rather than the 
compound, a risk which can be lowered significantly by employing an immunoaffinitiy 
purification step.3 
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3.1.2 Enzyme Immunoassays 
The role of antibodies within the immune system enables them to be targeted 
towards a vast array of antigens, from cells and biomolecules right through to 
synthetic chemicals.1 This flexibility has enabled the development of immunoassays 
targeting a wide range of different analytes. Immunoassays are based around the 
capture of a target analyte, even at minute concentrations, by a corresponding 
primary antibody within an often complex sample matrix.3 This process is afforded by 
the unique capability of antibodies to strongly bind antigens with a high level of 
specificity.  
 
Capture of the analyte by the antibody is followed by the addition of a secondary 
reagent containing the signal-generating component of the assay, commonly known 
as the tracer, which enables subsequent measurement.3 Generally speaking, the 
tracer is made up of two main parts; the first of these facilitates specific binding to a 
target such as the primary antibody or analyte, and the second is a label compound 
or molecule responsible for emitting a detectable signal.3 The original 
radioimmunoassay (RIA), developed by Berson and Yalow in 1959, used a 
radioactive iodine (131I) label for this purpose.6 A wide range of different RIAs were 
produced in the decades that followed, a number of which are still in use today.3,7  
 
Concerns over the safety and handling of radioactive material have led to the 
development of a variety of alternative labelling methods ranging from proteins to 
fluorophores and metal colloids.7-9 Of these, enzyme labels are currently the most 
widely used and will be focused on within this thesis. The presence of an enzyme 
can be detected at low concentrations by using its catalytic properties to generate a 
coloured, fluorescent, luminescent, or electrochemically active product from a 
‘neutral’ substrate.3 The rate at which the catalytic conversion of substrate to product 
occurs can be as high as 107 molecules per minute from a single enzyme.3 This 
signal amplification process enhances the sensitivity of the assay significantly when 
compared with labels generating just one signal event.9 The activity of enzymes 
commonly used in enzyme immunoassays are more stable than that of the 125I RIA 
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label, however the conditions under which the catalytic conversion reaction of 
substrate to product occurs is susceptible to interferences and therefore close 
monitoring of assay conditions at this stage is required.3,9  
 
Horseradish peroxidase (HRP) is one of the most commonly used enzymes in 
immunoassays.3 HRP is a 44 kDa glycosylated metalloprotein with an iron(III) 
protoporphyrin IX heme group, two calcium atoms and six lysine residues available 
for conjugation without any loss of enzyme activity.10 Its catalytic activity as an 
oxidoreductase enables the reduction of hydrogen peroxidase in the presence of a 
number of different hydrogen donors, and it can be used to generate coloured, 
luminescent or fluorescent derivatives in combination with various substrates.3,10 A 
typical chromogenic substrate for HRP employed in EIAs is 3,3',5,5'-
tetramethylbenzidine (TMB), which generates a blue coloured product with 
absorbance maxima at 370 nm and 652 nm, and which can be stabilised with the 
addition of sulfuric or phosphoric acid to yield a yellow solution with a maximum 
absorbance at 450 nm.11 The absorbance of colorimetric substrates of this kind is 
measured by spectrophotometry.  
 
Labelled conjugates made up of HRP covalently bound to an antibody or antigen can 
be formed using a number of chemical linking strategies. One of the simplest 
methods for coupling HRP to protein uses glutaraldehyde, a homobifunctional 
aldehyde which reacts with amine groups that are present on most proteins.12 
Although easy to perform, the reaction is prone to the formation of enzyme or protein 
polymers and is therefore less favourable than other coupling strategies.3 A more 
popular method for coupling HRP exploits the glycoprotein nature of the enzyme.13 In 
this method, the carbohydrate residues on HRP are oxidised by sodium periodate to 
produce aldehyde groups. These in turn react with amine groups on the protein to 
form a stable conjugate.13,14 Competitive immunoassays can require the coupling of 
HRP to a small, non-protein molecule which is almost always the analyte of interest.3 
In this case the coupling technique employed will depend on the functional groups 
available on the molecule. Carboxyl-based approaches, such as the reaction of a 
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carboxylic acid with a carbodiimide, are often used although other coupling reactions 
can be appropriate.3,15   
 
Many different formats of multi-step enzyme immunoassays (EIAs) exist, and these 
can be broadly categorised as homogeneous or heterogeneous depending on 
whether separation of bound from unbound enzyme is required prior to addition of 
the substrate.3,8,15,16 In a homogenous system, separation of the unbound enzyme is 
not necessary, as it can be distinguished from the bound enzyme via either activation 
or de-activation of its catalytic activity.16 The simple, one-step nature of this type of 
assay format makes it the fastest and easiest type of EIA. The most widely used of 
these is an EIA first reported by Rubenstein et al. in 1972 for the analysis of 
morphine, introduced commercially as the ‘enzyme multiplied immunoassay 
technique’ (EMIT) for the analysis of drugs of abuse in urine.3,17  In this competition-
based assay system, the tracer is an analyte molecule labelled with the enzyme 
glucose-6-phosphate dehydrogenase (PDH).17 In the absence of free analyte, the 
PDH-labelled analyte is bound to the antibody and this inhibits the activity of the 
enzyme. Free analyte in a sample will compete for antibody binding sites with the 
labelled analyte, resulting in the presence of unbound, catalytically active PDH from 
which a signal can be measured.15,17 
 
In a heterogeneous EIA format, the bound and free forms of the enzyme tracer are 
indistinguishable and therefore a separation step is required prior to measurement.3,9 
The separation step gives this type of assay two distinct advantages over a 
homogeneous EIA. Firstly, removal of potential endogenous interference from the 
sample during the wash step effectively acts to increase the sensitivity of this type of 
assay.3 Secondly, the presence of the wash step also removes potential matrix 
interferents, thereby negating the need for a preliminary extraction step and making 
this type of assay particularly useful for complex sample types.3,18 Although many 
variations of heterogeneous EIA exist, three main assay designs are the most 
commonly used; the indirect enzyme-linked immunosorbent assay (ELISA), the 
‘sandwich’ ELISA, and the competitive EIA (also known as the ‘competitive ELISA’, 
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or simply ‘EIA’).3 All three involve the initial adsorption of an antigen or capture 
antibody onto a solid phase in the form of a 96-well microtiter plate.3        
 
The ELISA assay design is based around the use of an enzyme-labelled antibody as 
a means of detection.19,20 Figure 3.2 shows a schematic overview of two commonly 
used assays. In an indirect ELISA (Figure 3.2A), the sample is added directly to the 
microtiter plate and the analyte of interest adheres to its surface.3,9,15,16 A primary 
antibody is then added, followed by a secondary antibody specific for the type of 
primary antibody (for example, rabbit IgG). The secondary antibody is labelled with 
an enzyme to enable detection upon addition of the substrate. The two antibody or 
‘sandwich’ ELISA (Figure 3.2B) differs from the indirect ELISA in that an antibody, 
known as the capture antibody, is bound to the microtiter plate prior to addition of the 
sample. A second primary antibody, targeting a different epitope on the antigen to 
the capture antibody, is then added and the excess removed by washing. Detection 
is facilitated by an enzyme-labelled secondary antibody as for the indirect ELISA. In 
ELISA assays a direct labelling approach is employed, producing a signal that is 
proportional to the amount of antigen present in the sample,3,9,15,16 as is illustrated in 
Figure 3.2.  
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Figure 3.2.  Schematic representations of ELISA methods. The formats for indirect 
ELISAs (A) and ‘sandwich’ ELISAs (B) are shown.  
 
 
Competitive EIAs are particularly suited for the detection of low-level concentrations 
of small compounds such as drugs.21 They differ from the ELISA assay format in that 
they involve an indirect method of generating a signal, involving an enzyme 
conjugated to the target molecule rather than a secondary antibody.22 In this type of 
competitive assay format (shown in Figure 3.3), capture antibody is first immobilised 
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onto the surface of a microtiter plate. Enzyme-labelled analyte and the sample of 
interest are then incubated together before excess enzyme and sample are removed 
by washing. During the incubation, the enzyme-labelled antigen competes for 
antibody binding sites with free analyte in the sample.22 The higher the concentration 
of analyte in the sample, the lower the concentration of bound enzyme; as a result 
the signal generated is inversely proportional to the amount of analyte in the sample 
as the calibration curve in Figure 3.3 illustrates.3,9,22  
 
 
 
Figure 3.3.  A schematic representation of a competitive-style EIA method. 
 
 
3.1.3 Enzyme immunoassays for the detection of cocaine 
Immunoassays were originally introduced to forensic toxicology laboratories for the 
preliminary screening of drugs of abuse in urine samples.23 The commercial EMIT 
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‘drugs of abuse urine’ assay (EMIT DAU), released in the 1970s, was the first type of 
EIA employed in this way.24 The manufactured immunoassay kits provided a means 
of testing for a variety of drug and drug metabolite compounds in urine samples that 
is fast, accurate, inexpensive and easy to perform.23,25 Since then, the variety of EIAs 
available for the screening of drugs of abuse in urine has expanded rapidly to include 
a range of different formats such as competitive EIA, ELISA and the homogeneous 
cloned enzyme donor immunoassay (CEDIA).18,23,25 Advances in technology have 
meant that EIAs can now be easily automated, enabling more accurate analysis of a 
larger number of samples and making them all the more suitable for screening 
purposes, as discussed in Chapter 1.26  
 
While most commercial immunoassays have been developed for a urine matrix, they 
have also been applied by forensic toxicologists to other matrices including blood, 
tissue homogenates, hair extracts, oral fluid, sweat and meconium.26-28 The use of 
non-urine matrices poses two main challenges; firstly, the concentration of the target 
compound is often lower in such samples, and so the sensitivity of the immunoassay 
may not be appropriate. Secondly, non-urine matrices, particularly postmortem 
specimens, are usually more complex in their composition and this can increase the 
potential for interference.28 
 
The cross-reactivity of an EIA is determined by its primary or capture antibody, and is 
therefore source (i.e. manufacturer) dependent.28 The ability of an immunoassay to 
detect cross-reactive species can be a useful characteristic or, depending on the 
specificity required for analysis, a nuisance and a manner in which false-positive 
results can be generated.3 Like other commercial EIAs for drugs of abuse, assays for 
cocaine detection are designed for urine analysis and therefore target 
benzoylecgonine as the primary metabolite.3,18,21 Cross-reactivity of some types of 
assays, marketed as ‘cocaine and metabolite’ assays, can be high for cocaethylene 
and cocaine (> 100 %) in particular.25,26,29  
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Some researchers have exploited this cross-reactivity by applying these types of 
competitive EIAs for the detection of cocaine, rather than benzoylecgonine, in non-
urine samples that may be of value in a forensic investigation. The use of commercial 
competitive EIA assays, such as the STC Cocaine Metabolite Micro-Plate EIA, has 
been reported for the detection of cocaine in postmortem blood and tissue,26 oral 
fluid,29 sweat,30 meconium,31 and hair extracts.32 In these types of sample cocaine is 
present at concentrations that are much lower than in urine, for example in oral fluid 
where the concentration can be up to thirty times less.29 Despite this, the assays 
evaluated were capable of identifying the presence or absence of cocaine to a 
degree of accuracy comparable to confirmatory analyses performed using RIA,26 
biochip microarray,31 and GC-MS.29,30 As outlined in Chapter 1, the definition of 
cocaine presence or absence was based on whether the concentration was above or 
below a cut-off concentration, respectively. The cut-off concentrations were as low as 
20 ng g-1 and 10 ng mL-1 for some sample types,29,31 so quantitative analysis by 
means of competitive EIA with a high level of sensitivity was therefore required. 
These studies illustrate the levels of sensitivity that can be achieved using 
competitive EIAs, and their suitability for the analysis of even complex sample 
matrices such as postmortem blood or tissue homogenate. At present, a commercial 
enzyme immunoassay specifically targeting cocaine rather than cocaine and 
metabolites is not available. The development of a cocaine-specific competitive 
enzyme immunoassay for the analysis of cocaine in a forensic setting is therefore 
presented in this chapter. 
 
 
3.1.4 Aim of the research presented in this chapter 
The high proportion of paper currency in general circulation contaminated with 
cocaine has been well documented.33 The methods of cocaine contamination,  
through trade or use of the drug, and the spread of contamination to other notes via 
bank sorting machines has been described in detail in Chapter 1. As transfer of 
cocaine to other banknotes is a diluent process, the concentration of cocaine on a 
note contaminated in this way would be lower than if the note had contacted cocaine 
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directly. As such, a concentration of cocaine on a note that is beyond that of the 
general circulation could be associated with drug use or trade and thus provide 
incriminating evidence. Circumstantial evidence of this nature can be crucial to law 
enforcement in combating cocaine trafficking and trade. 
 
Interest has also grown in recent years in gaining information from latent fingerprints 
beyond suspect identification. Additional information in a forensic context, such as 
the use by or recent exposure of an individual to illicit drugs, could provide a greater 
link between a fingerprint and a suspect. As already highlighted in Chapter 1, the 
successful detection of cocaine and other drug compounds in latent fingerprints is 
well-documented using a number of different analytical approaches, particularly for 
prints artificially doped with the compound of interest. Rowell et al. reported the 
detection of isolated patches of cocaine contamination in a fingerprint obtained from 
an individual being treated at a drug addiction centre.34 The non-homogenous pattern 
of cocaine contamination in the print was likely the result of the subject’s fingertip 
coming into contact with the drug prior to the time of sampling, and thereby indicative 
of recent drug exposure. Analytical methods for the detection of these types of 
cocaine residues in latent fingerprints could be used in a forensic context, as their 
presence would provide further evidence of a suspect’s involvement in drug use or 
trade. 
 
The methods used in previous studies for the detection of cocaine on banknotes and 
in latent fingerprints have been described in detail in Chapter 1. As mentioned, 
chromatography techniques coupled with MS are the most commonly used, although 
alternative approaches such as SALDI-TOF-MS and Raman spectroscopy have also 
been reported.34,35 The application of immunological methods of detection is limited 
to only a few studies. Examples of methods include; antibody-functionalised 
magnetic and gold nanoparticles with fluorescent labelling which were successfully 
applied for the detection benzoylecgonine in latent fingerprints,36-38 and the 
application of a strip-based urine immunoassay for the detection of cocaine extracted 
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from banknotes.39 These studies illustrate the potential of immunological methods for 
the detection of cocaine in such complex sample matrices.  
 
From the examples given in the introduction of this chapter, it is clear that 
competitive EIAs offer an attractive alternative to the current methods available for 
the quantitative detection of cocaine in forensic samples such as banknotes and 
latent fingerprints. Assays of this nature offer excellent sensitivity and specificity in a 
simple to use and cost effective manner, making them highly suited for forensic 
analysis without requiring specialised chemicals or advanced instrumentation. 
 
This chapter describes the development of a competitive EIA for the detection of 
cocaine in latent fingerprints and paper currency. The preliminary efficacy of the 
assay was assessed based on the analysis of ten Bank of Scotland (UK) banknotes 
obtained from general circulation, the results of which were compared with a parallel 
analysis performed by LC-MS on the same sample extracts. The competitive EIA 
was also used for the detection of cocaine in ten latent fingerprints obtained from five 
test subjects being treated for the habitual use of drugs, including cocaine, at a 
methadone treatment clinic. The concentrations determined in the extracted 
fingerprint samples were compared with the cocaine concentrations analysed in 
corresponding oral fluid samples by GC-MS. The application of a competitive EIA of 
for the detection of cocaine in forensic samples of this nature has not been 
previously reported.    
 
 
3.2 Results and discussion 
 
3.2.1 Anti-cocaine antibody purification 
Rabbit polyclonal anti-cocaine antibody was purified from neat serum by ammonium 
sulfate precipitation followed by an immunochromatography step performed using 
Protein A spin columns, as described in Chapter 2 (Section 2.1). The amount of 
antibody in the three fractions obtained from the spin columns was determined by 
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measurement of the absorbance at 280 nm. Figure 3.4A shows a typical elution 
profile from one of the columns, where the highest concentration of antibody is found 
in the first two of the eluted fractions. This was consistently the case over the course 
of three separate purifications where six columns were used at a time. 
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Figure 3.4.  Confirmation of the purification of anti-cocaine antibody from serum. Typical 
UV-visible absorption spectra of the three Protein A spin column fractions (i-
iii) are shown in (A). The corresponding SDS PAGE result shows the purified 
antibody (‘Ab’) alongside a molecular weight marker (‘MW’) in (B). The 
heavy and light chains of the antibody are indicated by the top and bottom 
arrows in (B), respectively.  
 
 
Analysis by SDS PAGE of the first two fractions obtained from the spin columns was 
performed in order to identify the presence of purified IgG antibody. A typical result is 
shown alongside the molecular weight marker in Figure 3.4B. As mentioned in 
Chapter 5 (Section 5.2.4), IgG antibody is made up of two fragments, a heavy chain 
and a light chain, which will separate in the presence of SDS, resulting in two 
characteristic bands (at around 20-30 and 50-60 kDa) in an SDS PAGE gel. Two 
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fragments of the correct molecular weights (shown by the arrows in Figure 3.4B) 
were present in the gel, confirming the presence of IgG. The absence of other major 
bands in the gel indicates that the polyclonal antibody is sufficiently purified for 
application in an immunoassay-based method.     
 
 
3.2.2 Competitive EIA method development 
The initial phase of EIA development involved the adsorption of the purified anti-
cocaine antibody onto the solid phase, in this case the polystyrene surface of a 96-
well Nunc Maxisorp microtiter plate. Adsorption occurs via the interaction of the 
carbohydrate moiety on the Fc region of the antibody with hydrophilic binding sites 
on the surface of the plate.40 Previously reported methods have noted that the 
optimum adsorption of antibody occurred at alkaline conditions.41 In order to confirm 
this, a comparison was made between the adsorption of antibody in 100 mM 
carbonate buffer (pH 9.5), and in 10 mM phosphate buffer (PB, pH 7.4). The resulting 
relative concentration of antibody immobilised onto the plate was then estimated 
using cocaine-HRP based detection, as described in Chapter 2 (Section 2.2.5). The 
concentration of cocaine-HRP bound, as indicated by the intensity of the coloured 
product, was considered proportional to the amount of antibody bound to the plate. 
The results shown in Figure 3.5 indicate that a more intense signal, and hence a 
higher concentration of adsorbed antibody was produced by dilution of the antibody 
in the alkaline carbonate buffer rather than PB.  
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Figure 3.5.  The absorbance intensity at 450 nm from cocaine-HRP bound to 
immobilised anti-cocaine antibody; a comparison between antibody 
adsorption buffers. PB represents 10 mM phosphate buffer (pH 7.4), and CB 
represents 100 mM carbonate buffer (pH 9.5). Results were obtained using 
a 1:20 dilution of cocaine-HRP in PBS/BSA. The anti-cocaine antibody was 
immobilised for 18 h as a 1 µg mL-1 solution, and the incubation time after 
addition of the cocaine-HRP was 2 h. Each absorbance value represents the 
mean ± SD of at least four measurements. 
 
 
The optimal dilution factor for the cocaine-HRP was similarly determined based on 
the coloured product produced by the bound enzyme. The cocaine-HRP was 
subjected to a series of dilution factors from 1:20 – 1:160 in PBS/BSA, and applied to 
a micro-titer plate containing anti-cocaine antibody bound at a concentration of 
1 µg mL-1. Wells with BSA bound at 100 ng mL-1 in place of the antibody were used 
as controls. As shown in Figure 3.6, the greatest absorbance intensity signal and 
hence the greatest concentration of bound cocaine-HRP was generated using the 
1:20 dilution factor. However, the control wells also showed that non-specific binding 
of cocaine-HRP occurred at dilution factors of 1:80 and greater (Figure 3.6).  
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Figure 3.6.  The absorbance intensity at 450 nm from cocaine-HRP bound to 
immobilised antibody; the application of cocaine-HRP at different dilution 
factors using wells with BSA bound in place of antibody as negative controls. 
Each absorbance value represents the mean ± SD of at least four 
measurements. 
 
 
Detergents such as Tween-20 are often used in immunoassays as an additional 
blocking agent, alongside proteins such as casein or BSA.42 Tween-20 was in this 
case added to the cocaine-HRP dilution buffer, and its effect on non-specific binding 
evaluated using a similar method to the one described in the previous paragraph. 
Four cocaine standards, at concentrations ranging from 0 – 1000 ng mL-1, were 
initially used to test the response of the assay. These were added to a series of wells 
containing immobilised antibody. Wells containing BSA were used as negative 
controls as described in the previous paragraph. Cocaine-HRP, at the determined 
optimal dilution factor of 1:20 in sample buffer (blocking buffer with 0.05 % v/v 
Tween-20), was then added to each well and the enzyme product measured as 
detailed in Chapter 2 (Section 2.2.5). As shown in Figure 3.7A, dilution of the 
cocaine-HRP to a factor 1:20 in buffer containing Tween-20 resulted in a significant 
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reduction in non-specific binding in wells without antibody. The addition of the four 
cocaine standards also led to a reduced absorbance signal in response to an 
increase in cocaine concentration, as expected for this type of assay. This is 
illustrated by the preliminary standard curve shown in Figure 3.7B, which has the 
beginnings of the characteristic sigmoidal shape of a calibration curve produced by 
this type of competitive assay.3 
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Figure 3.7.  The absorbance intensity at 450 nm produced by cEIA using four cocaine 
standards and cocaine-HRP diluted to 1:20 in blocking buffer containing 
0.05 % v/v Tween-20. In (A), the signal produced by wells containing 
antibody is shown alongside the signal from negative control wells (with BSA 
bound in place of antibody). A preliminary standard curve generated from 
four cocaine standards with concentrations ranging from 0 – 1000 ng mL-1 is 
shown in (B). Each point represents the mean ± SD of at least four 
measurements. 
  
 
Overall, it was established during development of the competitive EIA (cEIA) that the 
optimal conditions for antibody adsorption onto the microtiter plate occurred with 
antibody diluted to 1 µg mL-1 in 100 mM carbonate buffer (pH 9.5). In addition, the 
greatest degree of cocaine-HRP binding was achieved using a dilution factor of 1:20 
for the conjugate. Non-specific binding of the cocaine-HRP to the microtiter plate at 
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this dilution factor was prevented by dilution in sample buffer containing 0.05 % v/v 
Tween-20. All further analyses were performed using these optimised conditions. 
 
 
3.2.3 Calibration, LOD, specificity and precision 
Cocaine standards diluted in buffer were used to generate calibration curves for the 
analysis of cocaine extracted from banknotes and latent fingerprints. A series of 
standard concentrations were initially analysed to determine the linear range of the 
assay. Once this was established, the calibration curve was run alongside two 
extracted banknote samples to ensure that the absorbance signal of the samples fell 
within the range of the curve. The banknote samples used were two Scottish £20 
notes obtained from general circulation and extracted as described in Chapter 2 
(Section 2.2.2). The serial dilution range, from 1:500 and 1:4000, was based on a 
previous experiment which indicated that a sample extract diluted to 1:16 was too 
concentrated to produce a signal. As shown in Figure 3.8, the extracted samples 
were in this case sufficiently diluted to produce a signal, and the signals produced fell 
well within the range of the standard curve. Of the dilution factors applied, it was 
concluded that 1:500 and 1:1000 were sufficient for the generation of an absorbance 
signal which was suitable for the quantitation of cocaine using the standard curve 
concentrations shown in Figure 3.8. The results confirmed the suitability of the assay 
for the detection of cocaine even at ng mL-1 extract concentrations.     
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Figure 3.8.  The absorbance intensity at 450 nm obtained using the cEIA by a series of 
cocaine standard solutions (shown in blue), and from two extracted 
banknote samples (shown in grey and purple, respectively). The two 
banknote samples were diluted from 1:500 to 1:4000, as indicated. N1 and 
N2 are negative controls performed using wells without the anti-cocaine 
primary antibody. Each absorbance value represents the mean ± SD of at 
least four measurements. 
 
 
A further set of standard concentrations ranging from 0.78 to 100.00 ng mL-1, and 
from 0.195 to 25.00 ng mL-1 was used for the analysis of extracts from banknotes 
and latent fingerprints, respectively. Lower concentrations of standards were used for 
the analysis of fingerprint extracts to account for the lower concentrations of cocaine 
present in the samples. Examples of typical calibration curves for the analysis of 
banknotes and fingerprints are shown in Figures 3.9A and 3.10B. The curves were 
linearised by plotting the logarithm of the concentration against the logit of the 
signal,43 calculated as described in Chapter 2 (Section 2.2.4). The linear data 
showed good correlation coefficients (r2 = 0.999) on the logit-log plots using a linear 
regression for both calibration curves (Figures 3.9B and 3.10B).  
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Figure 3.9.  A typical standard curve developed for the analysis of extracted banknote 
samples. (A) The corrected absorbance response (B/B0) is shown as a 
function of cocaine concentration in the range of 0.78 to 100.00 ng mL-1. 
Each point represents the mean ± SD of at least three measurements. The 
corresponding logit-log linear calibration curve is shown in (B). 
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Figure 3.10.  A typical standard curve developed for the analysis of extracts from latent 
fingerprints. (A) The corrected absorbance response (B/B0) is shown as a 
function of cocaine concentration in the range of 0.195 to 25.00 ng mL-1. 
Each point represents the mean ± SD of at least three measurements. The 
corresponding logit-log linear calibration curve is shown in (B). 
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The detection limit of the cEIA was calculated from the average absorbance values 
from six replicate analyses of the blank minus three times the standard deviation of 
the average. The resulting absorbance value was then extrapolated from the log-logit 
standard curve. The minimum detectable concentration of cocaine was determined 
as being 0.162 ng mL-1. This detection limit compares favourably to the 0.95 ng mL-1 
limit reported for the detection of cocaine and metabolites in oral fluid using a 
commercial micro-plate EIA,29 and to the 1.0 ng mL-1 achieved using GC-MS with 
solid phase extraction for the detection of cocaine from banknote samples.44  
 
As discussed in Section 3.1.3, the cross-reactivity of an EIA depends on the 
specificity of the primary antibody, and is therefore manufacturer specific. In this 
study, the cross-reacting species of the primary antibody used were not specified by 
the manufacturer. As the antibody is polyclonal, it was assumed that some degree of 
cross-reactivity would be present. The analytical specificity or cross-reactivity of the 
cEIA was therefore determined for benzoylecgonine (BE), the primary cocaine 
metabolite in urine and an analogue of cocaine. The BE standard was diluted to 
three different concentrations in assay buffer (PB) rather than the recommended 
blank sample matrix, as this was not available for the analysis of banknotes, the 
reasons for which are discussed in more detail in Section 3.2.4.   
 
The relative cross-reactivity was calculated from a cocaine standard curve as 
described in Chapter 2 (Section 2.2.6). The results, expressed in absorbance 
intensity, are shown alongside the corresponding cocaine standards in Figure 3.11. 
Relative to 100 % for the cocaine standards, the cross-reactivity for BE was 71, 63 
and 41 % at 6.25, 25.0 and 100.0 ng mL-1, respectively. This shows that cross-
reactivity is present in the assay, and is particularly high at the low cocaine 
concentrations expected on banknotes and in latent fingerprint samples. Although 
this result may overestimate of the level of cross-reactivity possible in actual 
samples, it nevertheless indicates that the antibody inherently cross-reacts with 
metabolites such as BE, something which should be noted when interpreting the 
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results of the assay. The indication of cross-reactivity also stresses the need for 
confirmation of assay results using a different method of analysis.     
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Figure 3.11.  The cross-reactivity of the cEIA for benzoylecgonine (BE), shown alongside 
the corresponding cocaine standards. Each point represents the mean ± SD 
of four measurements. 
 
 
The precision of the assay was determined based on repeat measurements of 
calibration standard samples prepared in assay buffer (10 mM PB, pH 7.4). 
Standards at three different cocaine concentrations (6.25, 25 and 100 ng mL-1) were 
used. The intra-assay precision was determined using four replicates of each 
standard in a single analysis (n = 4). Inter-assay precision was similarly assessed by 
analysing the same sample, as four repetitions, across three separate tests 
performed on different days over a period of 30 days (n = 12). The results shown in 
Table 3.1 indicate that the developed cEIA shows an acceptable level of precision for 
cocaine quantification, with confidence variables of 1.58-6.54 % and 4.38-6.69 % for 
intra- and inter-assay precision, respectively.  
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Table 3.1. Precision of the cEIA for the quantification of cocaine. 
 
Cocaine (ng mL-1) 
Intra-assay (n = 4)  Inter-assay (n = 12) 
Mean ± SD 
(ng mL-1) CVa (%) 
 Mean ± SD  
(ng mL-1) CVa (%) 
6.25 6.100 ± 0.097 1.58  6.363 ± 0.279 4.38 
25.0 25.119 ± 0.894 3.56  25.849 ± 1.207 4.67 
100.0 98.723 ± 6.456 6.54  98.416 ± 6.587 6.69 
aCV is the coefficient of variation. 
 
 
3.2.4 Analysis of ten UK banknote samples 
UK banknotes comprise of cotton and linen paper.45 As described in Chapter 1, the 
way in which paper currency is handled and transferred means that a number of 
contaminants for example; dust, soil, food particles or cosmetics, can all be found on 
the fibres of a banknote. At a trace level, predominantly caffeine, nicotine, 
paracetamol and other pharmaceutical compounds have been reported on 
banknotes.46 However, drugs such as cocaine and its metabolite benzoylecgonine, 
tetrahydrocannabinol (THC), heroin, amphetamines, and ketamine are also often 
present.33  
 
Typically, cocaine is extracted from banknotes using an organic solvent. For 
chromatographic analyses, this is followed by a form of sample clean-up such as 
centrifugation or filtration.47 Such steps can be avoided with immunochemical 
analysis simply by diluting the sample in buffer prior to analysis.15 Optimising 
immunoassays for pre-diluted samples lessens possible matrix effects by reducing 
the overall concentration of potential interferents in the sample, while maintaining an 
analyte concentration that is within the working range of the assay.  
 
As highlighted in Chapter 1, extracts from banknotes could contain a number of 
potential immunoassay interferents. Consequently, the influence of the ‘matrix effect’ 
on the cEIA was determined. General practise to test matrix effects involves spiking 
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blank sample matrices with an appropriate standard at a known concentration and 
thus determining the accuracy of the results. As the majority of banknotes in general 
circulation are known to be contaminated with cocaine such notes could not be used 
for spiking. Previously uncirculated banknotes were also avoided as they lack the 
appropriate ‘handling and transfer’ contaminants to properly represent the sample 
matrix. Instead, cocaine was extracted from ten UK banknote samples using a 
modified version of the method described by Esteve-Turrillas et al., as detailed in 
Chapter 2 (Section 2.2.2).48 Esteve-Turrillas et al. reported recoveries of 101 ± 2 and 
98 ± 3 % in spiked banknote samples extracted using their method followed by GC-
MS2 analysis.  
 
The extracts from the banknote samples were each subjected to the two dilution 
factors (1:500 and 1:1000), as established in Section 3.2.3, and analysed using the 
cEIA method described in Chapter 2 (Section 2.2.4). The cocaine concentration in 
each sample was estimated using the standard curve, corrected for the dilution factor 
and compared to determine what effect doubling the optimised concentration of raw 
extract would have on the accuracy of the assay. Results showing the change in 
absorbance relative to cocaine concentration in the standard solutions, and the 
absorbance response to the doubled extract concentration are shown in Figures 
3.12A and 3.12B, respectively.  
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Figure 3.12.  (A) The absorbance intensity at 450 nm obtained using the cEIA by a series 
of cocaine standard solutions, and (B) from ten extracted banknote samples. 
The ten banknote samples were diluted to a factor of 1:1000 and 1:500. The 
results from each dilution are shown in the order of lowest extract 
concentration to highest as indicated by the figure legend. Each absorbance 
value represents the mean ± SD of at least four measurements. 
 
 
The absorbance values shown in Figure 3.12A were used to generate the standard 
curve. The absorbance values given in Figure 3.12B were then used to calculate the 
cocaine concentrations from this in Figure 3.12A, the results of which are shown in 
Table 3.2. The average difference in cocaine concentration between the two extract 
dilutions across all of the ten banknote samples was ± 0.810 µg mL-1. The 
differences ranged from ± 0.037 to 1.915 µg mL-1. The variation in concentration 
between the two sample dilutions showed that the matrix does affect the response of 
the assay, although the variation between the two dilutions was minimal and did not 
exceed the standard deviation obtained from the repeat measurements (Table 3.2). 
As described by Wild, a more dilute sample will often yield an improved 
immunoassay response given that the concentration of the analyte is still within the 
detection limits of the assay, as applying the dilution decreases the overall quantity of 
potential interferents present in each sample.3  As shown in Figure 3.12B, an overall 
increase in the absorbance signal was obtained using the more dilute (1:1000) rather 
than the more concentrated (1:500) samples, suggesting that the 1:1000 dilution 
provides a more appropriate matrix for the cEIA. Based on this, the quantitative 
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results obtained using the 1:1000 sample dilution were applied for the parallel 
analysis with LC-MS hereafter.  
 
 
Table 3.2. Results of the quantitative analysis of cocaine extracted from ten UK 
banknote samples undertaken using the cEIA. The average cocaine 
concentrations obtained using two different sample dilutions (1:500 and 
1:1000), and the variation between them are shown. 
 
 
Banknote sample 
 [Cocaine] / µg mL-1 Variation  
[cocaine] / µg mL-1 1:500 dilutiona 1:1000 dilutiona 
1 9.416   ± 1.182 9.322   ± 1.655 0.094 
2 9.232   ± 0.913 7.317   ± 4.233 1.915 
3 17.592 ± 1.294 19.131 ± 1.031 1.539 
4 6.884   ± 0.978 6.921   ± 0.553 0.037 
5 0.742   ± 0.532 0.385   ± 0.025 0.357 
6 0.292   ± 0.143 0.297   ± 0.143 0.005 
7 13.800 ± 5.686 11.945 ± 1.320 1.855 
8 0.656   ± 0.294 0.467   ± 0.107 0.189 
9 17.999 ± 1.567 19.950 ± 1.567 1.951 
10 2.048   ± 0.118 1.893   ± 0.177 0.155 
aEach concentration represents the mean ± SD of at least three measurements. 
 
 
3.2.5 Method comparison with LC-MS 
The results obtained from the cEIA for the banknote extracts were compared with 
those obtained by a conventional LC-MS method. The ten UK banknote samples, 
extracted and analysed as described in the previous section (Section 3.2.4), were 
also analysed by LC-MS using the same cocaine standard as a reference. The LC-
MS analysis was performed by Simon Hudson at HFL Sports Science using the 
method described by Hudson et al..49 Table 3.3 shows the concentration values 
obtained using the cEIA and the LC-MS methods. Using a paired t-test it was 
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determined that the concentrations obtained using the two techniques did not differ 
significantly from one another at P = 0.1.  
 
 
Table 3.3 Results of the quantitative analysis of cocaine extracted from ten UK 
banknote samples undertaken using the cEIAa and LC-MS methods. 
 
Banknote sample cEIA / µg mL-1 LC-MS / µg mL-1 
1 9.322   ± 1.655 4.181 
2 7.317   ± 4.233 10.026 
3 19.131 ± 1.031 13.044 
4 6.921   ± 0.553 4.699 
5 0.385   ± 0.025 0.448 
6 0.297   ± 0.143 0.245 
7 11.945 ± 1.320 8.583 
8 0.467   ± 0.107 0.529 
9 19.950 ± 1.567 13.780 
10 1.893   ± 0.177 2.205 
aEach cEIA value represents the mean ± SD of at least three measurements. 
 
 
A direct comparison of the two sets of quantitative data is shown in Figure 3.13. With 
the exception of two outliers, the linear relationship indicates a high degree of 
similarity between the detection of cocaine using the two methods. A possible 
explanation for the discrepancies in the data are the effect of interferents in the 
sample extract on the assay, particularly as some of the extracts analysed were 
observed as being cloudy and discoloured. However, it was also noted that overall 
the concentrations determined using the cEIA were slightly lower than those detected 
by LC-MS, the opposite of what would be expected if the assay were affected by  
either matrix interference or cross-reactivity.     
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Figure 3.13.  A comparison between the concentrations of cocaine extracted from ten UK 
banknote samples, determined by cEIA and LC-MS. Each cEIA result 
represents the mean ± SD of at least three measurements. 
 
 
BE and other analogous compounds were also detected by the LC-MS in the 
extracted samples (results not shown). BE in particular was detected at 
concentrations similar to cocaine in a number of samples. Despite the inherent cross-
reactivity of the assay for BE indicated by the results in Section 3.2.3, the assay was 
not affected by cross-reactivity when applied to the analysis of cocaine in real 
banknote samples due to the similarity between the results of the assay compared to 
those of the confirmatory LC-MS analysis. Overall, the results show that the 
developed cEIA therefore enables the quantitation of cocaine in complex banknote 
extracts to a degree of sensitivity that is comparable to the current chromatographic-
mass spectrometry technique. 
 
 
3.2.6 Analysis of twelve latent fingerprint samples 
The two main mechanisms by which latent fingerprints can become contaminated by 
cocaine have been discussed in Chapter 1. The first is through contact transfer, 
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known to occur when the fingertip of an individual comes into contact with the 
crystalline drug powder. The crystals of cocaine stick to the sweaty skin of the 
fingertip for a short time, and via the sweat are transferred to surfaces that the skin 
comes into contact with. The second route for contamination of fingerprints is as a 
result of the individual taking the drug itself. When a drug enters the body it is 
transported via the circulation to the liver, where it is metabolised, transported to the 
kidneys and then excreted in the urine. During this process, metabolites can be 
secreted onto the skin surface from the circulation through the action of sweating.50 
Hazarika et al. showed that drug metabolites such as BE were present at a 
detectable level in the fingerprints of cocaine users.37,38 In addition, the use of SALDI-
TOF-MS enabled the detection of EDDP, a major metabolite of methadone, 
alongside its parent drug in the same fingerprint from an individual taking 
methadone.34 As methadone is taken as an oral dose, it was concluded that the 
presence of the parent drug in the fingerprint arises from its secretion from the blood 
in the same manner as for metabolites. The presence of cocaine at a detectable level 
in the sweat of a fingerprint from a known cocaine user has not previously been 
studied. 
 
In this study, two fingerprint samples were taken from five individuals attending a 
methadone treatment clinic, for a total of ten fingerprint samples. Two additional 
fingerprints were obtained from two separate drug-free volunteers (one print per 
volunteer) to serve as negative control samples. The fingerprints were extracted and 
analysed by cEIA as described in Chapter 2 (Sections 2.2.2 and 2.2.4, respectively). 
The absorbance intensity produced by the extracted fingerprint samples are shown in 
Figure 3.14B, alongside the standard curve in Figure 3.14A (developed as outlined in 
Section 3.2.3). The signals produced by the extracted sample fell within range of the 
standard curve, indicating that the sensitivity of the cEIA was suitable for the analysis 
of this type of sample matrix. For the samples positive for cocaine, such as in P2(a) 
and (b), the signal was in the lower range of the calibration curve and therefore 
nearing the detection limit of the assay. This showed that cocaine was present at low 
concentrations but nonetheless detectable levels, as to be expected from low-analyte 
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samples of this nature. The low cocaine concentrations present in the fingerprint 
samples analysed during this study indicate that for detection using the cEIA in a 
forensic setting a suitable cut-off concentration would first need to be established. 
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Figure 3.14.  (A) The absorbance intensity at 450 nm produced using the cEIA by a series 
of cocaine standard solutions, and (B) from twelve extracted latent 
fingerprint samples. The first ten fingerprints, P1-P5, were collected from five 
volunteers at the methadone treatment clinic. The prints were collected two 
at a time as indicated by (a) and (b). P6 and P7 were single prints obtained 
from two separate drug-free individuals as negative controls. Each 
absorbance value represents the mean ± SD of at least three 
measurements. 
 
 
3.2.7 Comparison with GC-MS analysis of corresponding oral fluid 
samples 
As described in Chapter 1, studies have shown a strong correlation between cocaine 
concentration in oral fluid and in plasma, proving oral fluid to be an appropriate 
sample matrix for the detection of drug use.51,52 Due to its rapid elimination, with a 
half-life of only 3 h, the detection of cocaine in oral fluid is a suitable indicator of 
recent drug use close to the time of sampling.53 In this study, oral fluid samples were 
taken from five individuals attending a methadone treatment clinic at the same time 
C 
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as providing the latent fingerprint samples used for the cocaine analysis. The 
fingerprint samples were extracted and analysed using the cEIA method as reported 
in Section 3.2.6. The results were compared with the results of a GC-MS analysis 
performed by LGC Forensics of the corresponding oral fluid samples. 
 
The concentrations of cocaine determined in the oral fluid samples by GC-MS, and 
the extracted fingerprints by cEIA are shown in Figure 3.15A and B, respectively. 
Cocaine was detected in oral fluid samples from three of the five test subjects, with 
the sample from subject P2 containing the highest concentration (19 ng mL-1). This 
corresponds to the highest concentration of cocaine determined using the cEIA in 
both fingerprints from subject P2 at 0.728 and 0.879 ng mL-1 for samples (a) and (b), 
respectively. The oral fluid samples from subjects P1 and P3 also tested positive for 
cocaine. These positive cocaine results correspond to positive fingerprint samples, 
although the relative concentrations are slightly different. The fingerprints from 
subject P4 gave cocaine results where one print was significantly higher than the 
other print. Since the oral fluid results from volunteer P4 were negative, it is possible 
that contamination by contact transfer could account for this result. The fingerprint 
samples P4(a), both prints from P5 and the negative control samples (P6 and P7) did 
not contain cocaine at detectable concentrations based on the sensitivity of the 
assay. 
 
 
 
 
 
 
 111 
 
P1 P2 P3 P4 P5
0
5
10
15
20
A
 
 
[C
o
c
a
in
e
] 
/ 
n
g
 m
L
-1
Oral fluid samples P1
(a
)
P
1(
b)
P
2(
a)
P
2(
b)
P
3(
a)
P
3(
b)
P
4(
a)
P
4(
b)
P
5(
a)
P
5(
b) P
6
P
7
0.0
0.2
0.4
0.6
0.8
1.0
B
 
 
[C
o
c
a
in
e
] 
/ 
n
g
 m
L
-1
Fingerprint samples  
 
Figure 3.15.  (A) Results of a quantitative analysis of cocaine by GC-MS on oral fluid 
samples taken from five individuals (numbered P1 – P5) from a methadone 
clinic, and (B) results of the analysis of cocaine extracted from twelve 
fingerprint samples by cEIA. The first ten fingerprints, P1-P5, correspond to 
the individuals from which oral fluid was also taken. P6 and P7 were single 
prints obtained from two separate drug-free individuals as negative controls. 
Each cEIA value represents the mean ± SD of at least three measurements. 
 
 
As indicated in Figure 3.11 (Section 3.2.3), the cEIA showed a degree of cross-
reactivity for BE, particularly at low analyte concentrations. As mentioned in Section 
3.1.4, the detection of BE has been previously reported in latent fingerprints from 
known cocaine users.37,38 It is important that the potential cross-reactivity of the 
assay be taken into account when interpreting the results for this type of analysis.  
 
The overall trend of the data shows that the cocaine present in the latent fingerprint 
samples as determined by the cEIA reflects that of the oral fluid concentrations, 
particularly as the concentrations detected were similar in both of the fingerprint 
samples from the same subject. The developed cEIA method proved to be readily 
applicable for the analysis of these types of samples, even at cocaine concentrations 
within the fingerprint extract of less than 1 ng mL-1.  As the presence of the drug in 
oral fluid is a recognised indicator of recent cocaine use, the results obtained 
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suggest, for the first time, that the detection of cocaine in the sweat of a latent 
fingerprint can be similarly linked to consumption.   
 
 
3.3 Conclusions 
In this chapter, a non-destructive and sensitive competitive enzyme immunoassay 
(cEIA) has been developed for the detection of low concentrations of cocaine in 
complex forensic samples such as extracts from banknotes and latent fingerprints. 
The assay was developed using a polyclonal anti-cocaine antibody successfully 
purified from serum. The precision and sensitivity achieved by the assay, with a LOD 
of 0.162 ng mL-1, is suitable for the quantitation of cocaine in samples of forensic 
significance, and compares favourably to the detection limits of both a GC-MS-based 
method and a commercial micro-plate EIA.  
 
The quantification of cocaine extracted from ten UK banknote samples was 
performed using the cEIA and validated by parallel LC-MS analysis. A statistically 
significant agreement was found between the results from both methods, indicating 
that the cEIA has the required specificity for the analysis of complex, heavily 
contaminated banknote extracts. Despite showing cross-reactivity for BE during 
specificity testing, the results of the assay were not affected by the presence of BE 
and other potential interferents in the samples. Trace levels of cocaine were detected 
on all ten banknotes sampled using the assay. Although no dataset currently exists 
for the concentrations of cocaine present on UK banknotes, the concentrations 
detected were in agreement with the background levels of cocaine detected on Irish 
Euro banknotes in general circulation.54  
 
The cEIA was similarly applied to the quantification of cocaine extracted from latent 
fingerprints donated by five individuals attending a methadone treatment clinic. The 
results were compared to the cocaine concentrations determined by GC-MS in oral 
fluid samples obtained from the test subjects at the time the fingerprints were taken. 
The overall trend of the data showed, for the first time, that the cocaine detected at 
A 
A 
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similar concentrations in more than one latent fingerprint from the same individual 
could be linked with those in oral fluid, and therefore also be associated with 
consumption.  
 
Overall, the developed cEIA offers a straight forward, cost-effective alternative to 
chromatography-MS techniques for the quantitation of cocaine in forensic samples, 
without the need for specialised instrumentation. The simplicity of the developed 
cEIA provides a method that would be readily applicable for everyday analysis in a 
forensic laboratory. 
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CHAPTER 4 
 
Location-specific immunod  etection  
of cocaine on banknotes 
 
This chapter describes the development of an immunodetection method for the 
immobilisation and subsequent localised staining of cocaine on banknotes using an 
enzyme-labelled anti-cocaine antibody and an acrylamide gel matrix.    
 
 
4.1 Introduction 
 
4.1.1 Methods of immunodetection in biology 
Immunohistochemistry (IHC) was the first technique developed for the 
immunostaining of antigen in a solid, semi-permeable matrix, commonly a cellular 
component within frozen or embedded tissue.1 The principle began with a publication 
by Coons et al. in 1941 reporting the application of a fluorescently-labelled antibody 
for the detection of cellular antigen in frozen tissue sections.2,3 Since then, the 
technique has evolved to overcome initial limitations in sensitivity by the introduction 
of steps to prevent non-specific staining, as well as by the incorporation of different 
detection systems.1,3,4 The successful formation of HRP-labelled antibody by 
Avrameas et al. was particularly important in the development of modern methods of 
IHC, as it enabled the colorimetric localisation of antigen which can be directly 
observed via light microscopy.5,6  
 
Three main steps are involved in the preparation of non-frozen tissue samples for 
IHC staining. In the first of these, preservation of the tissue matrix is commonly 
achieved by treatment with a fixative such as formaldehyde.1  Treatment with 
formaldehyde or a similar cross-linking agent generates the formation of irreversible, 
covalent cross-links by the establishment of methylene bridges between the amide or 
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amine end-groups of proteins in the tissue section.7,8 The cross-links act to maintain 
the structural and antigenic integrity of the tissue, and thereby limit extraction, 
diffusion or displacement of antigen during subsequent processing.8 During the 
fixation process, previously soluble proteins become anchored to structural proteins 
in the tissue and are rendered insoluble; other cellular components such as nucleic 
acids, lipids and carbohydrates are not fixed directly but become entrapped within 
the network of insoluble cross-links.7 A gel-like proteinaceous network is generated 
within the cells of the tissue section, forming a semi-permeable solid phase in which 
location-specific immunostaining can be performed.1 Although the overall purpose of 
fixation is to render the cells in the tissue sample into a condition of stasis that is as 
close to in vivo as possible, it can also improve antibody penetration into the tissue 
section.9 The gel-like, porous nature of the network formed by protein cross-links 
facilitates the entry of antibodies, and the degree of this porosity can be controlled 
via the use of different types of fixatives.9  
 
After fixation, the preserved tissue is dehydrated, embedded, thin-sectioned and 
treated with a blocking agent to prevent endogenous staining prior to 
immunodetection.10 Addition of the primary antibody targeted to the cellular 
component of interest is facilitated by a simple incubation step in a solution of diluted 
antibody or anti-serum.4 During this incubation the antibody diffuses into the tissue 
section and binds to the antigenic material which has been rendered immobile via the 
process of fixation.8 As the antibody molecule cannot be seen using a light 
microscope, a labelling mechanism is required to enable visualisation of the bound 
antibody and thereby the localisation of the target antigen.1 A variety of labels 
ranging from fluorescent compounds to active enzymes have been used for this 
purpose.11 When using active enzymes as a label, it is crucial that the enzyme 
substrate remains situated at the source of the antigen rather than diffusing across 
the specimen. For this reason, the use of specialised enzyme substrates which yield 
a product in the form of a coloured precipitate is common.11 
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Horseradish peroxidase (HRP) is one of the most popular enzyme labels for IHC, 
particularly as its use enables visualisation via a wide range of different colorimetric 
substrates.4,11 HRP can be readily coupled either directly onto the primary antibody, 
or applied indirectly by means of a labelled secondary antibody as described in 
Chapter 3.1.2 for use in ELISA-style immunoassays. Although signal amplification is 
inherently achieved by the activity of the enzyme, the sensitivity of an HRP label can 
be further enhanced by the application of more than one enzyme per antibody, using 
techniques such as enzyme bridging or the peroxidase antiperoxidase (PAP) 
method.1 Substrates such as tetramethyl benzidine (TMB) or diaminobenzidine 
(DAB), which yield a blue or brown precipitate in the presence of the enzyme 
respectively, are commonly used.4 
 
IHC of cellular antigens performed on cultured cells, also known as 
immunocytochemistry (ICC), is based on the same methodology as that used for the 
immunostaining of tissue specimens.1 Only the medium in which the staining occurs 
differs between the two techniques. In 2D and 3D cell culture, cells are grown either 
as a monolayer or as a 3D network within a cross-linked, gel-like matrix designed to 
mimic interstitial tissue structures as closely as possible.12 Polymer networks capable 
of absorbing many times their weight in water, known as hydrogels, are commonly 
used as matrices for this type of cell culture.13 The swelling characteristic of 
hydrogels renders them semi-permeable, in that free water molecules can move 
within the matrix.13 This in turn allows cells to be mobile within the matrix in a manner 
that more closely resembles their behaviour in vivo than if the cells are grown as a 
monolayer.12,14 In addition to being biocompatible, hydrogels are inexpensive, non-
toxic and can densify over several orders of magnitude with only modest increases in 
concentration.15 Both natural and synthetic hydrogels have been successfully applied 
for cell culture applications.12   
 
Preparation of 2D or 3D cell cultures for immunostaining is performed in a similar 
manner as for the immunostaining of tissue specimens. The cytological specimen is 
first treated with a fixative such as PFA, followed by the application of a blocking 
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agent and subsequent immunostaining in the same manner as for the IHC detection 
in tissue specimens.16,17 The cells remain within the culture matrix throughout this 
process, and particularly for natural hydrogels this can lead to the cross-linking of 
protein or polymers in both the intra- and extracellular environment.18 However, as 
shown by the successful immunostaining of cellular antigen reported by Ma et al. and 
O’Conner et al. within natural hydrogel matrices fixed with PFA, the degree of 
polymerisation of the hydrogel matrix does not prevent antibodies from permeating 
the gel.16,17      
 
In addition to 3D cell culture matrices, unfixed hydrogels are also known to be 
permeable to antibodies. Prior to the advent of enzyme immunoassays, gels such as 
agar-agar, agarose, gelatin and polyacrylamide were used to visualise antibody-
antigen interaction.19,20 Known as gel diffusion analysis, the technique was first 
described by Oudin in 1946 who reported that the addition of an antiserum to an 
antigen-containing agar gel resulted in the formation of discrete lines of precipitate.21 
The method was furthered by Ouchterlony who developed a two-dimensional or 
‘double-diffusion’ version by showing that antigen and antibody in adjacent wells 
within a thin agar gel would diffuse towards one another in the medium, resulting in 
thin lines of immune precipitate where the reactants meet.22 Although the method of 
Ouchterlony double immunodiffusion was initially developed using agar, this gel 
medium has a strong negative charge and has therefore more recently been 
replaced by agarose gels, which possess little charge and therefore minimise gel-
reactant interaction.23 The technique illustrates the permeability of the 
aforementioned gel matrices to antibodies, and indicates their suitability as a matrix 
for immunodetection.         
 
 
4.1.2 Types of hydrogels used in this study 
As described in Section 4.1.1, agarose gels are commonly used for the analysis of 
antibody-antigen interaction by Ouchterlony immunodiffusion and have therefore 
been shown to be permeable to antibodies. Agarose is a galactopyranose-based 
 121 
 
linear polysaccharide purified from agar.24 Gelation of a homogeneous agarose 
solution occurs according to a coil-helix transition that takes place when the gel is 
cooled from 99 °C to a temperature below the ordering temperature, which is 
typically around 35 °C for normal agarose.15 The gel is formed when an infinite three-
dimensional network of bundled helical fibres of agarose connected by flexible chains 
develops, the process of which is shown in Figure 4.1.25,26 The pore size between 
these fibres varies from 100 – 300 nm and is inversely proportional to the 
concentration of agarose used to make the gel.27,28 Agarose gels have been used as 
a matrix for 3D cell culture and subjected to immunostaining as described for IHC 
specimens in Section 4.1.1. Wester et al., for example, transferred fibroblasts 
originally cultured in a monolayer into a matrix of 6 % w/v agarose prior to IHC 
processing.29 The resulting ‘cell-gels’ were successfully applied as control samples 
for the staining of tissue sections, showing homogeneous immunostaining of cells 
even in slices of different thicknesses.29   
 
 
 
 
Figure 4.1.  The gel structure of agarose.26  
 
Collagen and gelatin are naturally derived hydrogels which, like agarose, are popular 
as matrices for 2D and 3D cell culture.30 Collagen is a structural protein of a helical 
conformation made up of three polypeptide strands. These helices in turn aggregate 
to form elongated fibrils, the arrangement of which gives the collagen its unique 
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strengthening properties.31 Collagen is naturally present in abundance in almost all 
connective tissues in mammals including tendons, ligaments and skin. Insoluble 
collagen fibrils make up the greater part of the extracellular matrix (ECM), a 
proteinaceous network designed to arrange and provide mechanical support to cells, 
thereby maintaining tissue strength and structure.16,32 Due to their mechanical 
strength, ease of gelation and abundance in mammalian tissue, collagen hydrogels 
are now extensively used as scaffolds for the encapsulation of cells in culture.15,17 
The gelation of collagen occurs at physiological pH and temperature, and begins with 
the entropy-driven aggregation of triple-helical collagen monomers.31 The resulting 
small aggregates self-assemble into thin filaments, which in turn cross-link into larger 
collagen fibres.32 Non-covalent entanglement of these fibres yields the irregular 
three-dimensional matrix which makes up the gel, as illustrated in Figure 4.2.15 
Collagen gels exhibit large pore sizes, between 5 and 10 µM, the size of which can 
be fine-tuned via modest changes in temperature, pH, ionic strength and collagen 
concentration.30 The inherent porosity of collagen gels readily facilitates the staining 
of antigenic material in 3D cell cultures by way of immunodetection. Indeed, the use 
of ICC as a method of detection is well-described for cells embedded in collagen gel 
matrices,16,17,33 as well as for mixed gel matrices made up of collagen in combination 
with another hydrogel such as agarose.15,34  
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Figure 4.2.  The gel structures of collagen and gelatin.35,36  
 
The irreversible hydrolysis of collagen, via thermal denaturation or chemical 
degradation, breaks down its triple helical structure to give a heterogeneous mixture 
of single or multi-stranded polypeptides known as gelatin.37 An aqueous solution of 
gelatin will enter the sol state at around 40 °C and forms a thermoreversible gel upon 
cooling.38 During gelation the peptide strands in gelatin undergo coil-helix transition 
followed by aggregation of the helices, leading to the reformation of a collagen-like 
triple-helical structure.37 The formation and gelation of gelatin is shown alongside that 
of collagen in Figure 4.2. Like collagen, gelatin hydrogels are of biological origin and 
therefore popular for use in cell culture matrices, often in combination with other 
strengthening materials such as chitosan and PEG.39,40 Its application as a cell 
culture matrix followed by ICC staining has also been reported.41 In addition, gelatin 
hydrogels and films are widely used in the biomedical, pharmaceutical, and food 
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industries for applications ranging from tissue engineering, through to the formation 
of drug capsules and as a sealant for preserving food.38,42,43  
 
Casein hydrogels are, like gelatin, a mainstay of the food industry. They are 
commonly used as sealants for the preservation of moisture or gas-sensitive food 
products such as fresh produce.44,45 Caseins are phosphoproteins principally found in 
cow’s milk, where they are present in clustered formations, known as micelles, for 
the binding of calcium and phosphorous.46 Caseins are readily purified from milk via 
a number of different methods, the most common of which involves acid precipitation 
which produces caseins as an insoluble solid.47 The gelation of casein in an aqueous 
solution occurs via the formation of covalent protein cross-linkages, which yields a 
network of linear and globular aggregates.46 Polymerisation of caseins can be 
induced by increases in temperature or pH, or by the introduction of an enzyme such 
as transglutaminase.44,47,48 This well-described gelation process has traditionally 
been harnessed for the production of dairy products such as cheese and yoghurt, as 
well as for application in casein-based paints and natural adhesives.47 More recently, 
the various advantages of casein hydrogels, including biocompatibility and non-
toxicity, has led to increased interest in their use for biomedical applications such as 
drug delivery vehicles and soft tissue adhesives.49    
 
Acrylamide gels are synthetic hydrogels which are widely used in biological research 
for the size-dependent separation of macromolecules, including whole proteins, 
protein fragments or nucleic acids, by gel electrophoresis.50,51 Formation of the gel 
occurs via the polymerisation of acrylamide into long chains, which in turn are 
covalently cross-linked by a bifunctional compound such as bis-acrylamide to form a 
porous meshwork the structure of which is shown in Figure 4.3.52 Polymerisation is 
initiated by the addition of ammonium persulfate (APS), from which 
tetramethylethylenediamine (TEMED) catalyses the formation of free radicals to 
facilitate and accelerate polymerisation.52 The rate of polymerisation therefore 
depends on the concentrations of APS and TEMED used, as well as temperature, pH 
and the absence of oxygen, which acts as an inhibitor.52 The strength and 
 125 
 
permeability of the gel can be controlled by adjusting the total acrylamide 
concentration and weight percentage of the bis-acrylamide cross-linker, each of 
which is inversely proportional to the effective pore size of the gel.51,53  
 
 
 
Figure 4.3.  The structure of acrylamide, bis-acrylamide and polyacrylamide gel.52    
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The immunodetection of antigenic proteins in acrylamide gels is most commonly 
performed via indirect methods such as western blotting, where proteins within the 
gel are first transferred to a membrane prior to immunostaining. The direct 
immunoprobing of material within the gel has historically been avoided due to the 
common belief that acrylamide gels are impermeable to large proteins such as 
antibodies.54 However, the limitations of western blotting led to the development of a 
method for the in-gel immunodetection of antigenic material, first reported by 
Burridge and Olden and Yamada following separation by SDS polyacrylamide gel 
electrophoresis.50,55 The technique involves fixation of the protein fragments within 
the gel and simultaneously removing the SDS via an incubation step in trichloroacetic 
acid or isopropanol with acetic acid.50 It is thought that the action of the fixative may 
also act to improve the permeability of the gel to antibodies.50,54 Immunodetection is 
then facilitated by the direct incubation of the gel containing the antigenic material in 
solutions of primary and then HRP-labelled secondary antibody.50 Since its inception, 
in-gel immunodetection has been adapted to include different visualisation 
techniques such as radioactive and fluorescent labelling, and has been applied for 
the detection of several different cellular antigens.56,57 Due to the time involved in 
performing the analysis, several days in total, western blotting has remained the 
more widely used method for immunodetection in acrylamide gels. However, a recent 
improvement of the in-gel immunodetection method by Desai et al., involving a short 
incubation step in 50 % isopropanol in water in place of the previously complicated 
fixation process, now enables results to be obtained within hours rather than days, 
significantly improving its practicality.54   
 
 
4.1.3 Aim of the research presented in this chapter 
The presence of background levels of cocaine on paper currency in general 
circulation is known. As described in Chapters 1 and 3.1.4, it is of forensic relevance 
to establish the concentrations of cocaine present on individual banknotes, as this 
may enable banknotes to be linked to direct avenues of contamination through 
criminal activities. At present, the analysis of cocaine on banknotes performed by law 
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enforcement agencies in the UK is focussed on the use of ion-mobility spectrometry 
(IMS) as a means of quantification. The method involves taking a representative 
sample of cocaine along two strips on the side of the sample note by vacuum 
sampling as detailed in Chapter 1.58 Recently, concerns have been raised that the 
area sampled may not provide an adequate representation of the cocaine 
concentration present on the note in its entirety. For example, the primary location of 
cocaine on banknotes could be around the edges of the note rather than spread 
uniformly across it, in which case the cocaine present would be greater than 
indicated using the present method of sampling. An analytical method which enables 
the areas on banknotes where cocaine contamination most frequently occurs is 
therefore necessary to affirm the authenticity of the results obtained using the current 
means of analysis. It is of interest that the analytical method is developed to enable 
both the presence and location of the cocaine on banknotes to be determined.  
 
As described in Section 4.1.1, biological methods of immunodetection such as IHC 
and ICC enable the location-specific detection of cellular antigens in specimens such 
as fixed tissue sections. Immunodetection of this nature is useful for biologists as it 
enables the context of the antigenic material to be established in relation to other 
structural components in the sample. The specific and sensitive nature of 
immunological detection methods facilitated by the antigen recognition ability of 
antibodies makes them highly suited for the detection of molecules at low 
concentrations in complex sample matrices, as discussed in Chapter 3.1.1. The 
successful quantitative immunodetection of cocaine extracted from banknotes using 
a plate-based enzyme immunoassay was reported in Chapter 3. As discussed in 
Chapter 3.3, this study proved the efficacy of an antibody-based method for the 
detection of cocaine at the low concentrations present on banknotes, and in the 
presence of possible interferents present in the sample matrix.  
 
The present chapter describes the development of a novel immunostaining method 
for the location-specific detection of cocaine on the surface of banknotes, based on 
the use of techniques previously applied to biological samples for the visualisation of 
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cellular antigens. The application of IHC methods for the detection of antigenic 
material has been previously described by Miller et al., who reported the successful 
immunostaining of brain cells on cotton fabric using IHC-based methodology.59 The 
stability of cocaine in a proteinaceous tissue network formed by fixation using 
formaldehyde has also been studied by Viel et al. and Cingolani et al., who 
separately report the successful extraction of cocaine and benzoylecgonine from liver 
specimens up to seven days after fixation, indicating the suitability of a cross-linked 
hydrogel matrix for cocaine detection.60,61 In this study, cocaine was affixed onto the 
surface of the banknote via the application of a hydrogel matrix in a similar manner 
as for the ICC-based detection of antigenic materials within a 3D cell culture matrix. 
Different hydrogels of varying properties, as detailed in Section 4.1, were compared 
in terms of strength, stability and permeability to antibody to determine the most 
effective type of matrix for this purpose.  
 
Immunostaining of the immobilised cocaine on the banknote surface was 
subsequently performed using an anti-cocaine primary antibody, either pre-labelled 
with HRP or in conjunction with an HRP-labelled secondary antibody. Visualisation 
was enabled by the application of a chemiluminescent substrate, producing a 
luminescent signal on the areas of the banknote in which cocaine was present. As 
detailed in Chapter 1, UK banknotes are printed on paper consisting of a mixture of 
cotton and linen, with cotton being the major constituent. In the first instance, paper 
made from 100 % cotton was therefore used as a representation of a banknote. 
Cotton paper without cocaine added, and cotton paper spiked with a cocaine 
standard were used as negative and positive representative samples respectively 
throughout the study.  
 
The developed method was applied for the detection of cocaine firstly on partial 
banknote samples spiked with cocaine standard. Whole banknote samples obtained 
from general circulation were then analysed alongside whole banknote samples on 
which half of the note had been spiked with ‘street’ cocaine. Newly minted banknotes 
with or without cocaine were used as positive and negative controls, respectively. 
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The results obtained, for the first time, demonstrate the successful location-specific 
immunostaining of cocaine on banknotes within an acrylamide hydrogel matrix.  
 
 
4.2 Results and discussion 
 
4.2.2 A comparison of gel matrices for cocaine immobilisation 
Hydrogel matrices were investigated in this study as a potential means of affixing 
cocaine onto the surface of banknotes. The application of a matrix was required to 
prevent the movement or diffusion of cocaine during subsequent immunostaining. 
The properties of hydrogels, including their mechanical strength, biocompatibility, 
large pore size and high level of transparency make them highly suited for 
immunostaining-based applications. This is illustrated by their frequent use as 2D 
and 3D cell culture matrices for ICC staining. The properties of the different types of 
gel matrices of biological origin used in this study, namely agarose, casein, collagen, 
and gelatin, are described in detail in Section 4.1.2. Hydrogels made from natural 
polymers were primarily selected over synthetic polymers for this study as they are 
readily available, cost-effective, non-toxic, biodegradable and easily manipulated. 
Synthesis of the different gel types was performed as described in Chapter 2.3.1 
(Table 2.3).  
 
The gels were compared in terms of mechanical strength and adhesive properties 
based on the observed level of binding to cotton paper as a representation of a 
banknote. The strength of the gel was based on consistency; high was defined as a 
solid gel which retained its shape when light pressure was applied, medium as a 
semi-solid gel which yielded to pressure and low as a gel which was too weak to 
maintain its structure. The adhesion of the gel was similarly based on the level of 
adherence to the cotton paper; high was well attached even after incubation in buffer, 
medium was initially attached but adherence did not last for the duration of the buffer 
incubation, and low was not attached. The permeability of the gels to antibody was 
then determined using a gel column as described in Chapter 2.3.1.  
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The results of the hydrogel comparison are summarised in Table 4.1 in terms of the 
mechanical strength, level of adhesion and permeability of each gel type. As shown, 
the mechanical strength of both the collagen and casein gels was insufficient to 
properly adhere to the cotton paper, thereby rendering them ineffective as a matrix 
for immunostaining. Agarose and gelatin conversely provided the greatest degree of 
mechanical strength and proved sufficiently able to adhere to the paper. However, 
both the agarose and the gelatin hydrogels proved impermeable to antibodies when 
prepared using the concentrations of polymer required for a stable barrier around the 
paper. For this reason, synthetic polymers were selected in favour of biologically 
derived hydrogels as a possible matrix for the immobilisation of cocaine.  
 
 
Table 4.1.  A summary of the different types of hydrogel matrices compared in this 
study; the results are summarised in terms of mechanical strength, adhesive 
properties and permeability to antibodies.   
 
 
Medium Content Strength Adhesion  Permeability 
Gelatin 3, 5 and 7 % w/v Medium High Impermeable 
Cross-linked Gelatin 7 % w/v High High Impermeable 
Casein 7 % w/v Low Low Permeable 
Collagen 1.0 mg mL-1 Low Low Permeable 
Cross-linked Collagen 1.8 mg mL-1 Medium Low Permeable 
Agarose and LMP Agarose 0.2 % w/v Medium Low Permeable 
LMP† Agarose 0.5 and 1.0 % w/v High Medium Impermeable 
*PFA = paraformaldehyde and †LMP = low melting point. 
 
 
4.2.3 In-gel immunodetection method development for     
polyacrylamide gels using rabbit anti-cocaine antibody 
Acrylamide gels, commonly used for the separation of biomolecules by gel 
electrophoresis, were chosen as a potential alternative to a natural hydrogel as a 
matrix for the immobilisation of cocaine on banknotes. The properties of 
polyacrylamide gels and their previous application for in-gel immunostaining is 
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described in Section 4.1.2. As the mechanical strength of covalently cross-linked 
acrylamide gels is known, the permeability of the gels to antibody after treatment with 
50 % isopropanol in water was first investigated. The immunostaining of acrylamide 
gels was performed using the method of Desai et al. following separation by non-
denaturing PAGE as described in Chapter 2.3.2.54 The gels were run with a sample 
of cocaine-BSA hapten applied as the antigenic target, a BSA sample as the 
negative control and a sample of anti-cocaine primary antibody as a positive control 
of secondary antibody binding. Immunostaining was performed as detailed in 
Chapter 2.3.2 (Table 2.5). The 3,3'-diaminobenzidine (DAB) enzyme substrate that 
was used forms a visible red-brown precipitate within a gel when HRP is present. 
The results of the in-gel immunodetection are shown in Figure 4.5. The results 
obtained from the initial immunostaining of 10 % w/v PAGE gels, prepared as 
described in Chapter 2.3.2 (Table 2.4, experiments 1 and 2), are shown in Figure 
4.5B and C. A gel containing the equivalent set of standards and samples was also 
separated by non-denaturing PAGE but stained for all protein using Coomassie 
brilliant blue R250 rather than immunostaining; the results are shown in Figure 4.5A.  
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Figure 4.5.  The in-gel immunodetection of cocaine-BSA in a 0.75 mm thick, 10 % w/v 
acrylamide PAGE gel stained using DAB as an enzyme substrate. The total 
protein in the gel, stained by Coomassie brilliant blue R250, is shown in (A). 
The corresponding immunostained gels treated with a 5 % and a 1 % w/v 
BSA antibody diluent buffer are shown in (B) and (C), respectively. After the 
molecular weight marker (MW), the samples in each gel are labelled as 
follows; (1) BSA, (2) cocaine-BSA and (3) anti-cocaine primary antibody. All 
samples were pre-diluted to 1 mg mL-1 in PB prior to analysis. 
 
 
Overall, the results in Figure 4.5 show that the immunodetection procedure had not 
been successful when applied to 10 % w/v acrylamide PAGE gels. Anti-cocaine 
primary antibody, applied to lane 3 of the gels shown in Figure 4.5, was included in 
the analysis as a positive control which should always be stained after application of 
the HRP-labelled secondary antibody. It was therefore expected that brown-red 
staining would be present in lane 3 of the immunostained gels (Figure 4.5B and C) at 
the same position as the protein-stained band in lane 3 of Figure 4.5A. As this was 
not the case, the results suggest that the secondary antibody was not penetrating the 
gels to facilitate staining; this may have been caused by too high a concentration of 
BSA in the blocking buffer, or by a too high concentration of acrylamide used to 
prepare the gels. In order to determine if the blocking buffer was preventing specific 
binding of the secondary antibody, blocking buffer containing two concentrations of 
BSA (5 % or 1 % w/v) were compared on identical 10 % w/v acrylamide gels. The 
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results are shown in Figure 4.5B and C for 5 % or 1 % w/v BSA blocking buffer, 
respectively. As shown in Figure 4.5C, no specific staining was observed as a result 
of the reduced BSA blocking buffer, indicating that it was likely the concentration of 
acrylamide in the gel was preventing immunodetection rather than the blocking 
buffer.  
 
As detailed in Section 4.1.2, the concentration of acrylamide in a gel is inversely 
proportional to its effective pore size.51 The effect of decreasing the concentration of 
polyacrylamide in the gels as a means of enabling specific immunostaining was 
therefore investigated based on the results described in the previous paragraph. 
Gels with acrylamide concentrations of 7.5 % w/v and 5 % w/v were prepared as 
described in Chapter 2.3.2 (Table 2.4), and immunostained using the conditions 
defined in Table 2.5 (experiments 4 and 5). A sample containing HRP-labelled 
secondary antibody was run as a substrate control together with the other control 
samples included in the 10 % w/v gel. A molecular weight marker was not included, 
as the location of the bands was determined based on their position in the identical 
but protein stained gel rather than respective to the molecular weight standards.  
 
As shown in lane 4 of Figure 4.6, staining in the lane containing the secondary 
antibody substrate control showed that the substrate was generating a good level of 
staining. Otherwise, no specific staining was observed in either of the gels with lower 
acrylamide concentrations including in the lane containing the primary antibody, 
where it was expected that staining would occur as a result of binding of the HRP 
labelled antibody. Based on the results obtained, it was thought that the DAB 
enzyme substrate used may not provide the level of sensitivity required to enable 
visualisation of the cocaine at the low concentrations likely to be present on 
banknotes. It was also noted that the 5 % w/v gel was prone to frequent tearing, and 
at times proved too fragile to remain wholly intact throughout the immunostaining 
procedure (results not shown). 
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Figure 4.6.  The in-gel immunodetection of cocaine-BSA in 0.75 mm thick, 5 % w/v and 
7.5 % w/v acrylamide PAGE gels stained using DAB as an enzyme 
substrate are shown in (A) and (B), respectively. The samples in each gel 
are labelled as follows; (1) BSA, (2) cocaine-BSA, (3) anti-cocaine primary 
antibody and (4) HRP-labelled secondary antibody. All samples were pre-
diluted to 1 mg mL-1 in PB prior to analysis.  
 
 
Enhanced chemiluminescent (ECL) substrates are commonly applied for the 
detection of antigenic material in immunoblotting procedures, such as western blots, 
as an alternative to colorimetric staining.62 Chemiluminescence can be simply 
defined as a term describing chemical reactions which emit light.63 Reactions of this 
type require compounds which exhibit chemiluminescence, such as luminol and its 
derivatives.63 The oxidation of luminol in solution produces a dianion intermediate, 
the decomposition of which leads to the production of an excited state and the 
emission of light in the region of 425 nm.63 This reaction can be catalysed by HRP in 
the presence of hydrogen peroxide, the rate of which in turn can be improved up to 
1000-fold by the addition of an enhancer such as p-iodophenol (PIP).64 ECL 
reactions of this type provide more prolonged, intense and stable light emission, and 
are therefore preferentially used for the immunostaining of biomolecules present at 
low concentrations.64 An ECL substrate was therefore applied instead of DAB for in-
gel immunodetection in the next set of experiments, to determine whether the 
increased level of sensitivity offered by this type of HRP substrate would facilitate 
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visualisation of cocaine-BSA within the gels. The presence of the luminescent 
staining of the gel was facilitated using a cooled-CCD camera as part of the Fujifilm 
LAS-3000 imaging system, which converts photons into digital signals. The resulting 
gel image shows a negative version of the stained gel, in which the luminescent 
signal produced by the presence of HRP is converted into ‘staining’ of a grey or black 
appearance on a white background.  
 
Electrophoresis of a 7.5 % w/v polyacrylamide gel was performed with the same set 
of samples analysed by 5 % w/v and 7.5 % w/v gels. Immunostaining of the 5 % w/v 
and 7.5 % w/v gels was performed as described in Table 2.5 of Chapter 2.3.2 
(experiments 7 and 8). The results of the analysis are shown in Figure 4.7. The gel 
shown in Figure 4.7A was stained for protein using Coomassie brilliant blue R250 
and run using the same method as for the immunostained gels. The results showed 
that the increased sensitivity offered by the ECL substrate led to the increased 
specific staining in both gels shown in Figure 4.7B and C, particularly in lane 4 where 
a bright band of staining was observed at the same location where HRP-labelled 
secondary antibody was shown to be present by the protein-stained band in Figure 
4.7A. The anti-cocaine antibody was included in lane 3 as a positive control in all of 
the gels shown in Figure 4.7. Staining was expected to occur in lane 3 of the 
immunostained gels (Figure 4.7B and C) at the same position as the protein stained 
band visible at the top of lane 3 in Figure 4.7A, as a result of interaction between the 
primary antibody in the gel and the secondary antibody applied to the gel during 
staining. This staining can be seen to be present in both Figure 4.7B and C, and is 
indicated by the dark grey coloration present in Lane 3 which is not observed in the 
BSA negative control lane (lane 1) of either gel.  
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Figure 4.7.  The in-gel immunodetection of cocaine-BSA in a 0.75 mm thick, 7.5 % w/v 
acrylamide PAGE gel stained with an ECL enzyme substrate. The total 
protein in the gel, stained by Coomassie brilliant blue R250, is shown in (A). 
Immunostaining was performed on two gels identical to the one shown in (A) 
using two different types of buffer (PBS and TBS); the results of the gels 
analysed using PBS and TBS are shown in (B) and (C), respectively. An 
exposure time of 3.5 min was used for both gels. The samples in each gel 
are labelled as follows; (1) BSA, (2) cocaine-BSA, (3) anti-cocaine primary 
antibody and (4) HRP-labelled secondary antibody. All samples were pre-
diluted to 1 mg mL-1 in PB prior to analysis. The possible immunostaining of 
cocaine-BSA is indicated by the white arrow in lane 2 of (C). 
 
 
As described by Miller, the efficacy of both primary and secondary antibody binding 
can depend on the type of buffer (PBS or TBS) used during immunostaining, the 
preference of which can vary between different types of antibodies.65 A comparison 
was therefore made between immunostaining performed using PBS and TBS as the 
antibody diluent and wash buffers using the same protocol in order to optimise 
antibody binding. The resulting PBS and TBS-treated gels are shown in Figure 4.7B 
and C, respectively. Improved staining was observed in Figure 4.7C, as indicated by 
the darker staining in the anti-cocaine primary antibody control lane (lane 3) of Figure 
4.7C compared to the lighter staining in Figure 4.7B. This showed that 
immunodetection performed using TBS buffers led to improved interaction between 
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the primary and secondary antibody, thereby resulting in improved staining in the gel. 
TBS buffer was therefore applied for all of the in-gel immunostaining performed 
hereafter. Positive immunostaining of cocaine-BSA, present in lane 2, was not 
observed in the gel treated with PBS buffers (Figure 4.7B). However, a small band of 
staining present at the base of the sample well in lane 2 (indicated by the white arrow 
in Figure 4.7C), which was not present in lane 1 containing BSA as a negative 
control, may have resulted from the detection of cocaine in this area. This presence 
of protein at this location in lane 2 of the gel stained for protein (Figure 4.7A) 
increased the likelihood of the staining being indicative of the location of the cocaine-
BSA conjugate in the gel, although these results alone were not considered 
conclusive.    
 
 
4.2.4 In-gel immunodetection of cocaine on spiked cotton paper and 
partial banknote samples using rabbit anti-cocaine antibody 
The developed in-gel immunodetection method, applied using the optimised 
conditions described in Section 4.2.3, was used for the detection of cocaine standard 
on 100 % cotton paper samples as a representation of a banknote matrix. Spiking of 
the cotton paper samples with a solution of cocaine standard as well as cocaine-
BSA, a BSA negative control, and primary and secondary antibody positive controls 
was performed as described in Chapter 2.3.5. The paper was spiked by applying 
2 µL of each solution to each side of the paper sample in the grid pattern shown 
below in the images of Figure 4.8. The circles indicate the exact location of the 
spiked solutions within the grid. In-gel immunodetection was performed using a 1:25 
dilution of rabbit anti-cocaine antibody as described in Chapter 2.3.6.  
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Figure 4.8.  The immunostaining of a spiked cotton paper sample within a 1.5 mm thick, 
7.5 % w/v acrylamide gel. (A) and (B) show each side of the paper. Standard 
and control samples for spiking were applied to both sides of the paper 
using the grid layout shown; each circle indicates the exact location of the 
spiked substance within the grid. The stained areas on the gel are indicated 
by black shading in the diagram. The solutions for spiking were as follows; 
(1) BSA, (2) cocaine-BSA, (3) anti-cocaine primary antibody, (4) cocaine 
standard (1 mg mL-1 in MeOH) and (5) HRP-labelled secondary antibody. All 
samples, except the cocaine standard, were pre-diluted to 1 mg mL-1 in PB 
prior to applications. Imaging was performed using an exposure time of 
5 min.  
 
 
Both sides of a typical gel after immunostaining are shown in Figure 4.8. The 
presence of HRP-labelled secondary antibody is indicated by areas of dark 
(black/grey) staining within the gel. HRP-labelled secondary antibody, applied directly 
onto the surface of the paper as a staining control in grid 5, was indicated by the 
presence of dark staining around and underneath the circled area. The staining for 
this control appeared to migrate or ‘bleed’ away from the spiking location, indicating 
the possible movement of the secondary antibody within the gel. This was expected 
based on the solubility of the protein in the aqueous gel solution immediately after 
application and before the gel had set. The observed pattern of staining could not be 
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attributed to the location of spiked cocaine or cocaine-BSA on the surface of the 
cotton paper, therefore indicating that immunostaining of cocaine had in this case not 
been successful. 
 
In-gel immunodetection was performed on partial banknote samples in the same way 
as previously applied for the staining of the cotton paper sample shown in Figure 4.8. 
The partial banknote sample in Figure 4.9A was spiked with a higher volume of 
cocaine standard and cocaine-BSA (5 µL for each) than the 2 µL volume used in the 
previous experiment. The spiking volume was further increased to 10 µL for the 
partial banknote shown in Figure 4.9B. In-gel immunodetection was performed using 
a 1:25 dilution of rabbit anti-cocaine antibody as described in Chapter 2.3.6 for both 
samples. A similar result was obtained for the partial banknote shown in Figure 4.9A 
as for that of the cotton paper sample shown in Figure 4.8, with the greatest intensity 
of staining occurring in grid 5 around the region of the note spiked with the HRP-
labelled secondary antibody staining control. The migration or ‘bleeding’ of the stain, 
noted previously on the cotton paper sample, was once again evident. No further 
localised staining was observed, indicating the immunodetection of cocaine was 
unsuccessful.  
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Figure 4.9.  The results of the immunostaining of two parts of a £5 banknote sample 
obtained from general circulation within 1.5 mm thick, 7.5 % w/v acrylamide 
gels are shown in (A) and (B). Standard and control samples for spiking 
were applied to the notes using the grid layouts shown; the circle indicates 
the exact location of the spiked substance within the grid. The stained areas 
on the gel are indicated by black shading in the diagram. The solutions for 
spiking were as follows; (1) BSA, (2) anti-cocaine primary antibody, (3) 
cocaine-BSA, (4) cocaine standard (1 mg mL-1 in MeOH) and (5) HRP-
labelled secondary antibody in (A), and (1) BSA, (2) cocaine standard 
(1 mg mL-1 in MeOH) and (3) anti-cocaine primary antibody in (B). All 
samples, except the cocaine standard, were pre-diluted to 1 mg mL-1 in PB 
prior to applications. The images were obtained using 2 and 3 min exposure 
times for (A) and (B), respectively. The contrast of (A) was adjusted by +1.  
 
 
The application of an increased volume of cocaine-BSA and cocaine standard onto 
the partial note shown in Figure 4.9B was used to increase the antigenic 
concentration on the sample in the next experiment, and thereby improving the 
chance of successful immunostaining. Both the primary antibody and secondary 
antibody controls were omitted from this sample so as not to detract from any 
cocaine-specific staining. As shown in Figure 4.9B, a region of white staining was 
observed around the circled areas in grids 2 and 3 spiked with cocaine-BSA and 
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cocaine standard, respectively. The presence of white areas of staining in gels or 
immunoblots stained using an ECL substrate, known as hollow or ‘ghost’ bands, is a 
commonly reported phenomenon.66 These ghost bands are thought to result from the 
presence of too much antigenic material on the gel or membrane, although their 
actual origin is not well understood.66 It was thought that the white regions of staining 
on the gel in Figure 4.9B may also be the result of excess cocaine being present due 
to the high spiking volumes used. A repeat of the procedure on a partial banknote 
sample spiked with lower volumes cocaine-BSA and the cocaine standard solution, 
such as 7.5 µL, would be necessary for this to be determined.    
 
 
4.2.5 In-gel immunodetection method development for     
polyacrylamide gels using sheep anti-cocaine antibody 
At this point in the study, the manufacturer of the polyclonal rabbit anti-cocaine 
antibody discontinued the supply of this antibody. The immunodetection method was 
therefore re-optimised using a new sheep polyclonal anti-cocaine antibody with a 
corresponding HRP-labelled anti-sheep IgG secondary antibody. Immunodetection 
was initially performed on a gel containing cocaine-BSA, a BSA negative control, and 
primary and secondary antibody controls after separation by non-denaturing PAGE, 
as described for the rabbit primary antibody in Section 4.2.3.  
 
Immunostaining of the 7.5 % acrylamide gels was performed after PAGE using a 
1:2,500 dilution of primary antibody, and a 1:10,000 dilution of secondary antibody as 
described in Chapter 2.3.2. The results of the analysis are shown in Figure 4.10. The 
gel shown in Figure 4.10A was stained for all protein by Coomassie brilliant blue, run 
using the same method as for the immunostained gel in Figure 4.10B. The only 
staining present in the gel shown in Figure 4.10B was obtained from the HRP-
labelled secondary antibody staining control in lane 3. As expected, no staining was 
observed in lane 1 containing the BSA negative control. However, there was also an 
absence of staining in lane 2 where the anti-cocaine primary antibody control was 
present. This indicated that HRP labelling of the primary antibody via secondary 
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antibody binding had not been successful. The experiment was repeated using a 
higher concentration of secondary antibody (a 1:5,000 dilution) from which the same 
result was obtained (results not shown). Overall these results suggested that the 
primary and secondary antibodies were failing to interact with one another within the 
gel. A dot-blot style assay was therefore performed in order to confirm that the 
secondary antibody was able to bind to the primary in the absence of the gel.      
 
 
BA
 
 
Figure 4.10.  The in-gel immunodetection of cocaine-BSA in a 0.75 mm thick, 7.5 % w/v 
acrylamide PAGE gel stained with an ECL enzyme substrate. The total 
protein in the gel, stained by Coomassie brilliant blue R250, is shown in (A). 
The corresponding immunostained gel imaged using an exposure time of 
3.5 min is shown in (B). After the molecular weight marker (MW), the 
samples in the gel are labelled as follows; (1) BSA, (2) anti-cocaine primary 
antibody and (3) HRP-labelled secondary antibody. All samples were pre-
diluted to 1 mg mL-1 in PB prior to analysis.  
 
 
4.2.6 In-gel immunodetection of cocaine on nitrocellulose 
membrane samples using sheep anti-cocaine antibody 
A dot-blot style assay on nitrocellulose membrane was used as a means of testing 
for interaction between the anti-cocaine primary antibody and the HRP-labelled 
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secondary antibody. The assay was performed as described in Chapter 2.3.3. 
Primary antibody and BSA spotted onto the nitrocellulose membrane were used as 
the test and negative control, respectively. As indicated by the results in Figure 4.11, 
the primary antibody (circle 1) was successfully visualised using the HRP-labelled 
secondary antibody. No staining was present on the area with BSA bound in (circle 
2). This proved that a specific interaction was occurring between the two antibodies, 
indicating that perhaps the presence of the gel was interfering with secondary 
antibody binding. 
 
 
 
 
Figure 4.11.  The results of a ‘dot-blot’-style assay for the detection of antibody 
interaction, performed on nitrocellulose membrane spotted with anti-cocaine 
primary antibody and BSA, within the circles labelled (1) and (2), 
respectively. Spotting of the solutions was performed at a concentration of 
1 mg mL-1 for both proteins. Imaging was performed using an exposure time 
of 1 min. 
 
 
In order to determine whether the presence of the acrylamide gel was interfering with 
the interaction between the primary and secondary antibodies, a nitrocellulose 
membrane was prepared in the same way as for the dot blot, but with an additional 
HRP-secondary antibody staining control also included. In-gel immunodetection was 
then performed on the membrane as described in Chapter 2.3.6, in a similar manner 
as for the cotton paper samples. A 1:100 dilution of HRP-labelled secondary antibody 
was used. As shown in Figure 4.12, the resulting gel was only stained in the area 
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where the secondary antibody control was present on the membrane (circle 3). No 
staining was observed where the primary antibody (circle 1) or the BSA negative 
control (circle 2) had been spotted. This indicated that the presence of the gel did 
indeed interfere with the interaction between the primary and secondary antibody, 
and confirmed that an alternative means of enzyme labelling would be necessary to 
use this type of antibody for in-gel immunodetection using the developed method.      
 
 
1. 2. 3.
 
 
 
Figure 4.12.  The results of a ‘dot-blot’-style in-gel immunoassay for the detection of 
antibody interaction, performed on nitrocellulose membrane within a 1.5 mm 
thick, 7.5 % w/v acrylamide PAGE gel. The membrane was spotted with 
anti-cocaine primary antibody, BSA and HRP-labelled secondary antibody 
within the circles labelled (1), (2) and (3), respectively. Spotting of the 
solutions was performed at a concentration of 1 mg mL-1 for both proteins. 
Imaging was performed using an exposure time of 3 min. 
 
 
4.2.7 HRP labelling of sheep anti-cocaine antibody   
The results in Section 4.2.6 showed that the sheep anti-cocaine primary antibody 
could not be labelled using the HRP-labelled secondary antibody due to the 
interference with secondary antibody binding caused by the presence of the gel. The 
direct labelling of the primary anti-cocaine antibody with HRP to form an antibody-
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HRP conjugate was therefore performed to overcome this problem. HRP labelling 
was achieved using the well-described periodate-mediated method of conjugation as 
detailed in Chapter 2.3.4. This method of conjugation is performed as a two-step 
process; in the first, monosaccharide residues on the HRP are oxidised with 
periodate to produce aldehyde groups. In the second step, the aldehyde groups are 
allowed to react with amine groups on the antibody, leading to the formation of Schiff 
bases which are reduced to give a stable conjugate.67 
 
After conjugation, the resulting HRP-labelled antibody was separated from unbound 
HRP by gel filtration. The presence of protein in the eluted fractions from the column 
was monitored by absorbance at 280 nm as shown in Figure 4.13A. Two peaks were 
present in the elution spectrum, the first of which was thought to contain the labelled 
antibody based on its larger size compared with the free HRP in the second peak. 
The abrupt change in absorbance at 280 nm mid-way through the first peak was the 
result of an air bubble in the column. The presence of HRP-labelled antibody was 
confirmed in the fractions of the first peak by SDS PAGE, the results of which are 
shown in Figure 4.13B. The presence of antibody in the fractions B10 through to C2 
is indicated by the two bands in the gel of molecular weights corresponding to those 
of the HRP-modified heavy and light chains of the antibody at around 116–126 kDa 
and 30-40 kDa, respectively. The presence of free HRP in fraction C6 is also 
indicated by a single band corresponding to the molecular weight of the enzyme 
(Figure 4.13B).    
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Figure 4.13.  A typical UV-visible absorption trace at 280 nm obtained from the separation 
of HRP-labelled antibody from unbound HRP by gel filtration is shown in (A). 
The volumes of fractions B6 through C7 are as indicated below the 
spectrum. SDS PAGE confirmation of the fractions from the first peak (B7 
through B12, C1 and C2) and from the second peak (C6) is shown in (B) 
alongside a molecular weight marker (‘MW’).  
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The fractions from the first peak containing the labelled antibody as determined by 
SDS PAGE were combined, and the solution concentrated to a final volume of 1 mL 
as described in Chapter 2.3.4. The presence of the HRP-antibody hapten was then 
confirmed by UV-Vis absorption spectrophotometry. A typical example of the 
absorption spectrum obtained from HRP-labelled antibody is shown in Figure 4.14. 
The two characteristic absorption bands present at 280 and 403 nm relate to the total 
protein in the solution and the haem group of HRP, respectively. The Rz value of the 
labelled antibody was determined by the ratio of the absorbance at 280 and 403 nm; 
this value provides a measure of the haem content of the preparation and can be 
used as an indicator of the purity of the conjugate.67 The concentration of the 
conjugate was also calculated based on the absorbance of the haem group of HRP 
at 403 nm as described in Chapter 2.3.4. A typical Rz value of 0.3 and a 
concentration of 2 µM of labelled hapten was obtained. 
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Figure 4.14.  A typical UV-visible absorption spectrum of HRP-labelled anti-cocaine 
antibody. The hapten shown had an Rz value of 0.3 and a concentration of 
2.2 µM. 
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4.2.8 In-gel immunodetection of cocaine on partial and whole 
banknote samples using HRP-labelled sheep anti-cocaine 
antibody  
In-gel immunodetection was performed on partial banknote samples using the HRP-
labelled anti-cocaine antibody as described in Chapter 2.3.6. The method used was 
based on that previously applied for the immunostaining of partial banknote samples 
using a rabbit primary antibody with a corresponding HRP-labelled secondary 
antibody in Section 4.2.4. The same spiking volume of 10 µL per solution for the gel 
shown in Figure 4.9B was applied. Cocaine standard was initially used as a test 
sample, alongside solutions of BSA and the HRP-labelled primary antibody applied 
as negative and positive control samples, respectively. In-gel immunodetection was 
performed using a 1:200 dilution of the HRP-labelled anti-cocaine antibody. The 
results are shown in Figure 4.15A. As expected, localised staining was observed at 
the location where the HRP-labelled antibody positive control had been applied to the 
note in grid 3. Significant movement or ‘bleeding’ of the stain, as previously shown in 
the gel spiked with HRP-labelled secondary antibody shown in Figure 4.8, was not 
present. Localised staining was not seen in the area spiked with cocaine standard, 
indicating that the immunodetection of cocaine had not been successful (circle in grid 
1). Staining was also not present in the area where the BSA negative control had 
been applied (white circle in grid 2), as expected. Further staining in the gel occurred 
in an area where neither cocaine nor BSA had been applied to the banknote, in the 
position indicated by the blackened circle in the diagram (grid 2) below the gel shown 
in Figure 4.15A. The cause of this staining, whether it was specifically stained 
cocaine standard which had become mobile within the gel or another non-specifically 
stained element, is not known.  
 
Overall, the results showed that the cocaine standard could not be detected using 
the immunodetection method. It was thought that this may have been the result of 
the nature of the cocaine standard used for spiking, which was in solution rather than 
as a crystalline powder. Previous studies have shown that cocaine contamination of 
banknotes occurs by crystals of cocaine becoming embedded in the weave of the 
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fibres that make up the note,68 a mechanism which is likely to rely on the granular 
nature of the cocaine to occur. In order to better mimic this adhesion process, 
crystalline cocaine rather than cocaine as a solvent solution was applied for the 
spiking of the banknotes hereafter.  
 
 
 
 
 
Figure 4.15.  The results of the immunostaining of two partial banknote samples within a 
1.5 mm thick, 7.5 % w/v acrylamide gels are shown in (A) and (B). Standard 
and control samples for spiking were applied to the notes using the grid 
layouts shown; the circle indicates the exact location of the spiked 
substance within the grid. The solutions for spiking were as follows; (1) 
cocaine standard (1 mg mL-1 in MeOH), (2) BSA and (3) HRP-labelled anti-
cocaine primary antibody. All samples, except the cocaine standard, were 
pre-diluted to 1 mg mL-1 in PB prior to applications. The images were 
obtained using 2 and 3 min exposure times for (A) and (B), respectively. The 
contrast of (A) was adjusted by +2. Intense staining is indicated by the white 
arrow in (B). 
 
 
The procedure was repeated for another part of the same banknote sample spiked 
with ‘street’ cocaine rather than cocaine standard in solution. The street cocaine, 
which was received as a crystalline powder, was used as a more realistic 
representation of the form and purity of cocaine likely to be present on a banknote, 
 150 
 
rather than pure cocaine standard applied as a solution in solvent. It was also 
considered that the cocaine crystalline powder could behave differently within the gel 
in terms of solubility and mobility prior to gelation. Spiking was performed by rubbing 
both sides of the labelled area of the note onto a surface covered in crystalline 
cocaine as described in Chapter 2.3.5. It was noted that spiking in this way proved 
difficult and inaccurate, as the powder was prone to adhere to other parts of the 
banknote sample due to the small size of the area chosen for spiking. 
Immunostaining was performed on the spiked note in the same way as for the gel 
shown in Figure 4.15A. The resulting gel is shown in Figure 4.15B. As expected, the 
greatest intensity of the staining occurred on the part of the banknote in grid 3 where 
the HRP-labelled antibody positive control had been applied. No further localised 
staining was observed on the surface of the partial banknote in either grid 1, where 
the cocaine sample had been applied, or in grid 2 where the BSA negative control 
was present. This showed that the specific immunodetection of cocaine on the 
spiked banknote sample had not been successful. However, a dark band of staining 
was present at the top of the gel away from the banknote sample, as indicated by the 
white arrows in Figure 4.15B. Staining in this region was not present in the note that 
had been spiked with the cocaine standard shown in Figure 4.15A. This result 
suggested that this band could relate to the presence of cocaine within the gel, as 
the cocaine may have migrated to the top of the gel prior to gelation and been 
immunostained during subsequent analysis. Further analysis was necessary in order 
to confirm this. 
 
The immunodetection procedure was therefore repeated in order to determine 
whether the staining at the top of the banknote shown in Figure 4.15B was the result 
of movement of the spiked cocaine within the gel prior to gelation, or an artefact of 
the detection method. Due to the difficulty of accurately applying the crystalline 
cocaine to only one small area of a partial banknote as experienced in the previous 
experiment, two separate partial banknotes, one with and one without cocaine, were 
instead analysed. This enabled the presence of cocaine to be determined in the 
absence of possible artefacts introduced by the method of spiking. A £5 note 
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obtained from general circulation was pre-washed with methanol to remove any 
potential background cocaine and cut into quarters, two of which were used for the 
analysis. Cocaine was then applied to both sides of the positive partial banknote 
using a spiking method similar to that described by Ebejer et al.,69 which involved 
spreading cocaine over a flat surface before rubbing the note over the contaminated 
surface as detailed in Chapter 2.3.5. Immunostaining of the two samples was then 
performed as described in Chapter 2.3.6.  
 
The results of the immunostaining are shown in Figure 4.16. The two sides of the 
negative and positive banknotes are shown in A and B, and then C and D, 
respectively. A clear difference was observed in the intensity of the staining between 
the positive and negative notes. Significantly darker staining was seen on the 
positive note in Figure 4.16C and D than on the negative note in Figure 4.16A and B. 
The areas of staining in Figure 4.16C and D occurred both in the gel around the note 
as well as on the note itself, and the patterns of staining at the bottom of the gels 
(indicated by the white arrows in Figure 4.16) were similar to those previously 
observed where positive control samples had spread or ‘bled’ into the surrounding 
gel area. The results show that the staining of cocaine was successful based on the 
difference between the positive and negative samples; however, the results also 
indicated that the spiked cocaine is not static within the gel and instead appears to 
move around in the gel mix possibly prior to gelation.  
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Figure 4.16.  The immunostaining of partial banknote samples within 1.5 mm thick, 
7.5 % w/v acrylamide gels. (A) and (B) show each side of part of a £5 
banknote obtained from general circulation and pre-washed with MeOH. (C) 
and (D) show each side of a different part of the same banknote spiked with 
5 mg of street cocaine. Imaging was performed using a 5 min exposure time. 
All images were contrast adjusted by +2. Areas where the staining has 
migrated or ‘bled’ are indicated by the white arrows in (C) and (D). 
  
 
It was reported by Bohannon that the washing of banknotes with solvents such as 
methanol may affect the structure of the fibres within the note, and thereby also 
affect the adherent properties of the fibres to cocaine crystals entrapped within 
them.70 In order to eliminate the possibility of the methanol wash-step affecting the 
results obtained in the previous experiment, the immunostaining procedure was 
repeated on a £5 banknote obtained from general circulation which was not pre-
washed prior to analysis. The results of the analysis are shown in Figure 4.17, with 
the negative note shown in A and B and the positive note in C and D. The positive 
and negative notes are readily distinguishable based on the intensity of the dark 
staining as observed in the previous experiment. Overall, the staining on the positive 
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note is the darkest on the note itself rather than the surrounding gel, suggesting 
improved adherence of the spiked cocaine to the note. The more intense of the 
staining observed in Figure 4.17C, and to a lesser extent Figure 4.17D was situated 
around the edge of the banknote sample. The location of this staining could have 
resulted from the migration of cocaine towards the edges of the banknote during 
gelation, or may alternatively be the area on the banknote where the majority of the 
spiked cocaine is present. A higher intensity of staining was also observed in the 
negative in Figure 4.17A and B than was previously observed in Figure 4.16A and B. 
The higher intensity possibly resulting from background cocaine contamination 
already present on the note obtained from general circulation.  
 
 
 
 
 
 
Figure 4.17.  The immunostaining of partial banknote samples within 1.5 mm thick, 
7.5 % w/v acrylamide gels. (A) and (B) show each side of part of a banknote 
obtained from general circulation. (C) and (D) show each side of a different 
part of the same banknote spiked with 5 mg of street cocaine. Imaging was 
performed using a 5 min exposure time. All images were contrast adjusted by 
+2.   
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Furthering the successful immunodetection of cocaine on banknotes, the method 
was then adapted and applied to whole banknote samples. Immunodetection was 
performed as described in Chapter 2.3.6. The different steps in the method were 
performed as demonstrated by the images shown in Figure 4.18.  
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Figure 4.18.  A schematic representation showing the steps performed during the in-gel 
immunodetection for the detection of cocaine on banknotes. Images on the 
right of the figure are photographs taken during the immunodetection 
procedure. 
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As banknotes from general circulation are known to contain background levels of 
cocaine contamination, newly minted notes (obtained directly from the Bank of 
England) were instead used as a truly negative sample matrix for the initial testing of 
the method. A typical result obtained from the immunostaining of a newly minted 
banknote is shown in Figure 4.19A and B. A background level of light, grey-coloured 
staining was observed on the note particularly in areas where air bubbles had 
developed in the gel during gelation, which have been labelled by white circles in the 
figure. The results of the negative control were compared with the immunostaining 
obtained from a newly minted banknote spiked with cocaine over the whole of the 
note. A typical example of this is shown in Figure 4.19C and D. The staining present 
on the note spiked with cocaine was darker and more intense than that observed on 
the negative control note, although not the same degree of difference as observed in 
the partial banknote samples shown in Figures 4.16 and 4.17. The increase in the 
intensity of the staining was thought to relate to the level of wear of the banknotes, as 
the partial banknotes had been obtained from general circulation and was therefore 
more aged and worn than the newly minted notes. This association was based on 
two studies which showed that the wear or ageing of banknotes leads to loosening 
and spreading of the tight weave of fibres that form the material of the note.71,72 This 
in turn leads to greater porosity within the weave, in which cocaine crystals can more 
readily become entrapped and retained by the loosened fibres. 
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Although a clear difference was observed between the immunostained negative and 
positive banknotes, whether the staining occurred at the location where the cocaine 
had been applied to the banknote could not be confirmed using banknotes where 
cocaine had been applied to the whole of the note. In order to test the location-
specificity of the staining, newly minted banknotes where half of the note had been 
spiked with cocaine and the other left absent were used. The typical results of the 
half-spiked note are shown alongside another negative newly-minted note in Figure 
4.20. The division between the positive cocaine-spiked side of the note (labelled ‘P’) 
and the non-spiked negative side of the note (labelled ‘N’) is indicated by the white 
line in Figure 4.20C and D. Darker and more intense staining was observed on both 
sides of the positive banknote in agreement with the previous experiments (Figure 
4.19). The area where the darkest staining occurred was at the edge of the 
banknote, rather than over the whole of the positive side of the note. This result 
suggested that the cocaine had migrated towards the edge of the note during 
gelation instead of remaining in its original spiked location.  
 
The migration of the cocaine was thought to result from both the vertical orientation 
and the size of the cassette used for the application of the gel to the surface of the 
banknote. The results shown in Figure 4.20 illustrate the need for the development of 
bespoke equipment which would improve both the practicality and the results 
produced using the in-gel immunodetection method. For example, a horizontal rather 
than vertical gel cassette slightly larger than the dimensions of the banknote would 
reduce both the movement of the note during application, as well as the volume of 
gel solution needed. This could lead to a reduction in the mobility of the cocaine 
during gelation and therefore improve the repeatability of the method. The 
development of a gel incubator colander of the appropriate dimensions would also 
enable the gel to be transferred more easily between solutions, thereby preventing 
damage to the fragile edges of the gel (like the damage indicated by the white circle 
at the edge of the banknote shown in Figure 4.20C and D).   
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The entrapment and adherence of cocaine crystals within the fibres of banknotes 
was suggested by Moss and by Sleeman et al. as relating to the age and therefore 
the structural integrity of the weave of the banknote.71,72 The immunodetection 
method was therefore applied for the analysis of six aged banknotes obtained from 
general circulation in order to confirm whether this suggestion affected the results 
obtained. The also enabled the analysis of actual samples with unknown levels of 
cocaine contamination to be performed. All of the notes analysed were of a worn and 
yellowed appearance, and were more pliable compared to the newly minted notes 
used in the previous experiments. The results of the immunostaining of two of the 
notes obtained from general circulation are shown in Figure 4.21. Sides 1 and 2 of 
the first note are shown in Figure 4.21A and B, and side 1 and 2 of the second are 
shown in Figure 4.21C and D. The nature of the staining observed on both the first 
(Figure 4.21A and B) and the second (Figure 4.21C and D) from general circulation 
differed from that of the newly minted notes shown in Figures 4.19 and 4.20. For 
instance, small circular dots of intense dark grey staining were present on the older 
notes in Figure 4.21, as opposed to the overall grey hue seen on the newly minted 
notes. These localised spots of intense staining were thought to result from the 
detection of the levels of cocaine contamination present on banknotes in general 
circulation. The areas where the darkest staining occurred were on the right and left 
hand edge of the sides of the banknote shown in Figure 4.21C and D, respectively. 
This staining may have resulted from the migration of cocaine towards that edge of 
the banknote during gelation. However, due to the unknown nature of the sample 
and therefore the undetermined levels of cocaine contamination and location, the 
staining may also be indicative of the presence of a large quantity of cocaine on that 
edge of the banknote. The difference between the type of staining between the newly 
minted and the older banknotes was thought to be due to the loosening of the 
banknote fibres that allows the entrapped cocaine crystals to remain in place even 
during application and subsequent gelation of the acrylamide gel. However, due to 
the unknown levels of cocaine present on the banknotes obtained from general 
circulation, the genuine immunostaining of cocaine could not be confirmed based on 
these results alone.     
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In order to confirm whether the small, intense spots of immunostaining observed on 
the banknotes obtained from general circulation were the result of genuine 
immunodetection of cocaine on the surface of the banknote, the procedure was 
repeated on a set of half-spiked banknotes similar to that previously performed on 
the newly minted notes. A typical result is shown in Figure 4.22 alongside that of 
another non-spiked banknote from general circulation. Sides 1 and 2 of the non-
spiked note are shown in Figure 4.22A and B, and side 1 and 2 of the half-spiked are 
shown in Figure 4.22C and D. Overall, a greater number of stained areas were 
observed on the half-spiked banknote in Figure 4.22C and D as compared to the 
non-spiked note in Figure 4.22A and B. A greater number of stained areas were also 
present on the cocaine-spiked half of the positive banknote (labelled ‘P’) than the 
non-spiked half of the banknote (labelled ‘N’). In particular, the side of the banknote 
shown in Figure 4.22D featured a greater number of dark spots of staining on the 
positively spiked half. The areas where the darkest staining occurred were on the left 
and right hand edges of the ‘P’ sides of the banknote shown in Figure 4.22C and D, 
respectively. The staining at the edge of the banknote in Figure 4.22C and D was 
less intense than that observed on the edge of the banknote shown in Figure 4.21C 
and D. The nature of the staining also differed between the two banknotes; for 
example, the staining in Figure 4.22C and D appeared as circular spots, whereas the 
staining in Figure 4.21C and D was present as one band of dark colouration. The 
less intense and spotted staining in Figure 4.22C and D on the sides of the banknote 
where cocaine had been applied suggests that this result may relate to the presence 
of cocaine on the banknote, rather than the migration of cocaine towards the edge of 
the banknote during gelation. It was noted that although the spiking performed using 
an excess (ca. 10 mg) of crystalline ‘street’ cocaine proved more successful than 
spiking with the cocaine standard in solution, the overall amount of cocaine adhered 
to the banknotes spiked in this manner is unknown. The spiked banknotes analysed 
in this study may not realistically reflect the quantities of cocaine likely to be present 
on banknotes in general circulation (as shown in Table 1.2). The production of partial 
or whole banknote ‘standard’ samples containing known quantities of cocaine which 
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more accurately reflect those previously reported in general circulation would be 
beneficial for the validation of the in-gel immunodetection.   
 
Overall, the staining present on the spiked note was of similar appearance in terms 
of size and shape as the staining present on the non-spiked notes from general 
circulation rather than the newly minted notes. This indicated that the nature of the 
staining could indeed relate to the age and structural integrity of the banknote as 
originally suggested. The results suggest that using the developed immunodetection 
method enables the location-specific visualisation of cocaine on the surface of 
banknotes, thereby fulfilling the original aim of the study.   
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4.3 Conclusions 
The aim of the work presented in this chapter was to develop a method for the 
location-specific immunodetection of cocaine on banknotes in order to determine the 
efficacy of the IMS sampling method currently used by law enforcement in the UK for 
the detection of cocaine on banknotes.58 Immunodetection was selected as a means 
of detecting cocaine on the notes based on the previous application of immunological 
methods for the location-specific staining of cellular antigens in solid or semi-solid 
matrices such as tissue specimens. An acrylamide hydrogel was used as a means of 
affixing the cocaine on the banknotes to facilitate immunostaining. Hydrogels are 
commonly applied as scaffolding material in 2D and 3D cell culture which enables 
subsequent staining for cellular antigen by ICC methods. The porosity, 
biocompatibility and mechanical strength of hydrogels make them well suited for 
these types of applications. As well as being widely used for the separation of 
biomolecules by gel electrophoresis, hydrogels such as agarose have also been 
used for the testing of antibody-antigenic interactions by diffusion analysis. This 
shows that hydrogels are suitably permeable to allow the passive diffusion of large 
proteins such as antibodies.  
 
In the present study, the mechanical strength and antibody permeability of a number 
of different biologically derived hydrogels, namely collagen, gelatin, casein and 
agarose were determined in order to judge their suitability as a matrix for the 
immobilisation of cocaine on banknotes. Hydrogels of biological origin were initially 
chosen as they are non-toxic, biodegradable, easily manipulated, cost-effective and 
widely available. The results obtained after applying the hydrogels to cotton paper as 
a representation of a banknote showed that the gels possessed too little mechanical 
strength to properly adhere to the surface of the note at the low concentrations of 
polymer required to enable antibody permeation. Based on these results, the use of 
biologically derived hydrogels as a matrix for cocaine detection on banknotes was 
discontinued in favour of a synthetic polymeric hydrogel matrix.       
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An acrylamide hydrogel was selected as an alternative to a biological hydrogel due to 
its previous application for the in-gel immunodetection of proteinaceous antigen after 
separation by gel electrophoresis. The method involved treatment of the gel with 
50 % isopropanol in water as a fixative, the application of which enables the 
immobilisation of antigenic material within the gel and reportedly also increases its 
permeability to antibodies.54 In-gel immunodetection of cocaine-BSA as an antigenic 
target was initially performed in acrylamide gels after separation by non-denaturing 
PAGE. Immunostaining was achieved using a rabbit anti-cocaine primary antibody 
with a corresponding HRP-labelled secondary antibody, after which visualisation of 
bound HRP was enabled via incubation in DAB as an enzyme substrate. Inclusion of 
primary and secondary antibody controls in the PAGE gels led to optimisation of the 
method, during which the enzyme substrate was changed from a colorimetric to an 
ECL substrate. This enhanced the sensitivity of the staining method and resulted in 
the positive staining of the primary antibody control by the labelled secondary 
antibody. 
 
During the study, the manufacturer discontinued production of the original rabbit 
polyclonal anti-cocaine antibody. The remainder of the study was therefore continued 
with a sheep polyclonal anti-cocaine antibody, the cocaine-binding efficiency of which 
could not be compared with that of the original antibody due to variation introduced 
by the different labelling approaches used for each antibody type. The sheep 
polyclonal antibody was applied for in-gel detection on PAGE gels using a 
corresponding HRP-labelled secondary antibody. Labelling of the primary antibody 
via the HRP-labelled secondary antibody proved unsuccessful using this approach, 
despite the successful interaction between the primary and secondary antibodies 
established by a dot-blot style assay. Repetition of the dot-blot assay within an 
acrylamide gel proved that the presence of the gel interfered with the interaction 
between the primary and secondary antibodies. Direct labelling of the primary 
antibody with HRP was therefore undertaken to eliminate the need for a secondary-
antibody based method of detection. Labelling of the primary antibody with HRP was 
performed using the well-described periodate-mediated method of conjugation, in 
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which addition of HRP binds to the Fc region of IgG and therefore does not affect the 
antigen-binding capacity of the antibody.67 The successful formation of the antibody-
HRP hapten was confirmed by SDS PAGE and UV-Vis absorption 
spectrophotometry at 280 and 403 nm, yielding a conjugate of suitable concentration 
and purity.    
 
The HRP-labelled anti-cocaine antibody was initially unsuccessful at the in-gel 
immunodetection of cocaine standard, which was applied to small areas of partial 
banknote samples in a solvent solution. However, the detection of cocaine on partial 
banknote samples spiked with a sample of crystalline ‘street’ cocaine as a more 
realistic substance for spiking proved successful using the developed method. The 
presence of cocaine on the partial banknotes was indicated by darker regions of 
staining on the notes which had been spiked with cocaine, compared to the lighter 
background levels of staining present on non-spiked partial banknotes. The method 
yielded different levels of staining for partial notes obtained from general circulation 
after pre-washing with methanol as compared with those which had not been washed 
prior to spiking and analysis. The results confirmed the reports of Bohannon 
suggesting that pre-washing of banknotes in methanol affects the structure of the 
fibrous network that makes up the note, thereby affecting that way in which cocaine 
becomes embedded and retained by those fibres.70   
 
Based on the successful immunodetection of cocaine on partial banknotes, the 
method was adapted for application to whole banknote samples. Detection was 
initially performed on newly minted banknotes as a true negative sample matrix 
without any possible cocaine contamination which could be obtained from general 
circulation. Immunodetection of the newly minted notes showed a clear difference in 
the intensity of staining when newly minted negative control samples were compared 
with newly minted banknotes which had been spiked with cocaine over the whole of 
the note. The staining observed on the newly minted notes was uniformly grey in 
colour over the whole of the note, the hue of which was darker on the notes which 
were positive for cocaine. The results suggested that the cocaine was successfully 
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being detected using the developed method. As the location of the cocaine on the 
note could not be confirmed based on these results alone, further analysis was 
performed in order to achieve the overall aim of the detection of cocaine on the 
banknote in situ. Newly minted banknotes where half of the note had been spiked 
with street cocaine and the other half left blank were used as a means of determining 
whether the location of the cocaine on the note could be labelled using the 
developed method of staining. The results showed that the overall degree of staining 
was darker for the half-spiked note than for the negative control. An area of intense 
staining was also present but only at the edge of the spiked half of the note, rather 
than over its entirety. This suggested that the spiked cocaine had become mobile 
within the gel mix during application and prior to gelation, and had thereby migrated 
to areas of the note on which it had not originally been applied.  
 
The findings of previous publications suggest that the age and wear of a banknote 
may affect its ability to entrap and retain cocaine within its fibres.71,72 The fibres of a 
banknote loosen with age, and the weave becomes more porous and this reportedly 
facilitates increased entry and retention of cocaine crystals within the fibrous 
network. Based on this concept, the retention of cocaine on newly minted notes 
would be less than the used notes in general circulation. As such, six banknotes from 
general circulation were analysed by immunostaining to determine whether the 
nature and intensity of the staining differed from that obtained from the newly minted 
banknotes. The analysis of the notes also represented the detection of cocaine on a 
genuine sample matrix on which unknown concentrations of cocaine could be 
present. The appearance of the notes was described as worn and aged as compared 
to the newly minted control sample. The results of the immunodetection of cocaine 
showed that the staining appeared as dark grey or black spots on the surface of the 
banknote, rather than the overall dark grey stain present on the newly minted notes. 
Immunodetection of cocaine was also performed on banknotes from general 
circulation half-spiked with ‘street’ cocaine in the same way as for the newly minted 
notes. A greater number of dark, stained spots were observed on the spiked half of 
the banknote when compared with the unspiked half. This suggested that the 
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staining was related to the presence and location of cocaine on the surface of the 
banknote.  
 
Overall, the development of a novel in-gel immunodetection method for the 
visualisation of cocaine on the surface of banknotes is reported. The results shown in 
this chapter suggest that using the developed method enables the direct 
immunostaining of the cocaine at the location in which it is present on the banknote. 
The use of specialised equipment, such as a bespoke gel casting cassette for the 
gelation of the banknotes, would provide a more consistent matrix and decrease 
mobility of the cocaine prior to fixation and would thereby improve the developed 
technique. The production of a set of ‘standard’ banknote samples spiked with 
cocaine at concentrations reflecting those likely to be present on banknotes in 
general circulation would also be greatly beneficial for the further development and 
validation of the in-gel immunodetection method presented in this study.  The 
possible application of antibody-functionalised nanoparticles to enhance the 
sensitivity of the developed method is also suggested to enable the visualisation of 
cocaine at even lower concentrations that presently detectable. The formation of anti-
cocaine antibody-functionalised gold nanoparticles is described in Chapter 5. 
 
Overall, the results presented in this chapter suggest that cocaine can be present at 
variable locations across the whole of the banknote. Based on the banknote samples 
analysed during this study it is therefore possible that the current IMS sampling 
method used by UK law enforcement provides estimates which either over- or 
understate the concentrations of cocaine that are actually present on the whole of the 
banknote. A method in which the whole of the banknote, rather than a representative 
area is sampled would provide more accurate indication of the cocaine contamination 
on a banknote. 
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CHAPTER 5 
 
A comparison of four different approaches for the 
functionalisation of gold nanoparticles with 
anti-cocaine antibody 
 
 
This chapter describes a comparative study of four different approaches for the 
functionalisation of gold nanoparticles with anti-cocaine antibody via ligand or protein 
intermediates. 
 
5.1 Introduction 
 
5.1.1 Gold nanoparticles 
Gold nanoparticles (AuNPs) have been known to mankind for many centuries. The 
technical use of colloidal gold as a pigment in glass dates back to as early as the 4th 
century AD.1,2 The modern scientific understanding of colloidal gold began with the 
work of Michael Faraday in the 1850s. Faraday’s studies of the reduction of gold 
chloride using phosphorous produced the first concoction of gold nanoparticles, and 
led to the initial recognition that the colour of the solution resulted from the minute 
size of the particles.1,3,4 Since then, simplification of the routes of synthesis has 
enabled the production of gold particles in a range of different shapes and sizes in 
the nanometre range (1-100 nm) with a high degree of precision and accuracy.5  
 
The synthesis of AuNP in both aqueous and organic solvents typically involves 
addition of a reducing agent to a solution of gold salt (such as gold chloride), which 
leads to the nucleation of Au ions to nanoparticles.6 The presence of a stabilising 
agent, which is either absorbed or chemically bound to the surface of the AuNP, is 
required to lend an overall charge to the particle. This charge causes the AuNP to 
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repel one another and thereby remain colloidally stable in solution.6 For the most 
common route of synthesis in aqueous solution, citric acid serves as both a reducing 
agent by triggering the nucleation of gold chloride, and a stabiliser by then absorbing 
onto the particles to provide a net negative charge.7,8 Similar routes of synthesis can 
be used to produce particles of different geometries such as rods9 and stars,10 or a 
different combination of reducing and stabilising agents can be applied to enable 
synthesis of the particles in organic solvents.11 
 
The defining feature of all nanoparticles is their small size, and for inorganic 
nanoparticles this leads them to possess properties that are not found in bulk 
samples of the same material.12 One of the most prominent features of gold particles 
in the nm size range is their capacity to strongly absorb and scatter visual light as a 
result of their characteristic surface plasmon resonance (SPR). SPR is the collective 
oscillation of free electrons on the surface of AuNP in response to excitation caused 
by the absorption of energy from light.13 Change in the shape or size of the 
nanoparticle causes a shift in the electric field density on its surface, and this in turn 
leads to a change in the frequency of the oscillation.14 As a result, AuNP of different 
shapes and sizes can be differentiated based on their optical properties, such as 
absorbance at higher or lower wavelengths for larger or smaller particles, 
respectively.6,14 This phenomenon is responsible for the characteristic brightly 
coloured solutions of AuNP which makes them so attractive for labelling purposes. 
 
Certain properties of AuNP can be readily modified by replacing the stabiliser 
molecule present on the surface of the particle after synthesis with a ligand of the 
desired specificities.6 As thiol moieties bind with high affinity to gold surfaces via the 
formation of Au-sulfur bonds, thiol-modified ligands are most commonly used for 
such ligand-exchange reactions.6,13 The choice of ligand offers flexibility in terms of 
the environment in which the AuNP can be applied. For example, the addition of a 
ligand with either a hydrophilic or hydrophobic terminal group would enable the 
particles to be soluble in either aqueous or organic solvents, respectively. Ligands of 
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this type can also be used to provide a scaffold onto which additional molecules, 
such as proteins, can be bound.5    
AuNPs have become widely used in the field of analytical chemistry.15 Certain 
properties of AuNPs make them particularly attractive for analytical applications. The 
bright and photo-stable colouration of AuNP, ranging from blue-green to a deep red 
in the visible spectrum, that results from their unique SPR can be exploited for the 
purpose of detection.16 Resistance of AuNP to oxide formation lends stability under 
ambient conditions, thereby providing an inert metal scaffold onto which organic 
molecules can be bound.6 Controlled and straightforward immobilisation of organic 
molecules directly onto the gold surface is possible either by employing gold-sulfur 
bonds, or via the use of a ligand as mentioned in the previous paragraph.17 This 
enables AuNP to be readily functionalised for a wide range of different purposes.  
 
 
5.1.2 Antibody functionalisation of gold nanoparticles 
The advantageous characteristics of AuNPs are commonly exploited in the form of 
bio-functionalised particles, which can be assembled by encapsulating the AuNP in a 
coating of biological material such as DNA,18 protein19 or lectin.17 The addition of 
such biomolecules enables AuNPs to be specifically directed to targets of interest via 
molecular recognition.3 The earliest examples of such surface functionalised AuNP 
were the AuNP-antibody conjugates developed in the 1980s for immunostaining in 
electron microscopy.3 The immunological specificity of the antibody in combination 
with the electron density of the AuNP made antibody functionalised AuNP particularly 
attractive for such applications.15 Since then, a wide variety of different methods 
ranging from immunostaining within cells through to immunoassays have been 
developed which similarly harnass the molecular recognition of the antibody and 
combine this with the unique visual properties of the AuNP for detection.6,13,20 In 
recent developments, antibody-functionalised AuNP have been applied for a variety 
of applications including biological staining, disease diagnosis and cancer therapy.16  
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Although the most commonly exploited feature of AuNP for application in 
immunodetection is their unique colorimetric properties, another applicable 
characteristic which is true for all metal nanoparticles is their high surface to volume 
ratio.21 A large surface area is advantageous for the purpose of analytical detection. 
The binding of an antibody-functionalised AuNP to its target analyte, followed by the 
addition of a fluorescent marker or enzyme label yields a signal that is 10-fold greater 
than when only a single labelling molecule is bound.22 This signal amplification 
property makes functionalised AuNP particularly useful for the detection of small 
compounds, afforded by the molecular specificity of the antibody, in samples 
containing low concentrations of analyte.20 In combination with the other advantages 
of using AuNP, this makes antibody-functionalised AuNP particularly useful for the 
detection of small compounds, such as drugs, at the low concentrations present in 
samples of forensic interest. Antibody-functionalised AuNP are of particular interest 
in this study due to their previous application by Leggett et al. for the purpose of 
detecting nanogram quantities of cotinine, the metabolite of the drug nicotine, in 
fingerprints.23 Hazarika et al. reported a similar technique involving antibody-
functionalised magnetic particles for the detection of metabolites from various illicit 
substances, notably including that of cocaine.24 It is based on this principle that this 
study aims to produce a successful variety of antibody-functionalised gold 
nanoparticles for the purpose of detecting cocaine.   
 
The functionalisation of AuNP with antibody can be performed using a number of 
different approaches.5 The simplest of these involves the non-specific physical 
absorption of the antibody directly onto the gold surface via hydrophobic interactions, 
as described by Natan et al..25 Such particles have been used for many different 
applications such as for the staining of macrophage cells using a specific targeting 
antibody,17 as a labelled reporter antibody in a chemiluminescence-based 
immunoassay system,19 and as the solid phase in a similar immunoassay-based 
method.18 However, it has been reported that addition of the antibody via direct 
absorption could compromise the target specificity offered by the functionalised 
AuNP due to variations in the integrity of the antibody and orientation of the 
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binding.26 Instead, other methods have been developed based on the encapsulation 
of the AuNP in a monolayer of protein or functionalised ligand onto which the 
antibody can be covalently bound. This not only introduces potential for more 
oriented and reliable binding of the antibody, but can also enhance particle solubility 
and stability depending on the nature of the protein or ligand used.26-29  
 
 
5.1.3 Aim of the research presented in this chapter 
A number of strategies have been reported for the covalent binding of antibodies 
onto a gold surface by way of a ligand intermediate.3,26 The most robust form of 
anchorage onto gold was reported by Giersig and Mulvany as that provided by 
thiolated ligands, which exploit the strong gold-sulfur bond formed between a soft 
acid (gold) and an equally soft thiolate base.30 Because of this, the use of a 
heterobifunctional ligand with a thiol group at one terminus and a functional group for 
binding of the antibody at the other has proven advantageous for this purpose. In this 
study, four different approaches involving heterobifunctional ligands were used for 
the covalent binding of anti-cocaine antibodies onto the surface of AuNP.  
 
In the first of these approaches, a thiolated PEG ligand with terminal carboxyl 
functionality (PEGCOOH) was employed for the addition of antibody to the surface of 
AuNP. As described by Mason et al., PEGCOOH can easily be self-assembled onto 
citrate-stabilised AuNP and in doing so provides increased solubility in aqueous 
solvents.31 Activation of the -COOH functional group using the well-documented 
EDC/NHS method enables covalent binding of the antibody via any one of a number 
of exposed amine residues,32 as illustrated in Figure 5.1A. AuNP functionalised with 
antibody using this type of approach are highly stable in aqueous buffers and 
relatively straightforward to assemble. Their synthesis has been reported for a 
number of different applications including as part of an immunoassay for the signal 
enhancement of HRP,33 and for the detection of fingerprints by the targeting of 
specific amino acids.34 Due to the number of available binding sites on the antibody, 
functionalisation using this approach results in randomly bound antibody in a variety 
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of different orientations. As described by Puertas et al., this can lead to an antibody 
positioned in a manner in which the FAb region of the antibody is not available for 
antigen binding.35 In this study, a comparison was made between this approach and 
more directed methods of functionalisation to determine the effect of the antibody 
orientation on the efficacy of the functionalised AuNP.  
 
 
 
 
Figure 5.1.  The four different strategies for immobilising antibodies onto AuNP used in 
this study. The use of a PEGCOOH linker is shown in (A), Protein A/G 
modified with an SPDP linker in (B), a short cysteamine linker in (C) and a 
PEGNH2 linker in (D). The antibody is represented in blue and the Protein 
A/G in yellow.    
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In the second approach used for the antibody-functionalisation of AuNP, oriented 
binding of the antibody was achieved via a protein intermediate covalently coupled to 
the surface of the AuNP. Bacterial IgG-binding proteins, such as Protein A and 
Protein G, are commonly employed for the oriented binding of antibody, as their 
preferential binding of the Fc region leads to presentation of the FAb region for 
optimal antigen binding.26,36 As mentioned, Leggett et al. successfully detected drug 
metabolites in latent fingerprints using antibody-functionalised AuNPs with an SPDP 
modified Protein A intermediate.23 In this study, the chimeric Protein A/G, a fusion 
protein which offers four IgG binding sites with the combined binding specificities of 
both Proteins A and G, was used.36 The Protein A/G was immobilised onto the 
surface of the AuNP by way of a heterobifunctional SPDP ligand as described by 
Leggett et al., the structure of which is shown in Figure 5.2. The addition of SPDP to 
Protein A/G was facilitated by the lysine groups of the protein in combination with the 
NHS ester on the ligand. Once conjugated to the Protein A/G, the disulfide group of 
the SPDP was then immobilised onto the gold. By exploiting the interaction between 
Protein A/G and the Fc region of the antibody, this approach to functionalisation 
orients the antibody so that the antigen-binding region is directed away from the gold. 
This directed binding of the anti-cocaine antibody via Protein A/G is illustrated in 
Figure 5.1B.  
 
 
 
Figure 5.2.  The structure of the N-Succinimidyl 3-(2-pyridyldithio)-propionate (SPDP) bi-
functional linker. 
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Directed antibody binding can also be performed using a ligand with an amine 
functional group, as described by Puertas et al..35 In this method binding is achieved 
via the polysaccharide moiety located on the Fc region of the antibody, resulting in 
presentation of the FAb region for antigen binding in a similar manner as obtained 
using Protein A/G. In this method the aldehyde on the polysaccharide moiety is first 
oxidised before being added to the amine-modified particles. The oxidised antibody 
forms a Schiff base intermediate in the presence of the aminated ligand on the 
particle which, when reduced, forms a strong bond between antibody and ligand. 
AuNP functionalised with antibody using an aminated ligand have previously been 
synthesised by Kumar et al. for the imaging of intracellular biomarkers.37 Niidome et 
al. report the functionalisation of 40 nm aminated AuNP, synthesised by sodium 
borohydride reduction using a short cysteamine linker, with DNA using a similar 
method.38 In the third method for functionalisation used in this study, the synthesis of 
cysteamine-stabilised AuNP, as described by Niidome et al., was combined with the 
antibody functionalisation method of Puertas et al. for the functionalisation of AuNP 
with anti-cocaine antibody.35,38 A schematic of this approach is shown in Figure 5.1C.   
 
As 40 nm cysteamine-AuNP are charge-stabilised by only a short linker, it was 
thought that the length of the cysteamine may generate AuNP of insufficient solubility 
in aqueous solutes and at the conditions required for antibody attachment. Because 
of this, in addition to antibody functionalisation of 40 nm cysteamine-AuNP using the 
method shown in Figure 5.1C, 16 nm citrate-stabilised AuNP (cAuNP) with an 
aminated PEG linker (PEGNH₂) were also synthesised and functionalised via the 
polysaccharide moiety of the antibody as a means of comparison. This fourth 
approach to functionalisation is described in Figure 5.1D.  
 
In this chapter, AuNP functionalised with anti-cocaine antibody using the four 
different approaches described were compared in terms of antibody orientation, 
particle stability and solubility. UV-Vis spectrophotometry and transmission electron 
microscopy (TEM) were first used to characterise the AuNPs after synthesis. After 
functionalisation of the AuNP, the presence of anti-cocaine antibody on the particle 
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surface, and the overall cocaine-binding efficiency of the functionalised AuNP were 
determined by means of gel electrophoresis, enzyme-labelled antigen and 
application in a plate-based immunoassay. Based on the characterisation of each 
type of functionalised AuNP, the most effective functionalisation approach was 
selected for the production of anti-cocaine antibody-functionalised AuNP. The anti-
cocaine particles were produced for eventual use for the detection of cocaine on 
forensic samples such as banknotes.  
 
 
5.2 Results and discussion 
 
5.2.2 Synthesis of gold nanoparticles  
16 nm cAuNP were synthesised according to the method of Turkevich et al.,7 as 
described in Section 2.4.1. The particles, typically a deep red colour, absorb light in 
the visible spectrum with a maximum at ca. 520 nm, yielding an absorption spectrum 
as shown in Figure 5.3. The concentration of the newly synthesised cAuNP shown in 
Figure 5.3 was determined to be 3.35 nM using the extinction coefficient 
2.4 x 108 M⁻1 cm-1.39 AuNP of 40 nm diameter were synthesised by sodium 
borohydride reduction in the presence of a cysteamine stabiliser using the method 
reported by Niidome et al.,38 as detailed in Section 2.4.2. A similar absorption 
spectrum was produced as for the citrate-stabilised AuNP, but with an absorption 
maximum at around 528 nm. The concentration of the particles shown in Figure 5.3 
was found to be 0.24 nM using the extinction co-efficient 4.7 x 109 M-1 cm-1.40  
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Figure 5.3.  UV-visible absorption spectra of 40 nm cysteamine-stabilised AuNP (a) and 
16 nm citrate-stabilised AuNP (b). 
 
 
TEM was used in order to determine the size of the gold nanoparticles. The average  
diameter of 101 citrate-stabilised AuNP and 100 cysteamine-stabilised AuNP were 
measured from the TEM images shown in Figure 5.4. The size distribution for each 
particle type is shown in Figure 5.5. The calculated average diameter of the cAuNP 
and cysteamine AuNP was 15.6 ± 2.1 nm and 37.4 ± 4.1 nm, respectively. Of the 
two particle types, the larger cysteamine AuNP showed the greatest size variation 
when compared with the smaller cAuNP.  
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Figure 5.4.  TEM images of the citrate-stabilised AuNP (A) and cysteamine-stabilised 
AuNP (B), taken at 40,000x (top images) and 120,000x (bottom images) 
magnification. 
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Figure 5.5.  The size distribution of 101 citrate-stabilised AuNP (A) and 100 cysteamine-
stabilised AuNP (B).  
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5.2.3 Antibody functionalisation of the AuNPs 
The addition of antibody onto the surface of AuNPs was performed in this study 
using the four different approaches shown in Figure 5.1. For the first of these, 
antibody functionalised cAuNP with a PEGCOOH linker were prepared using a 
modified version of the protocol described by Mason et al..31 The self-assembly of a 
PEGCOOH monolayer around the particles was facilitated by the formation of gold-
sulfur bonds between the surface of the cAuNP and the thiol terminal group of the 
ligand. This was followed by the EDC/NHS activation of -COOH functional groups on 
the PEG, which in turn enabled the addition of antibody via the formation of amide 
bonds. Purification of the AuNP-PEGCOOH-antibody was performed by 
centrifugation. The modification of the surface of the cAuNP surface, in this case by 
the addition of PEGCOOH and antibody, was indicated by a red-shift in the 
absorption maximum by approximately 2 nm per addition (from 520 to 522 nm) of 
PEG or protein. The increase in wavelength of the extinction maximum is indicated in 
the UV-Vis absorption spectra of the AuNP, and enables each step in the 
functionalisation process to be monitored. Figure 5.6 shows typical examples of 
absorption spectra for the step-wise addition of PEGCOOH and antibody to the 
surface of the cAuNP. AuNP functionalised using PEGCOOH proved to be highly 
stable in aqueous buffered solutions, and generated a good yield of antibody-
functionalised AuNP as illustrated in Figure 5.6.  
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Figure 5.6.  UV-VIS absorption spectra of the stages of antibody functionalisation of 
16 nm AuNP via a PEGCOOH linker, as indicated by the numbers i-iii in the 
schematic shown. The different particle types and their absorption maxima 
at around 520 nm are as follows: (i) Citrate AuNP (520 nm), (ii) AuNP-
PEGCOOH (2x concentration; 522 nm) and (iii) AuNP-PEGCOOH-antibody 
(524 nm). 
 
 
For the second approach used in this study, 16 nm cAuNP were functionalised with 
antibody by way of an aminated PEG ligand. The method used for the addition of an 
antibody to an amine-functionalised ligand was based on that applied by Puertas et 
al. to aminated magnetic particles.35 In this approach, binding of the antibody to the 
ligand occurs via an aldehyde on the polysaccharide moiety of the Fc region of the 
antibody, as detailed in Section 5.1.3. Antibody functionalisation was performed as 
described in Chapter 2.4.5. A PEGNH2 monolayer was first self-assembled onto the 
surface of the cAuNP. The aldehyde group on the polysaccharide region of the 
antibody was then oxidised by sodium periodate before being applied to a solution 
of the AuNP-PEGNH2. The resulting antibody-functionalised AuNP-PEGNH2 were 
purified by glycerol gradient using a modified version of the approach described by 
Karthik et al..41 The reaction between the oxidised aldehyde of the antibody and the 
amine of the AuNP-PEG resulted in the formation of a Schiff base intermediate. This 
intermediate was reduced by incubation with sodium cyanoborohydride to form a 
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strong covalent bond between linker and antibody, after which the resulting AuNP-
PEGNH2-antibody were purified once again by glycerol gradient as previously 
described. 
 
The increase in the absorption maxima following the addition of both the PEGNH2 
and the antibody are indicated by the UV-Vis absorption spectra shown in Figure 5.7. 
As shown, the extinction maximum typically increased by 2 – 3 nm following each 
step in the functionalisation process, indicating the successful modification of the 
AuNP surface. The newly synthesised antibody-functionalised AuNP-PEGNH2 
showed relatively good stability in aqueous buffered solutions. The concentration of 
the antibody-functionalised AuNP obtained was lower than that of the AuNP-
PEGCOOH-antibody. This was indicated by the absorption maximum of 0.468 
obtained for the AuNP-PEGNH2-antibody (shown in Figure 5.7(iii)), which was lower 
than the absorption maximum of 0.631 obtained for the AuNP-PEGCOOH-antibody 
shown in Figure 5.6 (iii). The AuNP-PEGNH2-antibody were prone to adhering to 
both glass and plastic sample vials, although this was lessened with the addition of 
milk buffer as a stabiliser in the final stage of functionalisation, as described in 
Chapter 2.4.5. 
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Figure 5.7.  UV-VIS absorption spectra of the stages of antibody functionalisation of 
16 nm AuNP via a PEGNH2 linker, as indicated by the numbers i-iii in the 
schematic shown. The different particle types and their absorption maxima 
at around 520 nm are as follows: (i) Citrate AuNP (520 nm), (ii) AuNP-
PEGNH2 (2x concentration; 523 nm) and (iii) AuNP-PEGNH2-antibody 
(525 nm). 
 
 
In the third approach used for the immobilisation of antibody onto the surface of 
16 nm cAuNP in this study, a modified Protein A/G intermediate was employed as a 
means of facilitating antibody binding (Figure 5.1). Functionalisation was performed 
using a  modified version of the Protein A-based method reported by Leggett et al.,23 
as described in Chapter 2.4.6. Protein A/G was first modified to include a disulfide 
group via the addition of an SPDP bi-functional linker. The succinimidyl ester portion 
of the SPDP chemically reacts with the primary amine groups present on Protein 
A/G when the two are mixed. The SPDP-Protein A/G was purified by gel filtration, 
after which the presence of the SPDP was determined in the column eluent by the 
addition of a DTT solution as described by Carlsson et al..42 DTT was used to 
facilitate the release of 2-thiopyridine from the 2-pyridyl disulfide groups present on 
the SPDP-modified proteins. The release of 2-thiopyridine was confirmed by the 
appearance of a characteristic absorption band at 343 nm which is not seen in the 
absorption spectrum of the thiolated protein, as shown in Figure 5.8. 
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Figure 5.8.  The UV-Vis absorption spectra of a solution of SPDP-Protein A/G before (i) 
and after (ii) treatment with DTT. The characteristic absorption band of 2-
thiopyridine is present at 343 nm in (ii) only.  
 
 
The concentration of the SPDP modified Protein A/G in the eluent was not 
determined by the absorbance intensity at 280 nm due to the inherent absorption of 
the 2-pyridyl disulfide groups of the SPDP at that wavelength.42 Instead, the 
concentration was determined as that of the released pyridine-2-thione, based on 
the 1:1 ratio of separated 2-thiopyridine to 2-pyridyl disulfide present in the thiolated 
protein reported by Stuchbury et al..43 For this, the extinction coefficient 8.08 x 103 
M-1 cm-1 and the absorbance intensity at 343 nm were applied.42,43 Based on the 
absorbance intensity of 0.538 at 343 nm shown in Figure 5.8, a typical SPDP 
modified Protein A/G concentration of 66.58 µM was obtained.  
 
The modified Protein A/G was self-assembled onto the surface of 16 nm cAuNP in 
the same manner as for the AuNP-PEGCOOH and AuNP-PEGNH2, as described in 
Chapter 2.4.6. The AuNP-Protein A/G were then incubated with a solution of 
antibody, during which the antibody was immobilised onto the AuNP surface by the 
preferential binding of the Protein A/G to the Fc region of the antibody. The increase 
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in the absorption maximum following the addition of both the SPDP-Protein A/G and 
the antibody is indicated by the UV-Vis absorption spectra shown in Figure 5.9. 
Successful modification of the AuNP surface was indicated by a typical increase in 
the extinction maximum of around 3 nm following each successive addition of 
protein. The AuNP-Protein A/G proved stable in aqueous buffered solutions both 
before and after addition of the antibody, and yielded a higher concentration of 
particles than that produced using the PEGCOOH approach to functionalisation. This 
was indicated by the absorption maximum of 0.760 obtained for the AuNP-Protein 
A/G-antibody (shown in Figure 5.9 (iii)), which was higher than the absorption 
maximum of 0.631 obtained for the AuNP-PEGCOOH-antibody shown in Figure 5.6 
(iii). 
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Figure 5.9.  UV-VIS absorption spectra of the stages of antibody functionalisation of 
16 nm AuNP via an SPDP modified Protein A/G intermediate, as indicated 
by the numbers i-iii in the schematic shown. The different particle types and 
their absorption maxima at around 520 nm are as follows: (i) Citrate AuNP 
(520 nm), (ii) AuNP-Protein A/G (1.5x concentration; 523 nm) and (iii) AuNP-
Protein A/G-antibody (526 nm). 
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The final approach for the addition of antibody to the surface of AuNP used in this 
study was performed using 40 nm AuNP stabilised by a cysteamine ligand. The 
functionalisation of these AuNPs occurred through the binding via the 
polysaccharide moiety of the Fc region of the antibody to the amine functional group 
of the ligand, as used for the fuctionalisation of AuNP-PEGNH2 (described in 
Chapter 2.4.5). The resulting AuNP-antibody were purified using a modified 
approach to the one reported by Karthik et al.41. Prior to purification it was observed 
that the colour of the AuNP solution changed from deep red to purple, an indication 
that the particles had become aggregated. During purification by glycerol gradient 
(as described in Chapter 2.4.5) the majority of the AuNP became insoluble and 
adhered to the wall of the centrifuge tube. Aggregation of the particles was 
confirmed by the UV-Vis absorption spectra shown in Figure 5.10. Similar results 
were obtained during repeated experiments. Because of the instability of the 40 nm 
cysteamine-AuNP upon addition of the antibody, the application of this type of AuNP 
was discontinued at this point. Nanoparticle characterisation was continued for the 
three remaining methods of functionalisation. 
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Figure 5.10.  UV-VIS absorption spectra of the stages of antibody functionalisation of 
40 nm cysteamine-stabilised AuNP, as indicated by numbers i and ii in the 
schematic shown. The particle types and their absorption maxima at around 
520 nm are as follows: (i) Cysteamine AuNP (528 nm), and (ii) Cysteamine 
AuNP-antibody (aggregated). 
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5.2.4 Detection of bound antibody by SDS PAGE 
As described in Section 5.1.3., Puertas et al. reported the successful application of 
SDS-PAGE for determining the presence of antibody on the surface of functionalised 
magnetic particles.35 A solution of SDS and mercaptoethanol was used to fragment 
antibodies present on the surface of the particles, and the resulting fragments were 
separated and visualised by SDS-PAGE as described in Chapter 2.4.8. The findings 
of Puertas et al. indicated that the fragmentation pattern of the antibody is dependent 
upon the orientation of the antibodies when bound to the particle.35 A solution of free 
antibody treated with SDS and mercaptoethanol will fragment into two parts, a light 
chain and a heavy chain, which yield characteristic bands in an SDS-PAGE gel at 
around 20-30 and 40-60 kDa, respectively. A schematic of this fragmentation pattern 
is shown in Figure 5.11A. According to the research of Puertas et al., although the 
fragmentation pattern of antibody does not change, the components of the antibody 
that are covalently bound to a particle will remain covalently bound and thus will not 
be observed in a gel.35 For example, an antibody that is bound to the particle via its 
heavy chain will result in a gel with only the band from the light chain being present. 
This approach was applied to the three types of antibody-functionalised AuNPs used 
in this study. A schematic of the expected results of this study is shown in Figure 
5.11B. 
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Figure 5.11.  The characteristic fragmentation pattern of free antibody in an SDS-PAGE 
gel following treatment with SDS and mercaptoethanol is shown in (A). The 
fragmentation patterns of antibody in SDS-PAGE gels expected when the 
same SDS and mercaptoethanol treatment is applied to antibody 
immobilised onto the surface of AuNP using the three approaches are 
shown in (B). The expected results are based on those reported by Puertas 
et al..35  
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A typical example of an SDS-PAGE gel of fragmented antibody from the surface of 
antibody-functionalised AuNP-PEGCOOH, prepared as described in Chapter 2.4.4, 
is shown in Figure 5.12. Free antibody in the lane B of the gel shown in Figure 5.12 
generated the characteristic two-band profile as predicted by the expected results in 
Figure 5.11A. The two characteristic bands of the antibody, at around 20-30 and 40-
60 kDa respectively, are indicated by the arrows in Figure 5.12. The antibody 
fragments obtained from the AuNP-PEGCOOH-antibody (Figure 5.12, lane C) 
yielded two bands of approximately the same molecular weights as for the free 
antibody. No visible protein bands were present in the lane containing the AuNP-
PEGCOOH negative control (Figure 5.12, lane A). The results obtained support the 
prediction illustrated in Figure 5.11B that, due to the random binding of the 
PEGCOOH to one of several available amine groups on the antibody, the orientation 
of the bound antibody is variable and thus both the heavy and the light chain 
fragments can be present in the gel. The bottom of the two characteristic antibody 
fragments relates to the light chain of the antibody and was seen to be weaker in the 
fragments obtained from the AuNP-PEGCOOH-antibody (Figure 5.12, lane C) than in 
the fragments obtained from the free antibody (Figure 5.12, lane B). This result 
suggests that binding of the antibody to the AuNP occurs preferentially via the light 
chain of the antibody, as this would result in a greater number fragments and 
therefore more intense staining of the band relating to the heavy chain fragments in 
the gel as indicated in Figure 5.11B. Overall, the presence of the characteristic bands 
of the antibody confirms the presence of antibody on the surface of the AuNP, thus 
proving the successful functionalisation of the AuNP.  
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Figure 5.12.  A typical 15 % acrylamide SDS-PAGE gel showing the protein fragments 
obtained from antibody-functionalised AuNP-PEGCOOH following treatment 
with SDS and mercaptoethanol (lane C). AuNP-PEGCOOH without antibody 
were run as a control in lane A alongside the molecular weight marker (MW), 
and a stock solution of free anti-cocaine antibody was run in lane B.  
 
 
A typical SDS-PAGE analysis of fragmented antibody from AuNP-Protein A/G-
antibody (prepared as described in Chapter 2.4.6) is shown in Figure 5.13. The 
characteristic fragmentation bands at 20-30 and 40-60 kDa of free antibody in lane A 
are indicated by two arrows in Figure 5.13. A single band at ca. 50 kDa was 
produced by the antibody fragmented from the AuNP-Protein A/G, a band which 
corresponds to the MW of the heavy chain of the antibody (Figure 5.13, lane C). The 
band does not relate to that of the AuNP-Protein A/G control in lane B of Figure 5.13, 
the MW of which (ca. 66 kDa) instead corresponds to that of free Protein A/G and is 
thought to have been the result of insufficient purification of the AuNP-Protein A/G.36  
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Figure 5.13.  A typical 15 % acrylamide SDS-PAGE gel showing the protein fragments 
obtained from antibody-functionalised AuNP-ProteinA/G following treatment 
with SDS and mercaptoethanol (lane C). A stock solution of free anti-
cocaine antibody was run in lane A alongside the molecular weight marker 
(MW), and AuNP-ProteinA/G were run as a control in lane B. 
 
 
Based on the results shown in Figure 5.13, it was concluded that predominantly 
heavy chain antibody fragments had been dissociated from the AuNP-Protein A/G-
antibody rather than light chains as predicted in Figure 5.11B. The presence of heavy 
chains in the gel requires immobilisation of the antibody to have occurred via the FAb 
fragment, instead of the Fc region required for optimal orientation of antibody onto 
the particle surface. This suggests that although Protein A/G binds preferentially to 
the Fc region of the antibody, other mechanisms of binding involving the FAb 
fragment of the antibody can occur. This phenomenon has been previously reported 
by Clarizia et al., who showed that up to 50 % of Protein A/G interactions result in 
misalignment of the antibody.44 An additional possibility is that light chain fragments 
in the gel resulting from antibody bound to Protein A/G via the Fc region were 
present, but at concentrations insufficient for staining to occur. Overall, the results 
were considered indicative of the presence of antibody bound to the surface of the 
 197 
 
AuNP-Protein A/G, but the exact orientation of the antibody would require 
confirmation by additional methods of analysis. 
 
Stabilisation of functionalised AuNP-PEGNH2 with 1 % w/v milk buffer after addition 
of oxidised antibody (as described in Chapter 2.4.5) initially generated SDS-PAGE 
results from which the presence of antibody fragments could not be distinguished 
from the bands of the milk proteins. Functionalisation without milk buffer was 
attempted, but the resulting AuNP-PEGNH2-antibody particles proved unstable and 
aggregated during purification (results not shown). SDS PAGE was subsequently 
performed using antibody-functionalised AuNP-PEGNH2 following an additional wash 
step to remove excess milk buffer. The resulting SDS PAGE is shown in Figure 5.14, 
the lanes of which contain as follows; fragments from free antibody in lane A, a 
AuNP-PEGNH2 negative control in lane B, antibody fragments obtained from the 
AuNP-PEGNH2-antibody in lane C and protein fragments obtained from milk buffer in 
lane D. The antibody fragments obtained from the AuNP-PEGNH2-antibody (Figure 
5.14, lane C) yielded an additional band which is not present in either the AuNP-
PEGNH2 or the milk buffer control in lanes B and D, respectively. The MW of the 
band (ca. 60 kDa) corresponds to the heavy chain fragment of the free antibody 
solution in lane A, as indicated by the top arrow in Figure 5.14, rather than the light 
chain fragment predicted in Figure 5.11B. The low concentration at which the heavy 
chain fragment is present in relation to the milk proteins makes it difficult to confirm 
the presence or absence of antibody functionalisation using this approach. 
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Figure 5.14.  A typical 15 % acrylamide SDS-PAGE gel showing the protein fragments 
obtained from antibody-functionalised AuNP-PEGNH2 following treatment 
with SDS and mercaptoethanol (lane C). A stock solution of free anti-
cocaine antibody was run in lane A alongside the molecular weight marker 
(MW). AuNP-PEGNH2 and a 0.5 % w/v solution of milk buffer in PB were run 
as controls in lanes B and D, respectively. 
 
 
5.2.5 Visualisation of AuNP surface modification and size by agarose 
gel electrophoresis 
In this study, cAuNP modified by the addition of proteins and ligands were separated 
from one another on the basis of size using 0.2 % w/v agarose gels as described in 
Chapter 2.4.9. The method used has been previously applied by Hanauer et al. for 
the separation of gold and silver nanoparticles on the basis of their size and shape.45 
Haneuer et al. noted that modification of the particle surface via the addition of a 
PEG monolayer led to increased particle stability and therefore improved band 
resolution in the gels.45 This observation was exploited in this study as a means of 
visualising modification of the AuNP surface following the addition of either protein or 
ligand at each stage of the functionalisation process. The use of this approach was 
based on the prediction that each successive addition would incrementally increase 
the size of the particle, and thereby slow its migration through the gel. The predicted 
movement of the different types of modified and functionalised cAuNP is 
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schematically illustrated in Figure 5.15. Overall, it was expected that with each 
successive addition of ligand or protein the resulting band would be at a position 
further up the gel than the un-modified cAuNP. AuNP-PEGNH2 were the exception to 
this rule, as the positive charge of the amine functional group under alkaline 
conditions would cause the particles to migrate upwards in the gel towards the 
negative rather than the positive electrode. Addition of antibody to the AuNP-
PEGNH2 would reverse the charge of the AuNP to an overall negative, resulting in a 
band in the gel at a similar position to the AuNP-PEGCOOH-antibody due to the 
equivalent size of the PEG ligand.     
 
 
 
Figure 5.15.  The expected separation of cAuNP and functionalised cAuNP by agarose 
gel electrophoresis, on the basis of increased size resulting from the addition 
of protein or ligand. 
 
 
As illustrated by the typical agarose gel results shown in Figure 5.16, the band 
position of the AuNP following each successive addition of protein or ligand 
corresponded to the predicted migration in the gel shown in Figure 5.15. For each 
addition of protein or ligand, the overall size of the particle increased and its 
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migration through the gel was slowed sufficiently for the different stages in the 
functionalisation process to be separated. The characteristic burgundy colour of the 
AuNP, resulting from their surface plasmon resonance as described in Section 5.1.1, 
enabled visual recognition of the bands without the need for additional staining.   
 
 
 
Figure 5.16.  True colour photographs of 0.2 % w/v agarose gels of cAuNP at each stage 
of the functionalisation process. The step-wise addition of PEGCOOH, 
modified Protein A/G and anti-cocaine antibody to the surface of cAuNP are 
shown in (A), and the addition of PEGNH2 and subsequently anti-cocaine 
antibody are shown in (B).     
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The results in Figure 5.16A in particular confirm the observation of Hanauer et al. 
that the addition of a ligand or protein to the cAuNP considerably improves the 
stability of the AuNP,45 allowing them to migrate as a band through the gel rather 
than a streak. Separation on the basis of charge is also illustrated in Figure 5.16B, 
where negatively charged cAuNP can be distinguished from positively charged 
AuNP-PEGNH2 by their migration towards different electrodes. The positive charge 
of the PEGNH2 was reversed after the successful addition of antibody, causing the 
AuNP-PEGNH2-antibody to migrate downwards in the gel towards the positive 
electrode as predicted in Figure 5.15. Overall, separation of AuNP based on the 
successive addition of protein or ligand to the surface of the particles by agarose gel 
electrophoresis proved successful in this study. The successful step-wise 
functionalisation of AuNP was visually confirmed using this method.  
 
 
5.2.6 Estimating the number of bound antibody per AuNP using 
enzyme-labelled antigen 
Enzyme labelled antigen (cocaine-HRP) was used to simultaneously label and 
quantify anti-cocaine antibody on the surface of functionalised AuNP. The advantage 
of using enzyme-labelled antigen over indirect antibody labelling (by way of 
secondary antibody, for example) is that it enables not only detection of the antibody, 
but also the specificity and efficacy of antigen binding by the functionalised AuNP to 
be measured. This was particularly important in this study due to the undefined 
cocaine-binding ability of the polyclonal antibody.   
 
As described in Chapter 2.4.10, cocaine-HRP was applied to the antibody-
functionalised AuNP, after which addition of enzyme substrate enabled the presence 
of bound HRP to be determined. Negative controls in the form of AuNP without 
antibody, in the case of AuNP-Protein A/G, or AuNP functionalised with BSA in place 
of antibody were used to distinguish any element of non-specific binding. The 
presence of cocaine-HRP bound to the antibody-functionalised AuNP was 
determined by the addition of enzyme substrate, and the resulting visible colour 
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change in the presence of HRP was measured by absorbance as described in 
Chapter 2.4.10. A standard curve of cocaine-HRP at concentrations ranging from 
10 - 75 nM was used to determine the amount of the labelled antigen bound to the 
AuNP. From this, the relative number of antibody per AuNP was estimated based on 
an assumed 1:1 ratio of bound cocaine-HRP:antibody. Although a 2:1 ratio of 
cocaine-HRP:antibody is possible based on the two available antigen-binding sites 
on each antibody, the 1:1 ratio was used in this study in order to provide an estimate 
of the maximum possible number of antibodies present.  
 
A typical standard curve used for determining the concentration of cocaine-HRP 
bound to the antibody-functionalised AuNP is shown in Figure 5.17. The absorbance 
spectra of the enzyme product obtained from the standard solutions are shown in 
Figure 5.17A, alongside the corresponding linear regression of the curve based on 
absorbance intensity at 450 nm in Figure 5.17B.   
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Figure 5.17.  A typical standard curve of cocaine-HRP for the quantitation of anti-cocaine 
antibody on the surface of functionalised AuNP. (A) The absorption spectra 
of the enzyme product produced by cocaine-HRP standard solutions at 
concentrations ranging from 10 to 75 nM. Each spectrum represents the 
mean of at least two measurements. A corresponding linear calibration curve 
of absorbance intensity at 450 nm is shown in (B). 
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The absorption spectra of the enzyme product obtained from solutions of antibody-
functionalised AuNP treated with cocaine-HRP alongside their respective negative 
controls are shown in Figure 5.18. As indicated in Figure 5.18A and B, the 
absorbance intensity at 450 nm was significantly higher for the AuNP-PEGCOOH 
and AuNP-Protein A/G with antibody bound than those without. These results 
showed the successful identification of bound antibody on the surface of the 
functionalised AuNP using the enzyme-labelled antigen. It also confirmed that 
binding of cocaine-HRP occurred in a specific fashion, as indicated by the lack of 
enzyme product where no antibody was present. An absorbance intensity 
considerably lower than that of the AuNP-PEGCOOH-antibody and AuNP-Protein 
A/G-antibody was obtained from antibody-functionalised AuNP-PEGNH2 following 
treatment with cocaine-HRP (Figure 5.18C). As for the other types of AuNP, AuNP-
PEGNH2 with and without antibody could be distinguished from one another based 
on an increase in absorbance intensity in the presence of the antibody. However, the 
difference in absorbance intensity between the AuNP-PEGNH2-antibody and the 
negative control was significantly less than that of the other two types of 
functionalised AuNP. Based on this result it was concluded that the considerably 
fewer antibodies had been successfully bound to the AuNP surface using this PEG-
NH2 based approach for AuNP functionalisation.   
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Figure 5.18.  The absorption spectra of the enzyme product obtained from cocaine-HRP-
treated anti-cocaine antibody-functionalised cAuNP measured at around 
450 nm. The types of functionalised AuNP shown are as follows: (A) AuNP-
Protein A/G-antibody with un-functionalised AuNP-Protein A/G used as a 
negative control, (B) AuNP-PEGCOOH-antibody with BSA-functionalised 
AuNP-PEGCOOH as a negative control, and (C) AuNP-PEGNH2-antibody 
with BSA functionalised AuNP-PEGNH2 as a negative control. Each 
spectrum represents the mean of at least two measurements. 
 
 
As described in Chapter 2.4.10, the concentration of cocaine-HRP was determined 
based on the absorbance intensity of the enzyme product at 450 nm and a standard 
curve as shown in Figure 5.17. The number of antibody on the surface of the 
functionalised AuNP was in turn estimated based on the number of active cocaine 
binding sites present, using a 1:1 concentration ratio of cocaine-HRP:antibody as 
described previously. The estimated results for the number of antibody per particle 
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for each type of functionalised AuNP are shown in Table 5.1. As indicated, the 
highest number of antibodies per particle was achieved using the AuNP-Protein A/G 
method of functionalisation. As discussed in Section 5.1.3, the preferential binding of 
Protein A/G to the Fc region yields antibody positioned with the FAb region correctly 
oriented for optimal binding of the antigen. Conversely, binding by way of a –COOH 
functional group can occur via a number of available amine groups and therefore 
produces a variety of different antibody orientations.  The lower number of antibody 
per AuNP estimated for the AuNP-PEGCOOH-antibody compared to the AuNP-
Protein A/G-antibody using the labelled antigen approach could therefore result from 
this random orientation, as antibody positioned without the FAb region exposed 
would not be detected using this method. The low number of antibody per AuNP-
PEGNH2 fell outside the range of the cocaine-HRP standard curve for accurate 
quantification, and was considered indicative of poor binding of antibody to the AuNP 
when using this approach. Overall, the AuNP-Protein A/G directed approach to 
antibody functionalisation proved the most successful based on the results shown.     
 
 
Table 5.1.  The estimated number of antibody per AuNP, based on the number of active 
cocaine binding sites, shown alongside the concentrations of both the 
antibody and AuNP for each of the antibody functionalisation approaches 
used.  
 
 A450 [Antibody] (nM) [AuNP] (nM) Antibody / AuNP 
AuNP-PEGCOOH-antibody 1.722 52.40 2.75 19.1 
AuNP-ProteinA/G-antibody 1.666 50.45 1.43 35.2 
AuNP-PEGNH2-antibody 0.057 0.07 0.48 1.2 
 
 
5.2.7 Determination of antigen binding efficacy using a microtiter 
plate-based assay   
The binding efficacy of the antibody-functionalised AuNP was determined using a 
cocaine-BSA hapten immobilised onto a microtiter plate. As binding of the cocaine-
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BSA to the microtiter plate occurs via interaction with BSA only, the cocaine 
component of the hapten would be presented for binding in a manner that could 
mimic the position of cocaine on the surface of forensic samples such as banknotes. 
The cocaine-BSA was applied to each well of the microtiter plate in excess and 
under the same conditions to ensure that each of the wells was consistently coated 
with the maximum possible number of haptens. The presence of functionalised AuNP 
bound to the immobilised cocaine-BSA was determined using a HRP-labelled 
secondary antibody targeted to the primary antibody on the surface of the AuNP. 
Addition of the enzyme substrate enabled the presence of bound AuNP-antibody to 
be measured by absorbance intensity at 450 nm as explained in Chapter 2.4.11. 
Wells with BSA bound in place of cocaine-BSA were used as negative controls to 
distinguish any element of non-specific binding by the functionalised AuNP. The 
addition of free anti-cocaine antibody instead of the functionalised AuNP enabled any 
signal amplification generated by the particles to be measured. The anti-cocaine 
antibody functionalised AuNP and the free anti-cocaine antibody were applied to the 
wells in excess in order for the maximum number of bound AuNP or antibody to be 
measured. A comparison was made between the signal obtained from the free 
antibody, and that produced by the antibody-functionalised AuNP bound to the 
cocaine-BSA in each of the wells. As the free antibody and antibody-functionalised 
AuNP were applied in excess, the results were compared based on the assumption 
that the maximum possible number of each would be bound to the wells.   
 
The results of the cocaine-BSA plate assay, expressed as the absorbance intensity 
of the enzyme product, are shown in Figure 5.19 for the application of free antibody, 
AuNP-Protein A/G-antibody and AuNP-PEGCOOH-antibody, respectively. As 
indicated, the greatest absorbance intensity was obtained when antibody 
functionalised AuNP-Protein A/G was added to wells containing cocaine-BSA. This 
signal was greater than that generated following the addition of both the free 
antibody, and of the antibody functionalised AuNP-PEGCOOH. The signal produced 
by the AuNP-PEGCOOH-antibody was lower than that of the free antibody, indicating 
that AuNP functionalised using this approach were ineffective at producing an 
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amplified signal. A representative negative control, obtained using AuNP-Protein 
A/G-antibody applied to wells with only BSA bound, is also shown in Figure 5.19. As 
indicated by the absence of signal, non-specific binding was not observed during the 
assay. Overall, the results indicate that the AuNP-Protein A/G-antibody were the 
most effective means of labelling cocaine on a solid surface, yielding a signal that 
was greater than that produced by the antibody alone.  
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Figure 5.19.  The absorbance intensity at 450 nm from HRP-labelled primary antibody, or 
anti-cocaine antibody-functionalised AuNP bound to cocaine-BSA 
immobilised onto a microtiter plate. The results obtained after the application 
of antibody, AuNP-Protein A/G-antibody, and AuNP-PEGCOOH-antibody 
are shown from left to right. A representative result obtained from a BSA 
control well is shown on the far right. Each absorbance intensity value 
represents the mean ± SD of at least three measurements. 
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5.3 Conclusions 
Four different approaches for the functionalisation of AuNPs with anti-cocaine 
antibody using different ligand or protein intermediates were compared in this 
chapter. The AuNP were successfully functionalised with antibody using all but one 
of the approaches selected for the study. The successful modification of the gold 
surface via the addition of antibodies onto the gold surface was performed using a 
PEG linker with a –COOH terminal functional group, an aminated PEG ligand and a 
modified Protein A/G intermediate. The direct functionalisation of 40 nm cysteamine-
stabilised AuNP via the amine group on the cysteamine proved unsuccessful, as the 
linker was insufficient in length to provide stability under the aqueous conditions 
required for antibody addition.  
 
Modification of the particle surface following the addition of protein or ligand, and the 
subsequent attachment of the antibody was monitored by measuring the absorption 
maximum of the AuNP by UV-Vis spectrophotometry at approximately 520 nm. The 
adsorption of protein or ligand onto the gold surface affects the SPR of the AuNP, 
and this effect is expressed as a shift in the absorption maximum of the particles. 
During the functionalisation of AuNP by the addition of PEGCOOH, PEGNH2 or 
SPDP-Protein A/G, a shift in the maximum of 2 – 3 nm was recorded after each 
successive modification. This proved that the modification of the AuNP surface had 
been successful.   
 
The addition of protein or ligand to the particle surface was also characterised by 
visual separation using agarose gel electrophoresis. Using this technique, AuNP 
modified via the addition of the different ligands, and the subsequent attachment of 
antibody could be differentiated from one another on the basis of charge and size. 
Using this technique, it was shown that the modified particles travelled more slowly 
and showed increased stability within the gel when compared to the un-modified 
AuNP. Functionalisation using the PEGNH2 ligand was illustrated by the positively 
charged aminated ligand, which caused the AuNP to travel towards the negative 
rather than the positive electrode in the gel, and the subsequent reversal of this 
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charge following the addition of the antibody. Overall it was shown that the 
successful functionalisation of AuNP with antibody was performed using the three 
different approaches used in this study, and that these could be visualised by the 
position of different self-staining bands in an agarose gel.  
 
SDS-PAGE was used for the detection of antibody fragmented from the surface of 
the different types of functionalised AuNP. It was expected that the orientation of the 
immobilised antibodies on the surface of the AuNP would be demonstrated based on 
the presence of heavy or light antibody fragments in the gel. This in turn would 
provide a means of differentiating antibody bound at variable orientations, such as 
those immobilised via a PEGCOOH ligand, with the directed Fc-mediated attachment 
achieved using Protein A/G or PEGNH2 intermediates. Of the three different 
functionalised AuNP used in this study, only the AuNP-PEGCOOH-antibody yielded 
results consistent with a positive identification of variably-bound anti-cocaine 
antibody. Interference from blocking buffer protein used to stabilise the AuNP-
PEGNH2, and the presence of only one of the two characteristic antibody fragments 
derived from the AuNP-Protein A/G yielded inconclusive results for these particles.  
 
Enzyme-labelled antigen (cocaine-HRP) was found to bind to the antibody-
functionalised AuNP at significantly higher concentrations than for AuNP without 
antibody bound. Using this method, all three types of functionalised AuNP were 
confirmed as being specifically able to bind cocaine. The number of antibody bound 
to each AuNP was estimated based on the concentration of antigen bound. A ratio of 
antibody to AuNP of 19:1 and 35:1 were estimated for the AuNP-PEGCOOH and 
AuNP-Protein A/G, respectively. The AuNP-PEGNH2 was found to have too low a 
signal for the concentration of antibody to be accurately determined using this 
method. The results indicate that the optimal binding efficacy of the functionalised 
AuNP to cocaine-HRP was obtained when using the modified Protein A/G method of 
functionalisation, which may be due to the favourable orientation of the antibody 
when bound using this approach. AuNP functionalised with antibody by way of a 
 210 
 
PEGNH2 did not result in sufficient binding of the labelled antigen to be used for the 
detection of cocaine.  
 
A plate-based assay using a cocaine-BSA hapten was used to determine the binding 
efficacy of the antibody functionalised AuNP in a manner that might mimic the 
presentation of cocaine on the surface of a forensic sample such as a banknote. 
Using a HRP-labelled secondary antibody, the binding of the functionalised AuNP 
was detected by measuring the absorbance intensity following addition of an enzyme 
substrate. By using wells with BSA bound in place of the cocaine hapten, it was 
shown that the functionalised AuNP bound specifically in the presence and not the 
absence of immobilised cocaine. Furthermore, the intensity of the signal obtained 
after the application of antibody functionalised AuNP-Protein A/G was greater than 
that of both the AuNP-PEGCOOH and the free antibody. This showed that the AuNP-
Protein A/G-antibody could be successfully used for the detection of cocaine at low 
concentrations by producing an amplified signal when compared with that produced 
by antibody alone. In order for the binding efficacy of the AuNP to be more 
comprehensively compared to that of the free antibody, a similar assay where a 
gradient of different concentrations of cocaine-BSA immobilised onto wells of the 
microtiter plate could be applied. In this way, a response curve could be generated 
which would indicate whether the amplified signal produced by the presence of the 
AuNP-Protein A/G-antibody is present even at the low concentrations of analyte 
likely to be present on samples of forensic interest. 
 
Of the four approaches to functionalisation compared in this study, the PEGCOOH-
based approach was the simplest to perform and yielded the most consistently stable 
antibody-functionalised AuNP. However, the cocaine-binding efficacy of the antibody-
functionalised AuNP-COOH was lessened due to the random rather than oriented 
binding of the anti-cocaine antibody onto the PEGCOOH on the AuNP surface. The 
antibody-functionalised AuNP-Protein A/G on the other hand provided enhanced 
cocaine-binding due to the oriented nature of the bound antibody on the Protein A/G 
intermediate. Based on the extensive characterisation of each type of antibody 
 211 
 
functionalised AuNP, it was therefore determined the SPDP modified Protein A/G-
based approach proved to be the most effective method of generating antibody-
functionalised particles for the application of cocaine detection in forensic samples 
such as banknotes. 
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CHAPTER 6 
 
Conclusions and Future Work 
 
This thesis describes the development of a competitive immunoassay for the 
quantitation of cocaine extracted from banknotes, and a novel method for the 
location-specific immunodetection of cocaine on the banknote surface. The 
conclusions of the developed methods and their application for the detection of 
cocaine both on and extracted from banknotes are summarised in this chapter. The 
application of the competitive immunoassay for the detection of cocaine extracted 
from latent fingerprints, and a comparison of different functionalisation techniques for 
the synthesis of antibody-gold nanoparticles for cocaine detection are also described. 
Suggestions for future work in relation to the current study are highlighted. 
 
 
6.1 The quantitation of cocaine on banknotes by cEIA 
Chapter 3 described the development of a non-destructive and sensitive competitive 
enzyme immunoassay (cEIA) for the detection of low concentrations (ca. 1 –
20 ng mL-1) of cocaine in diluted extracts from banknote samples. The application of 
the cEIA for the quantitation of cocaine in complex forensic samples such as extracts 
from banknotes and latent fingerprints was also outlined. A polyclonal anti-cocaine 
antibody was successfully purified from rabbit serum to form the basis of the assay. 
The precision and sensitivity of the cEIA were found to be suitable for the 
quantitation of cocaine in samples of forensic significance, as indicated by the LOD 
of 0.162 ng mL-1 which compares favourably to the detection limits of both a GC-MS 
method and a commercial micro-plate EIA.1,2 
 
The developed method was applied for the quantitation of cocaine extracted from ten 
UK banknotes from general circulation as a representation of a genuine sample 
matrix. Trace levels of cocaine ranging from 0.3 to 20.0 µg mL-1 were detected on all 
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of the samples analysed, at concentrations that were similar to the levels of cocaine 
detected on Irish Euro banknotes from general circulation.3 The quantitative assay 
results were validated via a parallel LC-MS2 analysis of the same samples, and a 
statistically significant agreement was found between the two sets of results. This 
indicated that the assay performed to the desired level of specificity required for the 
analysis of cocaine in complex, heavily contaminated banknote extracts. The primary 
cocaine metabolite benzoylecgonine as well as other potential interferents were 
detected by LC-MS2 in the extracted samples, but despite showing cross-reactivity 
for benzoylecgonine the quantitative results of the assay were unaffected.  
 
The versatility of the cEIA was further demonstrated via its application for the 
quantitation of cocaine extracted from ten latent fingerprints. The prints were donated 
by five individual volunteers, known to be taking cocaine, who were attending a 
methadone treatment clinic. The concentrations of cocaine detected in the fingerprint 
extracts using the cEIA ranged from 0 to 19.0 ng mL-1. The results from the cEIA 
showed similar results for multiple fingerprints obtained from one volunteer; for 
example, the cocaine concentrations 0.728 and 0.879 ng mL-1 were detected in two 
fingerprint samples from the same individual. The results of the cEIA were compared 
with the quantitative analysis of cocaine by GC-MS performed on oral fluid samples 
obtained from the five volunteer subjects at the time of fingerprinting. Cocaine was 
detected by GC-MS in the oral fluid samples from three of the five individuals tested. 
The results showed, for the first time, that the concentrations of cocaine detected by 
cEIA in latent fingerprints followed the same trend as those of the oral fluid samples. 
The detection of cocaine in both oral fluid and the extracts of latent fingerprints could 
therefore be combined as an indicator of recent consumption.  
 
Overall, the developed cEIA presents a user-friendly, economical alternative to the 
more commonly used chromatography-MS techniques for the quantitation of cocaine 
in forensic samples such as banknotes, without the need for sophisticated 
instrumentation. Enzyme immunoassays such as the cEIA presented in this study 
only use aqueous solvents, do not require specialist training to perform and can be 
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easily automated, making them readily applicable for everyday analysis in a forensic 
laboratory. 
 
6.2 Direct immunostaining of cocaine on banknotes 
A novel immunological method developed for the location-specific staining of cocaine 
on the surface of a banknote is presented in Chapter 4. The method was developed 
as a future means for determining a pattern for the location of cocaine contamination 
on a banknote, with a view to establishing the efficacy of the method currently used 
by UK law enforcement agencies for the detection of cocaine on banknotes by IMS.4   
 
Immunological methods are widely used for the location-specific staining of cellular 
antigens in fixed tissue specimens.5 Hydrogel matrices, due to their strength and 
biocompatibility, are also widely used for gel electrophoresis or as 2D or 3D cell 
culture matrices, among other biological applications.6 The subsequent 
immunodetection of target molecules within these matrices is facilitated by the 
porous nature of hydrogels, which are known to be permeable to large proteins such 
as antibodies.7,8 In the present study, the mechanical strength and antibody 
permeability of the biologically derived hydrogels collagen, gelatin, casein and 
agarose were determined in order to judge their suitability as a means of affixing 
cocaine onto the surface of banknotes for subsequent immunostaining. The results 
obtained after applying the hydrogels to cotton paper as a representation of a 
banknote showed that the gels possessed too little mechanical strength to properly 
adhere to the surface of the note at the low concentrations of polymer required to 
enable antibody permeation.  
 
A synthetic acrylamide hydrogel was instead used based on its previous application 
for the in-gel immunodetection of proteinaceous antigen after separation by gel 
electrophoresis.9 Treatment of the acrylamide gel with 50 % isopropanol in water as 
a fixative enables the immobilisation of antigenic material within the gel and 
reportedly also increases its permeability to antibodies.9 The in-gel immunodetection 
of cocaine-BSA as an antigenic target was initially performed in acrylamide gels after 
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separation by non-denaturing PAGE. Immunostaining of the gels using a rabbit anti-
cocaine primary antibody, a corresponding HRP-labelled secondary antibody and 
3,3'-diaminobenzidine (DAB) as an enzyme substrate initially proved unsuccessful. 
However, further optimisation of the method and the introduction of an enhanced 
chemiluminescence (ECL) substrate for increased sensitivity led to the positive 
staining of the anti-cocaine primary antibody control by the HRP-labelled secondary 
antibody. 
 
Due to the discontinuation of the manufacturing of the original rabbit polyclonal anti-
cocaine antibody, a sheep polyclonal anti-cocaine antibody was instead selected and 
used for the remainder of the study. The cocaine-binding efficacy of the two antibody 
types was not compared due to variations introduced by the different means of HRP-
labelling used for each. The in-gel immunodetection of cocaine-BSA as an antigenic 
target in acrylamide gels after separation by non-denaturing PAGE was repeated. 
The sheep anti-cocaine antibody using a corresponding HRP-labelled secondary 
antibody was applied with an ECL enzyme substrate, however detection using this 
method proved unsuccessful. Staining in the control lane containing the primary anti-
cocaine antibody as a positive control was not observed, which led to the conclusion 
that interaction between the primary and the secondary antibodies was not occurring. 
This was investigated using a dot-blot style assay, which showed that interaction 
between the antibodies was successful, however not in the presence of the 
acrylamide gel.   
 
The anti-cocaine primary antibody was subsequently directly labelled with HRP in 
order to remove the need for secondary antibody-mediated detection. Labelling was 
achieved using the well-described periodate-mediated method of conjugation, in 
which addition of HRP occurs via the Fc region of IgG and therefore does not affect 
the antigen-binding capacity of the antibody.10 The successful formation of the 
antibody-HRP hapten was confirmed by SDS PAGE and UV-Vis absorption 
spectrophotometry, yielding a conjugate of suitable concentration and purity. The in-
gel immunodetection of cocaine standard (applied to small areas of partial banknote 
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samples in a solvent solution) using the HRP-labelled anti-cocaine antibody initially 
proved unsuccessful. It was thought that the effectiveness of the in-gel 
immunodetection may have been compromised by the solute rather than powdered 
nature of the standard used for spiking.  
 
A partial banknote sample spiked with a sample of ‘street’ cocaine as a more realistic 
substance for spiking was successfully immunostained for cocaine using the 
developed method. The presence of cocaine was indicated by darker regions of 
staining on the notes which had been spiked with cocaine, compared to the lighter 
background levels of staining present on non-spiked partial banknotes. The method 
yielded different levels of staining for partial notes obtained from general circulation 
after pre-washing with methanol as compared with those which had not been washed 
prior to spiking and analysis. The results confirmed the reports of Bohannon 
suggesting that pre-washing of banknotes in methanol affects the structure of the 
fibrous network that makes up the note, thereby affecting that way in which cocaine 
becomes embedded and retained by those fibres.11   
 
The in-gel immunodetection method was subsequently adapted and applied to the 
analysis of whole banknote samples. Initially, newly minted notes were analysed as 
true negative samples; a clear difference in the intensity of staining was observed 
between newly minted negative control notes and those which had been spiked with 
cocaine over the whole of the note. These initial results suggested that the cocaine 
was successfully being detected using the developed method. In order to confirm 
whether the staining was occurring at the location where cocaine was applied to the 
note, the analysis was repeated using newly minted banknotes where half of the note 
had been spiked with street cocaine and the other half left blank as a negative 
control area. The results showed an area of intense staining at the edge of the 
spiked half of the note rather than over its entirety. The staining observed was also 
more intense over the whole of the gel when compared with negative control notes 
rather than just in the spiked area. The results indicated that the spiked cocaine had 
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become mobile within the gel mix prior to gelation and had thereby migrated to areas 
of the note on which it had not originally been applied.  
 
The developed method was applied to the analysis of six banknotes from general 
circulation as a representation of a genuine sample matrix on which unknown 
concentrations of cocaine could be present, and to confirm whether the nature and 
intensity of the staining differed from that obtained from the newly minted banknotes. 
The appearance of the notes was described as worn and aged as compared to the 
newly minted control samples, which based on the findings of previous studies leads 
to an increased ability to entrap and retain cocaine within the banknote fibres.12,13 
The result of the analysis showed staining in the form of dark grey or black spots on 
the surface of the banknote, rather than the overall dark grey stain from the cocaine 
spiked on the newly minted notes. Analysis was also performed on banknotes from 
general circulation half-spiked with ‘street’ cocaine in the same way as for the newly 
minted notes yielding greater number of dark, stained spots on the spiked half of the 
banknote when compared with the unspiked half. The results suggested that the 
staining related to the presence and location of cocaine on the surface of the 
banknote. The problem of the cocaine migrating after application to the banknotes 
described in the previous paragraph was therefore partially overcome by applying 
cocaine to used rather than newly minted banknotes. The used banknotes provided 
improved adherence of the cocaine as described in previous studies.14,15 
 
Overall, the development of a novel in-gel immunodetection method for the 
visualisation of cocaine on the surface of banknotes was reported. The results 
obtained suggested that using the developed method enables the direct 
immunostaining of the cocaine at the location in which it is present on the banknote. 
The results obtained from the banknote samples analysed during this study suggest 
that cocaine can be present at variable locations across the whole of the banknote. 
Based on the sporadic levels of contamination on the banknotes sampled, it is 
possible that the current IMS sampling method used by UK law enforcement either 
over- or underestimates the concentration of cocaine that are actually present on the 
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whole of the banknote. A method in which the entire banknote, rather than a 
representative area is sampled would therefore provide more accurate indication of 
the cocaine contamination on banknotes. 
 
 
6.3 Method comparison for the antibody-functionalisation of 
AuNP 
Four different approaches for the functionalisation of AuNPs with anti-cocaine 
antibodies using different ligand or protein intermediates were investigated and the 
results compared in Chapter 5. The AuNP were successfully functionalised with 
antibody using all but one of the approaches selected for the study. The addition of 
antibodies onto the AuNP was performed using a PEG linker with a –COOH terminal 
functional group, an aminated PEG ligand and an SPDP-Protein A/G intermediate. 
Of the four approaches used only the direct functionalisation of 40 nm cysteamine-
stabilised AuNP via the amine group on the cysteamine proved unsuccessful. This 
was due to the instability of the particles under aqueous conditions resulting from the 
insufficient length of the stabilising ligand. 
 
The successful functionalisation of the AuNP was demonstrated by a shift in the 
absorption maximum of the AuNP by 2 - 3 nm after each subsequent addition of 
protein or ligand. The increase in the size of the AuNP following the addition of ligand 
or protein was also visualised by agarose gel electrophoresis; this showed that the 
modified AuNP travelled more slowly within the gel when compared with un-modified 
AuNP, and that the position of the self-staining bands formed in the gel reflected the 
size or charge difference between each addition. Differentiation between the three 
different modified AuNP at each stage of the functionalisation process was possible 
using this technique.   
 
SDS-PAGE was applied for the detection of antibodies fragmented from the surface 
of the different types of functionalised AuNP. It was expected that the orientation of 
the immobilised antibody on the surface of the AuNP would be demonstrated based 
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on the presence of heavy or light antibody fragments in the gel. Of the three different 
functionalised AuNP used in this study, only the AuNP-PEGCOOH-antibody yielded 
results consistent with a positive identification of variably-bound anti-cocaine 
antibodies. However, at least one of the two characteristic antibody fragments was 
identified in the lanes of both the AuNP-Protein A/G and the AuNP-PEGNH2. This 
showed that although SDS PAGE proved ineffective as a means of determining the 
position of the antibody on the surface of the functionalised AuNP, the presence of 
antibody was successfully demonstrated using this technique.  
 
Enzyme-labelled antigen (cocaine-HRP) was applied to the functionalised AuNP as a 
means of labelling bound antibodies on the AuNP surface. Using this method, all 
three types of functionalised AuNP were confirmed as being specifically able to bind 
cocaine. The number of antibody bound to each AuNP was estimated based on the 
concentration of bound cocaine-HRP. A ratio of antibody to AuNP of 19:1 and 35:1 
were estimated for the AuNP-PEGCOOH and AuNP-Protein A/G, respectively. The 
AuNP-PEGNH2 was found to have too low a signal for the concentration of antibody 
to be accurately determined using this method. The results indicated that the optimal 
binding efficacy of the functionalised AuNP to cocaine-HRP was obtained when 
using the Protein A/G method of functionalisation. This optimal binding is likely to 
have occurred due to the favourable orientation of the antibody obtained via the 
Protein A/G intermediate. AuNP functionalised with antibody by way of a PEGNH2 
did not result in sufficient binding of the labelled antigen to be used for the detection 
of cocaine.  
 
A plate-based assay was developed using a cocaine-BSA hapten as an antigen. The 
assay was used to determine the binding efficiency of the antibody-functionalised 
AuNP in a manner that might mimic the presentation of cocaine on the surface of a 
forensic sample such as a banknote. It was shown that the functionalised AuNP 
bound specifically in the presence of the immobilised cocaine-BSA hapten. The 
results also demonstrated that the functionalised AuNP would not bind in the 
absence of the cocaine-BSA hapten. Furthermore, the intensity of the signal obtained 
 223 
 
after the application of antibody functionalised AuNP-Protein A/G was greater than 
that of both the AuNP-PEGCOOH and the free antibody. This showed that the AuNP-
Protein A/G-antibody could be successfully used for the detection of cocaine at low 
concentrations by producing an amplified signal when compared with that produced 
by antibody alone. 
 
Based on the extensive characterisation of each type of antibody functionalised 
AuNP, it was demonstrated that of the four approaches of nanoparticle 
functionalisation that were compared in this study, the SPDP-Protein A/G-based 
approach proved to be the most effective method for the formation of anti-cocaine 
antibody-AuNP conjugates for cocaine detection in forensic samples such as 
banknotes. 
 
 
6.4 Future work 
In this study, a cEIA was developed for the detection of cocaine in samples of 
forensic interest. The versatility and robustness of the assay was demonstrated by 
applying the method to the analysis of cocaine extracted from ‘real’ banknote 
samples and fingerprints. Further comparison between cocaine detected in oral fluid 
samples and corresponding fingerprint extracts could be of interest in this area, 
particularly in relation to the timing of peak drug concentrations in oral fluid and 
blood, and between the peak concentrations in blood and sweat after consumption of 
the drug.16,17 The peak cocaine concentration in oral fluid, for example, occurs sooner 
after the drug is taken than the peak concentration in the sweat of a fingerprint, which 
is likely to occur later. Establishing a relationship between the two peaks in 
concentration may enable the approximate window of time during which the cocaine 
was taken to be estimated based on the combined analysis of oral fluids and of 
fingerprints. Furthermore, the adaptation of the assay for the detection of alternative 
metabolites of cocaine other than benzoylecgonine, such as ecgonine methyl ester 
or cocaethylene, is recommended. The detection of metabolites such as ecgonine 
methyl ester in particular, which derives from enzymatic action in the body rather 
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than spontaneous hydrolysis, would enable the critical differentiation between recent 
cocaine consumption and possible environmental cocaine contamination beyond that 
currently possible using enzyme immunoassay-style analytical methods. The peak 
concentration of ecgonine methyl ester following the consumption of cocaine could 
provide further information as to the window of time during which the drug was taken. 
Validation of the cEIA should be performed to enable this simple method to be 
introduced into a forensic laboratory setting. Particularly the application of the assay 
for the analysis of cocaine extracted from fingerprints would require a much more 
extensive study during which a suitable cut-off concentration for the differentiation 
between ‘positive’ and ‘negative’ samples would need to be established. 
 
In order to improve the developed method for the location-specific immunodetection 
of cocaine on banknotes, specialised equipment such as a bespoke gel caster for the 
more consistent application of the acrylamide gel matrix to the banknotes should be 
used. This would decrease mobility of the cocaine prior to fixation as was observed 
on some of the banknote samples during this study. The application of the in-gel 
immunodetection method to a greater number of cocaine-spiked and negative control 
banknotes is also recommended to ensure the repeatability of the staining method. 
The development of ‘standard’ banknote samples harbouring known quantities of 
cocaine at concentrations reflecting those likely to be found in general circulation 
would be beneficial for this process. The analysis of a larger cohort of banknotes 
from general circulation should then be performed. This would establish with 
certainty whether cocaine contamination occurs over the whole or specific parts of 
banknotes in general circulation, thereby completing the overall aim of the present 
study. The results from this sample survey could then be related to the effectiveness 
of the sampling method currently used by UK law enforcement agencies for the 
detection of cocaine, in terms of whether the area of the banknote presently sampled 
is genuinely representative of the quantity of cocaine present on the whole of the 
note.4 
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The application of the antibody-functionalised nanoparticles described in Chapter 5 
to enhance the sensitivity of the developed immunostaining method for the detection 
of cocaine on banknotes is also suggested. The use of the functionalised AuNP 
would enable the visualisation of cocaine at even lower concentrations than presently 
detectable due to the signal enhancing properties of the functionalised nanoparticles 
which were demonstrated in this study. Permeability studies to determine whether 
the acrylamide gel is sufficiently porous to allow passive diffusion of the particles 
would first be required.  
 
Overall, the results shown in this thesis have demonstrated the suitability of 
immunological methods for the detection of illicit substances such as cocaine in 
complex sample matrices of forensic importance.  
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